var title_f9_54_10080="Dx bacterial arthritis";
var content_f9_54_10080=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F53631&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F53631&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 620px\">",
"   <div class=\"ttl\">",
"    Diagnostic approach to suspected bacterial arthritis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 600px; height: 466px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     CT: Computed tomography.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_54_10080=[""].join("\n");
var outline_f9_54_10080=null;
var title_f9_54_10081="Aortic regurgitation five chamber color Doppler echocardiogram";
var content_f9_54_10081=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"videoplayer\" h264=\"./images/CARD/79578/5chcodop_conv.mp4?title=Aortic+regurgitation+five+chamber+color+Doppler+echocardiogram\" style=\"width:320px;height:256px\">",
"  </div>",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Aortic regurgitation",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 344px; height: 257px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Five chamber view from a 2-D echocardiogram demonstrates mild aortic regurgitation. The left ventricle and atrium are normal in size.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Thomas Binder, MD. University of Vienna.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_54_10081=[""].join("\n");
var outline_f9_54_10081=null;
var title_f9_54_10082="Erythema gyratum repens lesions";
var content_f9_54_10082=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F57355&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F57355&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Erythema gyratum repens",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 282px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Concentric erythematous plaques are present on the skin of this patient with erythema gyratum repens.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_54_10082=[""].join("\n");
var outline_f9_54_10082=null;
var title_f9_54_10083="Chapter 6J: Erythropoietin";
var content_f9_54_10083=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Chapter 6J: Erythropoietin",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/54/10083/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/54/10083/contributors\">",
"     Burton D Rose, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/54/10083/contributors\">",
"     Theodore W Post, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/54/10083/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/54/10083/contributors\">",
"     Burton D Rose, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/54/10083/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/54/10083/contributors\">",
"     Theodore W Post, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?9/54/10083/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 14, 2000.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Erythropoietin (EPO) is a glycoprotein growth factor that is the primary stimulus to erythropoiesis, promoting the terminal differentiation of CFU-E into normoblasts and then erythrocytes [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10083/abstract/1\">",
"     1",
"    </a>",
"    ]. Mice with homozygous null mutations of EPO or the EPO receptor (EPOR) genes form BFU-E and CFU-E normally but fail to differentiate into mature erythrocytes [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10083/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Erythropoietin is produced by the kidney and to a much lesser degree (&lt;10 percent) by the liver. A population of interstitial fibroblasts appears to be a major source of renal EPO synthesis [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10083/abstract/3,4\">",
"     3,4",
"    </a>",
"    ], although some studies have suggested an important role for the proximal tubular cells [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10083/abstract/5\">",
"     5",
"    </a>",
"    ]. Interstitial cells positive for EPO mRNA are limited to the deep cortex and outer medulla in the unstimulated kidney. With increasing anemia, the number of positive cells increases in number and spreads into the superficial cortex [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10083/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Decreased oxygen delivery, most often due to anemia or hypoxemia, is the primary stimulus to erythropoietin release [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10083/abstract/1\">",
"     1",
"    </a>",
"    ]. The oxygen sensor is probably a heme protein [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10083/abstract/6\">",
"     6",
"    </a>",
"    ] that may be a cytochrome-b-like flavohemoprotein [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10083/abstract/7,8\">",
"     7,8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The following model has been proposed to explain the action of this sensor (",
"    <a class=\"graphic graphic_figure graphicRef53801 \" href=\"UTD.htm?3/26/3503\">",
"     figure 1",
"    </a>",
"    ). Binding of oxygen to the sensor shift its conformation from a deoxygenated (off) state to an oxygenated (on) state; the oxy form activates a series of events leading to repression of EPO gene transcription [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10083/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]. This sequence is reversed with decreased oxygen delivery, activation as the deoxygenated state leads to synthesis of a protein that binds to the active site on the enhancer region of the EPO gene, resulting in increased EPO production [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10083/abstract/11\">",
"     11",
"    </a>",
"    ]. The ensuing rise in red cell production will tend to return oxygen-carrying capacity toward normal.",
"   </p>",
"   <p>",
"    Downstream events from the oxygen sensor involved in activation of EPO gene expression require de novo protein synthesis, including the production of specific transcription factors [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10083/abstract/12\">",
"     12",
"    </a>",
"    ]. One of these is hypoxia-inducible factor-1, the activity of which is essential for enhanced EPO production [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10083/abstract/13,14\">",
"     13,14",
"    </a>",
"    ]. Mice which lack this factor die at midgestation, while heterozygotes, although developmentally normal, fail to respond adequately to chronic hypoxia [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10083/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The kidney is well suited to be the site of EPO production because it is able to dissociate changes in blood flow alone from those in oxygenation. Reducing renal blood flow, for example, will also tend to diminish both the glomerular filtration rate and total tubular Na+ reabsorption. Since active transport is responsible for most of renal oxygen consumption, the relation between oxygen delivery (reduced by hypoperfusion) and oxygen utilization (reduced by decreased reabsorption) is relatively well maintained, thereby preventing an inappropriate increase in EPO synthesis [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10083/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPO IN CHRONIC RENAL FAILURE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The importance of erythropoietin has been demonstrated in patients with chronic renal failure. Anemia is common in this setting and is due primarily to reduced renal EPO production, a presumed reflection of the reduction in functioning renal mass [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10083/abstract/1,16\">",
"     1,16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This relationship has been convincingly demonstrated in studies in which recombinant human EPO has been administered intravenously, subcutaneously, or intraperitoneally to anemic patients undergoing chronic dialysis (",
"    <a class=\"graphic graphic_figure graphicRef54593 \" href=\"UTD.htm?32/9/32925\">",
"     figure 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10083/abstract/1,17,18\">",
"     1,17,18",
"    </a>",
"    ]. Elevation in the hematocrit to the desired goal of 33 to 36 percent can be achieved in the majority of patients if an adequate dose of EPO is given. Both lower and higher hematocrits have been associated with increased mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10083/abstract/19,20\">",
"     19,20",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/45/33496?source=see_link\">",
"     \"Erythropoietin for the anemia of chronic kidney disease among predialysis and peritoneal dialysis patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/31/5626?source=see_link\">",
"     \"Erythropoietin for the anemia of chronic kidney disease in hemodialysis patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Correction of anemia with EPO in patients with end-stage renal disease is typically associated with an often marked improvement in the sense of well-being [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10083/abstract/1,17,18\">",
"     1,17,18",
"    </a>",
"    ]. This observation demonstrated that many symptoms previously attributed to toxins retained because of the renal failure were due to anemia (or possibly to EPO deficiency).",
"   </p>",
"   <p>",
"    A continuation of the text, and discussions concerning endothelin and nitric oxide and the kidney, are found in the following topics. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/1/3090?source=see_link\">",
"     \"Chapter 6L: Summary of hormone actions on the kidney\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/5/35925?source=see_link\">",
"     \"Endothelin and the kidney\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/61/24533?source=see_link\">",
"     \"Nitric oxide and the kidney\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    (From Rose, BD, Post, TW. Clinical Physiology of Acid-Base and Electrolyte Disorders, 5th ed, McGraw-Hill, New York, 2001.)",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10083/abstract/1\">",
"      Erslev AJ. Erythropoietin. N Engl J Med 1991; 324:1339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10083/abstract/2\">",
"      Wu H, Liu X, Jaenisch R, Lodish HF. Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell 1995; 83:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10083/abstract/3\">",
"      Maxwell PH, Osmond MK, Pugh CW, et al. Identification of the renal erythropoietin-producing cells using transgenic mice. Kidney Int 1993; 44:1149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10083/abstract/4\">",
"      Ratcliffe PJ. Molecular biology of erythropoietin. Kidney Int 1993; 44:887.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10083/abstract/5\">",
"      Loya F, Yang Y, Lin H, et al. Transgenic mice carrying the erythropoietin gene promoter linked to lacZ express the reporter in proximal convoluted tubule cells after hypoxia. Blood 1994; 84:1831.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10083/abstract/6\">",
"      Goldberg MA, Dunning SP, Bunn HF. Regulation of the erythropoietin gene: evidence that the oxygen sensor is a heme protein. Science 1988; 242:1412.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10083/abstract/7\">",
"      Acker H. Mechanisms and meaning of cellular oxygen sensing in the organism. Respir Physiol 1994; 95:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10083/abstract/8\">",
"      Ebert BL, Bunn HF. Regulation of the erythropoietin gene. Blood 1999; 94:1864.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10083/abstract/9\">",
"      Blanchard KL, Fandrey J, Goldberg MA, Bunn HF. Regulation of the erythropoietin gene. Stem Cells 1993; 11 Suppl 1:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10083/abstract/10\">",
"      Porter DL, Goldberg MA. Regulation of erythropoietin production. Exp Hematol 1993; 21:399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10083/abstract/11\">",
"      Beck I, Weinmann R, Caro J. Characterization of hypoxia-responsive enhancer in the human erythropoietin gene shows presence of hypoxia-inducible 120-Kd nuclear DNA-binding protein in erythropoietin-producing and nonproducing cells. Blood 1993; 82:704.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10083/abstract/12\">",
"      Semenza GL. Regulation of erythropoietin production. New insights into molecular mechanisms of oxygen homeostasis. Hematol Oncol Clin North Am 1994; 8:863.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10083/abstract/13\">",
"      Wang GL, Jiang BH, Rue EA, Semenza GL. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci U S A 1995; 92:5510.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10083/abstract/14\">",
"      Wang GL, Semenza GL. Purification and characterization of hypoxia-inducible factor 1. J Biol Chem 1995; 270:1230.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10083/abstract/15\">",
"      Yu AY, Shimoda LA, Iyer NV, et al. Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1alpha. J Clin Invest 1999; 103:691.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10083/abstract/16\">",
"      Besarab A, Caro J, Jarrell BE, et al. Dynamics of erythropoiesis following renal transplantation. Kidney Int 1987; 32:526.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10083/abstract/17\">",
"      Eschbach JW, Egrie JC, Downing MR, et al. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial. N Engl J Med 1987; 316:73.",
"     </a>",
"    </li>",
"    <li>",
"     Cronin, RE, Henrich, WL. Erythropoietin for the anemia of chronic renal failure. In: UpToDate in Medicine, Rose, BD (Ed), UpToDate, Wellesley, MA, 2000.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10083/abstract/19\">",
"      Besarab A, Bolton WK, Browne JK, et al. The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med 1998; 339:584.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10083/abstract/20\">",
"      Ma JZ, Ebben J, Xia H, Collins AJ. Hematocrit level and associated mortality in hemodialysis patients. J Am Soc Nephrol 1999; 10:610.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7296 Version 3.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-183.166.191.243-1D72A0B336-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_54_10083=[""].join("\n");
var outline_f9_54_10083=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPO IN CHRONIC RENAL FAILURE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEPH/7296\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEPH/7296|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?3/26/3503\" title=\"figure 1\">",
"      Oxygen sensor model",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?32/9/32925\" title=\"figure 2\">",
"      Erythropoietin dose response",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/1/3090?source=related_link\">",
"      Chapter 6L: Summary of hormone actions on the kidney",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/5/35925?source=related_link\">",
"      Endothelin and the kidney",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/45/33496?source=related_link\">",
"      Erythropoietin for the anemia of chronic kidney disease among predialysis and peritoneal dialysis patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/31/5626?source=related_link\">",
"      Erythropoietin for the anemia of chronic kidney disease in hemodialysis patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/61/24533?source=related_link\">",
"      Nitric oxide and the kidney",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f9_54_10084="Bullous Vibrio vulnificus";
var content_f9_54_10084=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F51674&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F51674&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Severe Vibrio vulnificus infection",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 398px; height: 255px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAD/AY4DASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDyaO3tjaO08jiUjKqFzzmp76/ja3gitrWK2dFKtJG7Ey/UEnBPX6mtCNDfSWcGozGCJIgsPygCVDt4UHADc5J6cVTi024t9RNtK6wyFPOjZZQGIzwdw4GMZyccCvnE73bPupvkso6GVCD5/wA52ZHIYf5/yKuqwvrpSQPO2BIjCFjGR0J/x61IsL3V+i3bMZnk2NIzEk5/iOMk888f1q5LBdRXz28Jjm8mXKSWqjJIUcow4B5GR60SmTTh9xSaFrF5HcjLFkYsuSG7/Vu4PvkGjR7X7fcyQQbfM5bl8LwONxPQdvxFaMEMmp3s5tLSZZ3hfzVCCTY+SDtXjaMkDPUdagsreXSNQQX0KZj3Aqdu5lZSDjII468+1S5aPuXyO6svdKF5Hp01tmNLl5QwMvnMhUjHbnnn+lcvfaVFczn7Gqo5yNgIC5Az0Neo39tp9/4fjMQW7v0jyklvldo+80bRgYyoPUYz1ODXF3OnxyWrbUD7XH3TyOcAit6FdxZwY3BqrHZM4y8sbm0SNrmIqsy70kOdsg9j3qqVGTsO4e/yn8q6iS0M07W1xvlFuhdN+RjJGc849KzPEFhJZ3IXetzDzslWHyy3fkdfzzwK9WnWjPR7nzVfCSppyS0MnaQASMZ6E96n0+KKa6VZyREAS2DgnjgficVEYWEix8MzYwFYNnI4HFPmLxSEuYyzrluA2MjpjsR+lbtaHJF2dzQv7rfdCbbLHdnGXDcHHTb/AHcDA6npVNJXjV2QK4IZUL4YoO+B68/r61EhaR2jRN+77uMkgDnjFbqW1ha6NbTTXlut5KfLeEuzywhXIYjaCACMYDc9SM5qOR2N1Pmd72KELzRKbHyR5twyyM0oVXAxkbXP3Qc8nODkelT2VnLJprXaWheCKVBLL5oDZ+Y8AkZ4VuQDgiqmm2893eiCzZJJJcoEZgNw992Oe/4VYjs5YrlNOu2igYvtY3XyCE+pJ6e9RJdC4N2v0INRuIXuzJZNMYzyol4fr1JHc9/rWk0Rtt1nLGLi4E/lpcQsXQgE/Ko6MCWB6Z4qOxtZTakzQO0JUzKwHzKc7QRj1Ixg8Vo6XfpoypLaSs2pOGG+3YqItw6Anv7jrkiobWyLjF35pdSzFB9nulaW0M6NFuiyMKGAxnjpz1B9q6Tw9ate3Tkuq5AUJwdo69T09zWFoiST3LxjJty28K0gDKCOTz6mvZfgh4dj1HxFAL5A0durTyKeC2MAAevOOPStqEL7kVqlkexfDjwwnh3w5F52Pt12qzTFQeBjhD649u+a64w4XZg7CBwQM596dCoxvVVAbAwD0qQg/e2k9TgDn2rtueY/e1ZBIzpGf4vm5z9fun2qPyxHE6YYpklm3E7Dx1PepJ5AjrjvgLmTGfYUkskqyFBF5kan72ffp700SxBIc+dabZ2IAbJxkA44PQ96AFePesgR1G3IbIA9DQsBt2YQKPIYEttwvPoAMY604QfKRKA+UGQwGFx7DrzRoFhyyI0ZMTZ35EeTwcd/pTZWKq0jbTF3YE5yMfpUr7UTcSEGMHcOPqe1QMzOUUSSBem/BBByPlOP50kDInjF4Elt3MeD88iDiQdNoB9eRSKyzLLBCWt7hUwWVduzP3eCOelPlVoV22UaFFOWRuMc9h6jFMmfzY4GtZTHdYyqSYy2eOc9uOopiHKQkeZgJJXIUruBMrY5K+mP5CgwrFGi3YR4/lUFiQQB0LHoTUfkROrTSxJHdIuHPVk78EckE/nUNq8t/LKl2skY+ZDCxwXTPU9sY7dafmBYU+Y5eNWmhACckAnjO5getFxcAW6NaP8AaLnaQqqBvP8AIAZ6mmFmtlWGFmeBEz55+YoMcAc88etNnjFlta1heaCVf3giALlQPU9/b8KAEtEG0S3PF8CcEndjB7HrtGe/tRGDIrQajHErBSXCMSrJnhznk+uO1OSOJvs99GyoVGwOVxsQ9Qw9eB+VIxkuAqu6xSShWETEZc5Pp2PcU3uIVvO2r5VzgKy7Cqgsy4x0Pb39ac+Y2MQClVbcEJOASc5Y9j1wBxTBFKkzKSElCB5Nh+c+yngBfb3qwnmlvlXadvyheRt9h/F9TjFJgRo6y3UqLKu7ZjcV2sTjr7DkfWsxbkzy/Zp4ZBbcKs00WUcdMAcgY5yfpV6QNLDMLeIsSmxZA2Rz1wPT1NVXl+1KsEOLa3RtqlSULuP7rfiePaqRLKDiWLzLOzxNYfN5zxNxGeNoUDBPQg9hU15mARmyec3UiiRrEyAeaBkgFiOM9KeY7ixgls7dIourNNIpcOeuDn7xx79aksLZEuEaJo8yLuAOSZgBjcSfukc8Crb6iSIk2T2u64Rvtg2j7PM21i2MhEcdic1UV4LZhNfuxSFgJbjGDC+SAjjowAPUipmVp/tFyz+QNmxptu5oUzwGU9cnB9QKmmjVrI7lKlFWIMfnbbjADjqd3XPajbQDMv4opLJB5xEMzK8FuFyjgEYdzjOOclTxippYWtrZvs8cBjMRbYX3AL0MobPI6kITViWMS7ZJpAVx++EYLG4kUZ2AdAFwOnvUV9bh4ofuRNLIphhQFkkcY/ecdFHPy9ME0+a+hNipa2yrb2DSeRLMUIjimyrKhORM55Jz1GehbFWZYiGJSKJXgBTF22UhB6szfxFsnae1Lc2s9xb3cdhHGsqOTGBJhpT1Zd39zO7gdxWfBe2Vzdi2YwPMAY/KuJdxQYOWdujZPC+lHxahsSxtbYe3hgESxDdudM+SOAVkX++xJ2k5PSpo7SL7GpubWVYSwKoshVozzlZW3Dc/8gKr6lHJYyPCCfNaQSKWYsZIwQCGA474DHIAqul1FJaxxxi0jlUkvMwGEHaPB+8cdXHHHvRa6uib23PleWU7gIpJhFAGjzJhwmTkKuMe/OBzVCP7XeaikcCohlfPmyZyzN1z7dTmtKwgi1LV1Tb5Mcm50DNwDgYJPXH8+3ap7S2sl+3XEizzrGSsSpEdnGRli3Y+nUZ9eK+R0jd2P0dqVWyu9ypZ+bHPtS4jjZVZTIjbQw5yNwPOf1q+lslpYRS3EELoLpJGTdg7dpOAV5Geh9CKr2sdrcahDFKGgtoxtY267nbH8ShjgsT7/hxU8073l7cNdpEk8QJZJgwMzD+Ihf4iMHsOPzxk23c7KcVGNv8AM6LwLNeaUXk+ySlL51gWcDcr4BZ1DdCQGXI7d8UzxKqX15HGz74okZz5MoIzkhVUYGCCDx1Na3hCzht9IivG3PLao1xGByFH8TqvHJ6H2+lZety2puDvsbQz3L/bHuRubCsAoQKPlAyC2eo5ye1c0pKUro7VFRXK0cw0E1vcqXvilwW2StuKmEnOdx6dOpGao31rqMCRXVxEY7eTIjZlPzEfewfXvWtpdtLqJlhjk2sqs7HcQrgHhVHTOckZ610U5+2zWt/qaLcW00ao53eWI5FGMsFGASRwR/d5rX23I9Tllh/aR3sjhLWNbl3kdDuEZYHpsx1bA6fSpbOzubqOU2cyEkmF2M4jO0jPJJHy8Y9+B7V3XgvT7IWOr3t3blIBE0a73BRkdwuAcYzwxz7H2rCvvs4ht4/t1rNDauGDwKRHASTyoH+txkHcctxjpW9OqnLQ46tHljZmDqujaV4dhjjtM3Oqgb5GljASJ8DAUHOWHPXA6cZrjGtJrvUW8+RpJpWLbvvFie5J610l/aLLuCyO8e4sZCOo6hiD3Peo2kitLIrI0s86uGRAoSMDIz05OQMdq74VnsmeLWwkb3cbJGBJpV2LowqitcSSBAufLZWJ6EcAd+DWWUYMy7TkdQO1dRqOq6tcpDaSSRG2jY7X8kbl3nncfvMfrk8cVRuLSTT9Rnjhnt7mKNikciEosqno4B55Azg8810QqSt71jgq0Ic1oXsUbEWIS6+3yzx7ImNuIoVZnlI4DEkYT1PJ6YHpVMjvteQl8f3zkfStK4tUn8kzSw2ryZJkdmZSOnOAT1BHGf61nR4jYOrRNjnBGc+2D3raMuZXOecHB2Jo7yWMqAVKDHyY+U4FaenSI3l+dGA0swxIwHTnPPbPf6VnW01lCbeSWF5zuPnwH5FKjG3a4yQTzngdsUryTQxKjwKgIyDLGd3XIIJ6+n0qZQTKhNrVnpGjoJ0hgZYy6PI/mDHC5wV4GApPI9z719YfDvQodF8M2MEkBW4uI/PmlZeVJAwo/A4r4f8ADmuXVjf2skMCzPE28qQzbwDnBA7fSvorwx8dXujHb67pkSJO25ZICUIB/ur36YFdOHtFWbMcQ3U+FH0GHKtggqT85Bbj0AB9ae0mRkAM4TPGT+IryqH4w6Ak/wBmuYbkBz+/YhSVJOeinn3HrWvbfEfQ38wQ3tzb2mPlnlQMV55GBkgY6ZFb8t9jlcZLdHdh0mZkTcAnUrw27vkY/wA5qCK4jlJt4wV8vC7XQkMD3B7nrXOTeLtBCv8AZL5XdU3JJBGWLlhyT6NTIfGsF8YYLezuWncEKqjdMrbchtuOR9M0+V2uLld7HVuCqtF5gC7gTIed2T9w0vm4Z1QM20cblKjPPU9v5Viw65GBxHcqjcCVo/LViBglcnLMfTr6U9/EMIhim3BEf5EZn3bz3VR1IHc9RS5WFjYUPKp2BQEGNysQQcenbrVc3SyubTcA6qN5aTuehyOh9BXCan8QreJ3/s8O8kS4SWIkqwBwQAw+YE9+tZ+p+PYo9kdlpkSyFfMjkkcZQE5JfJOc56ZB5pK17NmnsZtXSPRJLq5gElvEjeSicuOXgGepBJLfX8alEcVpBJf2kbSGQiRlEZLMTgbgBz0AOBxXlUPxGuZoY0lt7cQhz5b7S5B/utvbge/+FRaZ4/u7K7eS7iW5tS+AHnAmt09tvGB7D1p3XQPYT7HrBxfW4uonBdGJAAG5VJ7j3A/WnSmS/maCQSW7xqH2xPiTaTxg+hxg5rgE8ZXkiXF79nKxIgcxQMJAhyAGY9XADA7eDmpn8RRCKItI8/myPI8kEb+Y6dA5RfmQEgjaelVy3IcJLdHarPMUa2e3OYsASt80RHfJHcDtUtpshDlLcRdXaHeCcdmzznPavLdW8WX0V4sFk7wPBP5q2VygdgFGWd2HGc7hgYPHIrWi8YXTXUcL2dlbzsFm8wSBV9fM+Y8cHoT70+S+wuRo7eKVpLl5RMTI6llVchY0BxuYdSeRxTxgO/l7Ii0e4SBQRz1dh6HHSsfT9TNzcEW7FYo9zYhZZZJHz94qvO0En6/lW0zvHEJj0YFixwDjHXb3P+z7VLTTJFgDAyxuMKoBIYkjOOCT6njA9Kay5EgkVZMgFhLnJOBgN6H0Helt1wmcSAImRlshWP8A6FnOc84oYtGvQ7/L3MrNu2A/+hfXtSAhuz5coML+VIcJ5iJkk91A/v8AHSmzKyTxmFfKCN8hYfuUyP7vB3c8j3qe4DxoijcFYKpfOXX2x3b/AGqr3MirexMspAY7d6ruyT1AXoDjqfemhMbEH8+KOUxGNl+RBys7jq5P8I6YphKyCZ5Nk2Y1djKCh46cjpjHTv1qaGBBNKQY1VV8t4FO9H64Rc9OnIAqA+a97BZRv5oVcy7hjC9g3rjtj0p7iYhkVbd8MHkwZEbZtkXJ++4PUdeKiVglsJchI/P2homO+Pnk4754x6ZqN7s2Mf70LefaJfJV5FAzwTuOAcYHr0qvHANIjhne7VoFBbbIu7yUPJClfvA8YGCatJEk9mqi1JDqt0u5FYN8wUHkk+nqeM1BdlGvT58GyyKlA0cvDEZyylckDHHbPpTHik1JI9RiaSxjcn9zBhGk9d4I3YHHy4+tEN1Lq/8AxKb20W2nU4nxKqF0/vAAkcg9R0PpTt1J8ipeCSN5E0GBUg8oF5JIye+cJg/IcHv061YuDFd2CWixs0yAK7YWR4CuCCwxyvPX1qCKRdAsjp0N0YYTHt+2rEPLjHIIY/xHgj1ycmolt54A98rRWLrFskmjQPIQTg+eTjjoRgZ71dr/AKElSMzi7ZZri+SUBoXnGczdCTGp4Cj+IH6Cr10IGAKS5iXCxnyR5WO/l7uRz1Hc9OlS3ikyM86WE11gqqK2Etx13Ow6McZB4znHvVae3M8avJPeQt2eFlNzMD3dOgUYwD707p67CtY+bp7gWdzfS2cLiGWP7IwlhDPjaCg2njB24yee9dtoejTaf4YniljlNlkJdtHJhgTjAUZ/Ue1c/O1v/wAJBa3Li1XRdOl8xViX7Q5UtvLMB1BPc8V6NDY39vYQaldRQJbzF7hYmJEkowdsqoM7cDp25GfWviZRufqcWoopWPhvQ49NW4tIAt/KGZfNA3deSB27AV5nMlzqPifULeGCC8uZ50lEsSF3wOMKB2wQSvPTtivT9f8AsNp4X1Cxn82zvZ4lFtC8n7l85Jy3ccHp19euOB8N6Xq0viqWKynNvJahnea2AiRN2Cyq/wDD2GV5/nUWsVzOVmtk+pY0PWLKwSOG5uHjiM5SVYs435JBVlzlTgAjgjPfJwthpS3ksd9qJkGhidlCl2UR7s7RxkgA9vX8aguvDjT6oYomSNfK+0SQxMzKPmxlT/ExHJGM84rp7Xw5baTosovbsta3MeZCo2lnOSECkd+BggckjmsJRaXunXF3V59dizYaNpknhcyRSJA0QcQXJOScFuv1z054NY0NpFbxS2+owSG8uo2QrEAyXDKBgxnpuPBwccYPrXZRWVzZ2sqx3cMdw0COJSV2RMAAGUE9sYOa4PxXZ3nnWib5LmKSUv8AZygRIg+FPIAxuOPpu96xkk99CXJu9mNl1WystIfTJILK4NoRKttt+R5iSDGQMFgh6AnJ5NY8Hh7V724S4wjOMmOBwMqOeAnQDJIArso/D8WmwmDURBIiqZtzKQA4OWUnv12j296dqsMssN+8wlSF4xtkD7PKOMjEbZDALxjv1pe2cdEZcq66nnl7pMtskkhiKwCfysuNqvgEnDH02kfUViR3KWtyzW1jbzRbg2Lpd+5Qc7eCMA9DjGcY9a1rm3eeJI7e6ae3RwiAt1Lc5254+v61E0UNsktvKC94HABTlVX1z/ET0AHpXfSqcm25z1qTm7M52+iiu5neO0aCLhgpcttwMkn1yefbOKoSRzRRqI1iCMciRVO/Hofwr0MaC/8AZ6XwIgspoyXlnAOQH5KYyfTJ46EDvVebQLhr8WwAaUoWVbYecSR0yB05wMn61tHFpuxyVMt0cr/MyNO8P+Gb62fWfE2tLb2fnGCLT9LhH22baBhijYWNDn7zZJweK5G5063a48u1WRIUlkVZWfeXXcdhOABwPTrXc6jpqafbGBpkN2Xy8MYD4Azku4OAQRwvXvx3NMEFnb3V1NIYpGi8uGAQ+ZvYkfeJwEU9dwyenHNdKxbtocMsrTbcn+Bx58LXFxBbnSpP7QumhlnubaKNg1okfJZyRggr82QTgdeeKo2sEl39ntpbmRLdWI3tudVyOyj8uK6d/mhIV5jNIxEwi+4Yxg9uSd3OOnSp004F1SFHS3kfKSSKN5GfvEDvx0FW8U4rUxWWqU3y7HPQafdWQWdY2jdgTFIH+bI4re0q+fT1uN1la3MUwEYSRWDKQOqnOVA+96Vo22lRyyyRJKGaTcbd3wpcrn5WGcKWyMc9frTLW182GVIVTewABIy2Ovy9h06+lZxx8oapnT/ZMZ6WI4Ynj8xdRLLcbFlUszARjGSrADJbkfQ1e0+YfabeK3VHySplfIbJ4wSeMDGeg71ZtrG0uooyZHiuJZGklldvkVAOxOSWJyefXHPUado8XnzyahaxTO0QSNEyFibaBuPPtkjPJbtgVMsycdjqhkTkk0jVhS3l02MQ3cQuxKsUyoWVdxzyoA+YALzn1GAc0Rz6sLpLhLkziAEQsrtFIFHA5BB9qt6dpl4be3njP2S2Y+Y4hThnHGDnn646cV0D6G0pitYmUQzJ5swfghR0HJ7/ANKTzOc9lYqGRU4fxJFYapemT7O8EV24hEayWytI42/MCpY5HBIJxzzVrTrTVFSOUO8EpQpFMsjKy5GCBjnJ4zjrVuwhjtZS9pA07rkR4YhSf97qfp0rei1G5htH+0QxRTOAck7TkddgA6nNDzCrJWcjV5Rh6TvGN/VlSPRo/Jt7cEAINzKrHjtjAxjmmX2l6TFiK3soRPI4GFi8xhx2B47Dr+dLa3Bnu5SombP3mHyjHYep/wDr1r7reBVJiMXoAuA2e3ueK55YiUupo8NCm7JHJS6DawrLNclEnYjbDtLq369fXtVNvD0ktwit5UUbAfJznvna3YCt3V5vtE7JEbiMrtyiggsueg49eDj2pbaOWa5kWOR0iPVZAD0HGfQ9s96y9q7m6oQ5feRQt/DjxGJ47iaPbkM0LsC3qCB16Cq76fcWk8klvcSNIx2vI37s8DA755+v510UlwbGWNZ5VePoNyHI4weRxTYYbW8u5pI5t3ORskIyD2x+Fbwxc46XOeeCpS95x0OPujcrqK3NrI6XAIZpVJIBHfPfn61mXMDCUyySNMJMH5mJLdsH0Peu61DTb5pgLYpLGBlsyfMfQEelc3PePHNJbEJ5O7cyoMnceMn2rpjjb6N2OOeXxesVcx2Q20glWWW3kJO1oyd3XjJ/TNdj4b8S6/plxChl+1xKSNk0m9eRkjOflPoRWa0do7+c+F3HG5+QBjpj0/WmWdjJBue5uPJs5MjbsLu3cFRkA/ieOa6I4iX2Wck8DT2nE9j0bxBZ6kvm2swhdyF+ySHEgHAwT0K5z05rZ+cDYCCxBI2YyUH8MY/u+ua8AjvgkaQSEu+eGRMke2e/aum0Lxhd6aPs9wfPhDbkLNhlI44I5x/sniuilj1J8tRWZwYrIpRj7Sg7rserrskdRdRrsZAyFCNqKOQVPUn8KqQyzi+SS5Vo4nbaLuIj5uSFBX+HtWLF4i0nUYZUcpbcBgp3OTIOhBH3QPTitNdSXV53tlkRraEeXIdysJwVB3DPpzz9a9CE4z+FniVcPVpP34tCahFK1xK9oYmSNxJMxJMUfoUAx8/vzjnNR3Nz9ojgg04TLfFd+JGPlq3Zmx94eint6VDLcyacsdnE039nRnC3MIyqnjCtwTgDgZ+uaWa0js42m0y6hjuLn550Zwm4nnfJ169PT0ra1rX+Rz77EqXVvZR3A1Il55MNMICQ24nBKjuM4/KqkUA0+5iub6JPsKFmt4stJJEhOS7E9OQMKOBVyMR6qjiYxpdIxeOJz5ioARyrEAdO/NRx6ldTXAja3uogHcpc7g29Qw+XOOxB4x2BHWhCI5lma9S40mW1WOKT98zhy8qEDOAehORzTtRubJICsfF1IrLbXKKQwY8HccZwSRzjtUMpHhuxMVlLGbe4crC6Z3WzMOBt5KjPUkgDOTSwWEenwvq1qUkuWXZMuzDseo5HUZ9PrTst2LqVkeztrf8AszWSBdvHl5V+7I/HBUdD1x9PWkWGSxsYjIIkkZwouI8tHKGwAHU8luo59jRD5GtXEy38lzCrsJFt3DKYnQY3Efw4bPU9xVmY3ixTQSTFoI7gQeakivLOcccEffJ/QGrvbT+vkTa+pXKLbwTxeTDEsMgdgq7jEAesh/5aDnOAeMYqGeSyiYm9SNnY52KC0n+8GXoh67O1WHlSKGWPc6BJCEIQ+VBj73YnzMZ9u1LZl9YuruCwuVhSNgzxtCEllbGPMIbkDt070ebF5I88j8EWWpWN8jtFY21oY4k2lndN2AFBzyCWzg59Kw7jR9fCy2unbojaB4Yb1ZiDJDEApUxe/ORxwc4xmtXT72bWNQuLbSp2vLkyq0FwuU80bCVU5HBAON3sK6zRopXisJL6eYtcusrRR4yUAITtyWYnOOwINfFpqWx+ntulvZ9l/Xp1PPtLtPtlnYf27dBppC8rQSIWERUEIWPSMNj5QP4s1e0aXT9FufEpuLS4e83WyiBDvZgyDLED+E8j8ATWh4i028hiu20/yZL66gDlwoKyxxy5eV8cJjjsenvVLwrYatBNqE1iuk3MqxR27TpIzpNhlOY3PLE8cA4UDGR0qbJDlUc1o9P+CZ+sT2emeLL+9nDtdWsezySQVQn5ui/x8j5emByakiv/AO0bWLU7pIUeW4iePzyzm5iL4VQB0AwWCnk4rfmtDC2oQT2SDU7aUzw3UgRpRM2eHJ3Dbt46/wAq4zQLaJ9DhsjJLPdTSrFsVQzQYbDIUHPynocHg5qJRcrnTTmlFX+/+uhq2N+8OsXxs7e4uIxGi7Vj3FGB+d9o5PROBk85xWheGe50mPU9OnkvrqO5YTllAWMkAqgzyPmUE5HRa0tDUWtvA9lGFLPgJDjzDHnALD1zj3wKz454LzxAJbq4gtI980JR5NiuzY3uvTIBDAA8fMa55QS0Yqk4yd1si1Yt/bSwT3cflSTiPylxvDv34PQZ3HIzVfxHELW2lt5rV9yM6GV35kfP8J7KAPwxim3M1jbTz2I1aze3IMlu/DIoI3PtxyGycY9Mn1rC1K+uLqC3ZLWFtTtyCbKDmFouxcH+DsccbuMVDirNNak0m20zidVtgLs+WQ3nOXVFO7aPf6jJ9almt5oLGBUjhUyuzLEgDPu4HHfHA68Z6c13EJs5Xh1eS0Sxyd7rKFJiPbJ45JPft0pusFri6YWdlCJYo3u7i5ZQytEFwGJBOw5BGMZyBwaIuT0S2OnngnqYGiQrBZ3U+oWhNr0kkBLMjjG0hVI6N2Jx1yDWdeR3N0I4dPgmYSgTywxYPljPyjjPXcODzVKyvA1+tw0f21QdxhmUtGzkYy4Bxu9MeldlB4httP0QrbI7XhKj7S0awjdkFgFXsMcEn6UP3XruN3ktDh9Z065t7mO1uYwkyqWMe7mMdAD6d/1qq8K3DGOW7tdz2bSEuHPluDlUBA/1jBcAnKjfyQeR2WoajH4h1K+aW3EdvhnMrOMyMOMs2OScZOCcDjOOayNL0+3lubmfKzRWyrLMJZFjyMhTjn7u5hjHOAK2p1eR27HNOjzrV2vuN0bw6JoSzswmjKloh2jIyWJ7846VtWGkW9osk8saXDuvlxRlSueeW56/hV/Sh9tAV5zcKkSpOsS8AgnqfwJptzDJ9lSOCTeLc7ky2ACTjCk+w5FclSpJ7nVCkloYEmkxm5thDJFNFLM6b4xsxgHPDcHA5J7kHHNZItCtsrp97HKMOo6Db69yfbFbWvXM8VxaBI4YprQL5caKPkYEHJHrnn8qntNMlIku5oFO8PJ8zEqrnn1z34z+tae15YXe4RpOUrFbT7THljeowAMkcDjrj/PSrtnHbNdwrdymKBpMySAbsD1x+FWr3SPstpBdG4Vy6jKAHK56Dnr+HSoIUG1p2ijdYRgK4yOeMkH8vrXNz3dz1oWULRLNrq4gshCJpoVUqAsQyzjJJ5PCjkcetdJbarCIpH1KYxghWW32MzqvXJYDaM+hNcjZW819fhRbNMAQrDlufQn/AOvXb6P4deayANtbwAndIjlyEweAvPrjPFdFOT6HNinSiry0Ktpq5MQFum23C5ZxkbRnjPcL/Oui060t5oo2aRyOnLkluMk5z3IHAqs+iNCyiLazB952/dY5zzRLeC1RzIomlxsULkbecDHFaRbXxHFUaqfwjRvp4rK2knXaQoJJdjtUAen9KpwXkWS/nLI0pDlnOdq442jt24rO1ISXLxSTAPb8eZGFw3ByMDv16cUWCSRp5MMarFHJujWRcHyz1556Gnzu+hMaCULt6l15pUKSRlN+NpZxtLZ960LERSL5gkIuCh2MSGUjHT39cHn0rLnnQxlLqNFRW6SncWI78cVXntpLlBc2MpJEh2og7gYOfTufX8Kcb3ugdJSVnoaXiKAtAsgkLoOWjDYyf88VgWtwzyhd3kdCNjDI+uf6V0FnHJeKBqAeK4QAHzCACfbB6mq1/ZSSM09qdsa8Fs4J7YUEcDOOaUu46VRQXs5FW61e6tYtxkiRTuRSqkke/HXp9axf7Qs7+VC8kMJYje7/ACrn16ZwT7H3qjrsLGbzXgFvbrhXkJOC2MZ7jv1Fc/cFHnfyTujDEAht2RWLlK51woU2rrcvveSy6xHbafPHKY2dWjB+TAOCyschuoxx69c1ca91OyvEjurC4mVP3jKuXV1A5dAO35HHriuWuAv2qNVBDL8wI4x2/OtexlvlSSSO6DMUKgFzvYkY/HPGa3p1+RpnHWwnNfqbk6w3Um+BIkc/vFdc7wR79VprKpZTZgvIQWMbfJk9WAPsBxmual1S8hsRNPNZvIn7pV3ESEjAz8vfvVODxPdi4V2kJCkFt5JOR35716Dqwqq70fc82FOdF2Wq7f5M7Cw1lJp7e0kRmlkLEgY3KR1GfrjkcV0DTsm0OCdvBLA+tcbp+s2eoT79RsEa6UhhIp8tiM5zxjPpivbPD0Okapp8b6fuMkQ/eRSj50Pqf8axvNapmlWtRppc8TiDfXkasI5J49xIbDEbu2CO9a2i6zqRRIlaKWJMF9yDe6/3Ceu32rr5fDqy3CsYlC9Wz2NJcaULUN5USjtuA61rDGVobSPPqxwVfRwVyCG6jeONbmCURFw0gR/u4+6iDsnqDmt24u4Z7VUkMEzOQYxDJsLKv93+6wHr17VhixkHVGXp0pJraNAwdFJPr3rup5tP/l4rnlVcmoyf7qVvxNaCFbF2vdTMTRiJYxcABYl5PB9vXOST+VZKW07yrfXCt/ZnJiEakSQPnJYFRyOwU9+aqyW++MwtuKryoJJAOc5A6UHVLuKI2t9MXs5XxM2MNgken8xzxXfh80p1HaWh5+IySrTi5QfN+ZpaiZtReWaGyE0MIKbN+/7QpHKsRyCcrnPoRVeMoHIZmEqqluzRDdIQBny8A/Kef9Z0p3m29pOlvod5bosChPOZwTbpnlgp4YY7ZyaDboVlQO0bzgyLEij7RefNnIIIGwj+H0Jr1Va3keK07+ZYvbmaBZpbaQIE2K7kFWRSdvlgHIfkjLDpjNZ+rabaXkscU1s8rwxpvjeby3iJBxhuN4I6n2HrU7pvlQT2tqsUTCGKQ/PBbsRjCkckknnd0IxVPXWGjpG8EL38YZkeN5VOHbncCwORxjjp0oj7vX+v6/rvEtTza6aayWC8iZ4pYZo5I5YBg7AcbSq9R8w4/rV7RPEOq6F4mvNN0oQ6rDMvm2pEjJ5QYF+c5PG4jGe9UlvY71LCzxPKrRETyoBkdQQD9QKm0u2sbuyFuilNQQyIxwTIYk+UIB33/pivgY1P5T9inGm4/vFe/wDX6HQ+G2XWdPspLy7uoIwjQXTCQq20t/qwQPuEAsQc5J5HSuvu7K2juooo82ltBdGRYNoKo7LxhQPod3bPvXNyzRQ2slquIUIjXcU+bjGPw9R39q1o9VhyJ9Vcht4DhDgqAAOcD2HX0x1rWNTueTWpS5uaK0109f6ZFd6DrlrqbzSarELW4tzFdIsKHeS2MqezYPUeteSeMdKvdPv7Oa3hkSSdfkktD5UispIV8qcsdoYfjnvXuP8AatvFqBZELyFoxIFjbABAwc46NknjtmuU17ToNfksWtzEk8CyP50jhSoRug9cZzjvzVPbQdGtNK1RL1tYk0SG2t4/Mury6usSC6FtK5AkIQhSzDqvAH1HTiuik0y3uFFtItubEWJaeQxLtNsuRwpGcsd3PHArmYrjz7eYJeRRWsqxJb3zp5YMjMA3mEg4IBcZ4xgECtXwxc3F9rerxtfQyyvcx2gJIaM26Zxt/vFiD9eaUX0Oeu3dtO39foYcvgzTYJrmKTRLR7pYwSdm5ZjJ/q4yB93anJ5IOK8/vvDt94at57pYTdxRx+ckjTEKsQDDhTzk7iRgjGK9eluBd6iltp0k1vqVxLsG4kNGMNvdvQsG4x0C9OlcZ4hkAj+y6euYcfZ55n3MxxyFx6HHYdGziolGKVzooOT0kv6/rb/I8uudavrpfJlSKASEFpIomZmUDbuO4kkY44xVOe7OpTSSRxCzsWdfOjt2YhixGOGOWOR39q6Lxhpi6VY3EEA8s3RV8QEqjDcuyMA+7EgexPbmtaeCSLaWW/1GGJbe2+0MVBYK3GI89N3Oc+gPpRolc151z2QaVbabFHI2sRTh1OArfu0Rsch1X5ifQDHSm3FxZw/vojLcwj9zv27FJwDsG7lQMnnmo7TVtTv5ESC7uDd7XeR5rlY05HLEt95sHGST0GBWQjTiAWavshRiSVPDMcc579K53Tu/eZ2e1afuovX2sSTXJ+5lR5SFEyoXkcA/XrUKWUhga5KptRlTmTJBIznH4HJHSks7RhhlZcDPSum0jT4p2/dFZXAykasjYyOQwOO354pNqOkDaFOUveqDbK5vIIHgurSKWV1QRXcHyyIvOBxgSZ6Zb86LC/S3uLaaSEPIARJC+Wjc8kt/s9vp79KfqckSQzW1x50U0EaojzINzgD5Rnt7D/8AWYLaB7+9jULiY8COJc5HXgc8dTWM3d3ZvGCVxVs7zU9SaaVFVmzICmANvGOntiu207R9QlhjS1aO3jZmIymQ4XAALHr6/wDAsUaBoBsJ0+1CZbm4iBAC53AndwMcdF9evPauvtNEexEkKKXvHZYUG3JJOWK8+nNVCi6ju0c1bFQpq0Wv6/yPMNQuUkeWLapkVj+9XkdccADvWfIu1Nqqwk3cljtwOmCvXORXo1p4at47WKzimka5DPJLheFjGcBie5yT+VFlots8E1zqYEuoPIRE0g3EIMjj8Tj8Kz9g4nV9epRVl/X/AADN8LW0sVoiLFABzuJJyvHU+/Wt26vpTIYoAygJl954c+3tj0q/DAiNuiCvORlwy7VU/wCPcmpL7T4iIppgsu7OWY8BTxx6c1pTjJK1zzKmIhOpeSMd9SW1kED3AYsOFjX5gME8e2B3p+nyWeoMFtGLOMFnb5TjtkHpXHeJ0hXUZv7Lt5fKEgRp1Q5BA+7wORye/fFSacDblLlrks0hVFYAljgcgA/1pSq8rt0O54WLpqcW02drfWDvEWiQO4OSXb5c9himTRPJFmaM4TG4KnUY/wAauaUssuyKOPapwzEfMzd+TW/cWYWVBcyKA64AxyD7/rXRGz1PJnifZNRZ5y72cMUn2qIZbA2scLjOAOeck9/rWzFqFqdOKvKrEAM6bcY44x6HgflUXibT7KztZ5LtwqRgfvF5+fP6e3rmvMtUj8qNZ4JYHjcblhhuBM8SnAy4Xhf/AK9ZOc4u0T1KVOnio812jtZvEa/aooba3iliVmDMZcOEAHtz6++KpXWt6Xkzb7q4lLjALFQ3Pb/CuLt7i5SOUQmRYShVyq8bff8AWqjTEsxbzFUc7gBj8axkpT3Z0vD0opHSa5qa3bQymyWGF8+WGwxIBwTxjPOf84rnDG0cZOUVjmYhjyQDjIz171oWVv8AbZ0hWOGIBS7Sl9u9f7xJOD+FbV14Xgknh+xXEJQxkh1YuCc8kt09s9KpKw5yjFJbHKXELXFqkloS9xkqYgCWI5O4HHI4+vtVKO/O3zCFJKkEFdwIxVia3eyupoOZGVim0A/Ke/HtXQWnhbbo0txNLBgZneJozuxjGA/H19M1srWOacne6ZxbyiTd1CsRlQ3BxnH9ajXaZFYKSc9ADyc8D/61WpLRQw8snywcgd6u2oKyCYKsUgGMquMfh68f/qrT2iS0MVSlJ67i21ilpaefqVvIlvwDIjkOnoSvTHPUV3Oh6xcaLc289lcMxUADdn514O1vUHFcfps2oJDNFAYpoYhuMMi5bbnsP84rcsdt7tHlNGQgb5eh/wAK6KNWHNZs4q9CpJPT+vQ+kPDuuWfiHRUvrFhtZsSpnDRuOx/oasSxwuCoVgy/ePavH/Ad2/h/VHurcGa2kXZcW5xlh2YHpuBzj2Jr2XRr7Ttat5Li0O7DfvFcbXQ+hHatnS5nofN16UsO72djOkUDkHcOhz2qvcW+ArADB5AHWuiit4ngy3TJz7c1nXttHCmCd074CoO5NZOm0rjp103ZHPlypbK9u4rPurdZ2yB3roJbB33qqNkfL6nNZ01rKhOFOQetRax6NKrHozKhMmnbliRJYHcO0TY+8OhB7GtS3lju7eRopEWaZiboLDtZjj7vPEWAT8+eap3NsUznhj1qn5N6jmS1kKNjaxA4YejDuPY16uEzGVK0J6o4MblVPEJ1KbtL8GacggS3c2bRfNlGjBLW8pHDJjsx4JYD15rxr41a7Ppt9DokTstzA7SzSIfk+blY1XooUHt616brevjSNP8At180dtqdghaNVixHOvRVXHHpnOD6cV8ueKtXm1TVZryZxJNMxkd2+YliSf8AOK9itiYyglB3ufNrCzpSbqK1j0fS/EVvZRWMrC3jiM8ikMxOEVcoxGO5LD6ipIZSPFOnagl29rNJcTBnYgFZCFZFP+z79ATXBX/lrL5aOHi2ABtuCTx/jU1xqD3cdqLnzJBbRlflVFYc9c4549a+N9ntY/TOdI9H8QeJpINTeKSB3XYHZhLtDjG0EHuS3OBium19byHwtdXI857TDvkthgQA7AMDzz0DDv7V4/qb38axreI0QjEabGnWZk3AOCgLHaSoHA/TNa8/iu/bTYJYYXjjgKwM1xMsizOF5LocN6EdgeCTScGvmR7RSUeU7vQvEkbXskjwXVsJTAFkVgxdNnLMoJwQMMDjnnHSs6416Kx1u2uYJoZ4pIZSYZM8SrwQ+cYBABAHPTjmvN476AXEfmC8ZWlDSSrII1TDFk2YBC98DtziruuahG09otpdXDjLTETsJEIyCG4zzxg9DxjnvXJKxLlG9jpNe1G0tbzVLLSVkmtbywimMUgMiCVF+dh2xk9uMjnuK63wZqJ0XTdFS2u1uJ5I/OnadwBCxj4UE9wowHHcnmvK4L+XTNWf7XYhI3iniggZsIpcjOOcEA8c5A9OK9E0fVdKvtf2QWsdlBZ6dKxjjwWhaNhhJAAVYjP8Od3AOOabi90RLlas9V+Z2Hh2G2vpdQ1Z5zJflYkiUMysryKA3bsGPWt6e3DD7VFDEI5cTJ1wNgIVmzyMnn2Arx7UNbl0e61maCSS50OadUjuLd/K3P8AKwUqc4yF3YOBnODmt/VvHGoR2N3vuYpb2ANbssMJZkRo9qsMEBSBwScEFjwRg1pCS6nPUp1L80df6X6/1qcX451G2vtZurdrn7YmnzIqSx/LHJlv3nTO7uFxgAZ71N4t8Radq1pZWOgWEkVlb5ae4dAjzzlT1HZFHQd+9YNwLaTRUlJjiuZnWKOEj7kMYwTk9WJGcg8k4q1oujDUSDJO8lix8u3kRlDZHO1kzwQD3qJO60OijTXMpyKNtY3IsWuY0Yocbtoy2DnHHXtWppdvp8kcJBeLaoadZxtwc7cKccjpx15NdUNOht7VHabzWLCMSbiGJPC9+O3T0rW0vw4WuzNcpckKDkhv4R2rP2bb1OyVRRRWtNFW/jtyqwO4f96QgUFcYHXHftzWv4hsJtF00ypIBcMpAXCqAMHHAHb+lejeG/Dtr5KSNHtZRgHeXz9M1xfxM8oNKjoXuGyPk5XjoPXH8zW06ShByPPo472tb2a2R45ezSS3BkllaedTneWz+PpivR/hNpt1/aUt/wDvBdTRmJUEAYOrHnB+6DjJOccDjNedqIY5x85RGmCDd/CMZ/Hjv719A+GdQtv+EVa3SJwxG2J1OxS3TAxgnjJ6fWuSirz16anfmdZxpcsVe+hkx3Vxbi71CY2hSyJt7a0LnzBydzKe/T/PGXR2l1NokM1w0SMIfOdppCVdmOBgDkEDj9TWnbaFCdUGnpLI8bSiTcTndhfvEHr6euKu6rEkHlxCWKO3dSihnI+ZCSVzjuM8VurpanlvER5lGG71+X9XZxmhyAXmpRz358q3mYSPJ8pjiAVhkjgA5GMfjVHUNRWKG2OmyyTTSyeYrqMrEO+CevcVyXiSSKw1G/g06fz7e4KCYI28CTHRW9cAKw6YIxnPEqeZJqUEUywtdK7jEBCqm4ksGGOmepPTpzzWNWaSsj6CnhU/3knv0+R2Ul68qMxaMRrhimSQRjrxz+dUb3xI8CRyRxRyRvLnzPMABVeflA98Yx7VgapEdHtJFLW0k1595ohtwDzgD6Hj079ayJLee6mZrW3kjs/M2RrtGFPGePwGSPzrBya2Lp4Sm1zPY7Ox1r+04ZxDC6qsh2sxALcZy3v+tZxupTqgBLOj4VTHhvwx2PX86wZI7rSnClQDJGSVDbsjnqPUYrb8ECR7uUu4RQV+Z1yqgg4Ye9RNuTSZpOjCjGU47HQx3mpWU8KDIdx8q9dvsT3Jq7Nq1+IWljVGuFIIR8nOeOtV2Fxf2UslvHJJ5L7WPRQ2ex79qwJ7DULq4hW8aZfMkKwuEKkv3Vvbr25pxhLpc4I0qdR3nZNblq/a11qAw3cpAYee7oTlCOw4xx361z1jBp0+oX1tHGzIYwYFVsh36c98Z7f/AFsbetQG2t7eO5kjgEJby3IK7c9jjse+fSsPRb8WWpJ/ocMssgCq8I5OOrDnIXjPSrUbPU7qUf3TcPka8F8lrY2st1bKrRxlcCLcVGPm+72659KxJms0WO40+wMkcLb5XkwVaRiQNuOMKBwPWvSptHt9U0o3DxTLu3b1UAbR3JHoSM4rE1LS763sIRptuAk3yyl27DkNj+HjjgZ6Vs4StY5KWKpy063110OJktXvNQley0+SSFySM8OR3YgHAJHbpW7pVpLYaeEk2Bv4HX5i4PYemM1qJa28cJSS4W3jlYq6p1ViPY/Stl/sJjtUuzm5jbcJHcKHVflOPrk/lWfsG2VWxO0UtDzfxVos9peTXab9kzb/ADXccluTg5yapv4gvVtBb+XbbM/OxTJOOh/+tXeeJNMuNbKPb3cKwJkLlCRkfoa4vRY7Wz1eSTUYlxbscQtyJCDggk8HjJwetKTcWy6TVSHmjnxCgkMmCN3IK9/enwlYnBbCgnBPtXX+MYdNnvLcWESRXtxIpZk2rGFPGGGeD0Pbvmue1Wwl027FvOPnKBlbbgEHvQ7+prTtyqW3kMikkWZJ7dFL/MAWK8Y5J9u2DW/bwzW86yPOk2SNzqed2eQCRz1x6dqwbO2ld/LgUkycAAdc9q67TYpLrTNsqg7cx8fX17c1k99Aqx+0y3Dli0kbguoOULYI/wA+tXNL8Q3unz/uHkSQqMnGQRnow781gKBepLZXEbGaPdsnj7EcAZ6np0+tUrlriztkt2YfaIfvs2TkZ6iuiGIcdTkqYaNROMkesaZ48guXFvdsbW5J+ViD5Unbg9j7GtTTNTD3qXDPna3ynPGK8jdVu7NVmUNFJjdk4I98jpWro97PYKInY3FvuAVgfnT6g9R/jXZGrdpnkvBQSaS3PddNvIZbdssMlix980k1kJQxtyoBbcAB0461wmj6wJIXMExYEDndkYrVi1/yGHmSFBkDI71vzJqzPIngKkJtwNibTHMXKhpAefeqE8Yt1ZVQ8+2cfWpbnV/MHLkY44Ncl4z8YJpWnXFxuG9Vxgcbj2FRKxVKnVfxbHl3xi11JdXj0x7iKOG3DSt94jzNuVHAPOe3TPXArxhYHvHlPyoyty0jqnJzkEHvWr4i1YT3kjXIM6PMZmkZvnfI5G7sM/yrJvZLmCNJBHcNOT+8aRGClGAMeSp5bAbjr9a9ChCy1PMxdRTm30OgUrtjVGDP5ny88Y2g4z654pl8Vad5Vg8qNmIVBzjHv3+veqaSOsizBvnXABYA9P8A61a+m3H2OYTwNBcziLcWKHjcOVw2OnqPUEV5kouOqPro1FP3WZbFlBjQFFJ+8fl/z3q1DLG7qznIztYYJ5xz+n8q0ZrW81K2jjjIWykneaC3DgRwtgBiCe+ABmqFgY4boNNGoDjBZkLeXg/eABGcen/6qSlGS8wSlCV+hs+Ih58sdxPqMd84ijYo8m5XVc7Qu3soGOcEZ7ZrA1a8tGunmjtzbWYJZrYy8oWHIVzyVBAxnt7nNWbu8lme52ytHFcMHmji+VGIORlQAOOcema5zUcxypty+Puhh8pGen61dCLejZz4ypyR5kidL1xeea0sUhXDYcAhyPUdMeorX0zVZomR4bhof3bxruG0KW5ZVIPAzyP5VzCwhbRDlSw+bcinj2rShMUcIMCNg8urN8pPOD7da3qwi1Y5MPWne7Oqvr9LuYNZC8+zzKkd3LPtYM+MscnGcEEjOPrzSQeJr610y3g0+6uYpo5y6zKQjY3Ej1JOMcnp05rmpJysaojkcnnB5yB26dqitZvNmKFXADAZI7468e9ZRpWV0dcsQpNQfU6ewa3NtJIvmpIlwpUuVZVUnnPQsePTH0rVeK2W6OpWV1BEXZsQGEFYV6DI569cDkZ+lc3ErK2VYFxxj1BrUiny3nkBSW3GPaAh7Dj61yz0d0enSipLU7XSWW5nlsvMcxlVDzHGQDyCB+teheGY1nit7eZinmyANITgZB4x6fyNeTaHqK+ZFHIPLRB87qB0Gcfqf1rt/DHiOKa7uIyGKoiqjAcdD0J64xz9adGSTsZ4qm3HQ990iLydPjXaGZflO05yQcZ/LnmvLfiaqDVJvtqYSTptGOMev+RXd+E9Vhk0vLyA4xgDnr2Fcx48T+0LiRY1AWMlpGPQcHA9ulehWanSSR8zgYypYuXN954pru63/exBJI7QB2KvkxF+FGccjI7V6H8N9VsJ0t2viVmBzGVVQx5OS2eQAcdMnivPdY0qS5uw6yGNE3F1PO1ecYPqTVvwkJ7W1llkj85GkB3ddzc9zyfevI+GWh9TKHtabhJnrFzr9udeYWeohlil8uaXYGA4OWAHJxn2rnfGepWl5b21tBqbxzySje04BWMnOShJGARgEn3rj9PmvILuS/j/ANLmlmeUt5YcA54yG6kAY+lJf3+oX9uYJUFtaqHDeUmDIC2QHbq/zL8vpg1Eqjlcqll8ac4yi9vT/IZaRQ/aL6aeaOI2b5DW7jZI4G07H6nJyf8Aa+Ws2wmNraB42s/Nm+TeZMunrxnCg+p7Gt/wp4WaXe10kZYPtK54Ge3ufp611mk+A2iupL4xFiq/KpQABvYdPrT9nKVrHXVxtKk2qkjz3SvlvVvdTt3uUOdmT8rPkfMeegzn0ro2vbTUbeBGw06/Lt8sBsZ4Gff0/OtrUdMS9tpp3t3iikKiJE53MD09RnkcY4qPTdDD3FusUSxhDkFRlVfoWHrxxzQozj7sdUxSxVOa53o0cpaeH5kdWUoizHBZlJ4/vD8sV2FitvbYFt5m91/fsecsAMj6Dp+ta001jpiOjkvJuwxcDJPsO34Vc0A2c8McL2hUOCyOGB38nI9jUxpWdkzixGNlOHPKLsS6AttDpW6S3Y3VyD5YbhUH17jpTpLG2uL6I6m+2GL5mfOOcVcmJjjCIjsInPcEKPSsBr7N/IQyMsLnMbsMkk5XGeo5zW+2h5cFKrKU4u1zoNY0O1NlIbcvJHOuGR+T1zxx9K4a10BrO+Sa8kT92MKWiwwyehxx6V2st7PLBEGnD7PmBXjr61n/AG+PUCsirGJVPHzYDfQU7xurl4WrXpRcW7rqXoZrdYoCEkUkYOOeKZq9xA1uo2iOYnt0254ya4+/8SkXkEc0DKpk8sLnJHBILe3FWluJtTglgNxHHa7wJJFOcjvj6VfNzbGv1GUGpz0JLS6tNSuVjeIDy18vzBznnOB3z60/xJpSWkO14I2EnIlYbmAxgY7jFX7S2ttGTzhB5juCV3D9aIU+0h57qYuWbITPCj0HpTcWlZle1tPnh8K/E5i68Q3VhaCNvKAUEbicEGvOJ5ZDcTNcqPMkYsWwQcnk47V6F4lgtkDCRNz5LBR1P41xl9FaRoY8bY9hAKjgH0zj1OcVzzg+rPoMBGny3jHVlW30yW8gMkaoqZK5Jxk8f5/Co3s5oGKyRSHywACQSAPb2rb8NWplmSSK8hjZT/qnbGTx8xHuK6LVTawB2ug5YL8wiOePQf8A16zUU4XNKlZQny2ucI1vIhjMyt8wygHfnpx3rvbK1+w28Ygiby25cIeg6nn61BM9pqLCGWECEjHBAxnuPf1781jSzLp0ksaTyTpGCY1BKr17msm+V825z1G62mzLmrrJ5W6xYIXJcqW2Zx/I+tYukayrTG3vWVGUlpHkOdnPIHqP1pgtJdQtzcbiZ3Zi2JO3GOOuOPqayL3yJ7cPcMRdJxjHEi+mfrn6VppLQwlG2lza1S6gkeOe2ntyNwVjEw29iG/x9Kv2N/JP9ogkWNZImKtgg7hzgjgZHTivP9MkH21I3IWNjlj7d8ev0r0qx0EyXpvLWQ+S7RiLac7v3YLHHpyMU/Zyi7Imm4ON5E9testo8bRtuTB+Q849R+NUpNblZGWYGcEYMbjDsB7+3XFdFf6VD9rAQMJvl3kc98YNQa1pFu9tJI21XjGFVDzu7Yx1BJrVOorrsZv2cneOlzDg8X2tuvkfbSxUfxEkoMcgnHTOPfmuA8e+Jzqt7HbpJILSEkjByS394d/T9aj1jSbq0v3F/hWZypbnGe+Pbr/9aqVzoM8jXTQJ/q1KyPgOXzjkD+orrpThdOTPMxsKzg4xRykhmug6xIHKZcgHoo6nHepLzUVeL7BZ3d5DpQKzLFNKT+82gMcKAByWxx0PJNOvLOWweOaJnQ8Mkqgqc+3fjpmstopCpK5IVsH2z/k17FOUWtD5CtCcJNS0Z0SBkjOCpJzkke/8xVpOEw2GHU+h9/rVBmy6YIyCenYg96sRbQCzMwyP0rzpo+noVE9Df0vUGs7ecKglk24RJCcAk8sOcA9O3PFULu4kDqsu3arMcBcbWbr0+nTpVNjhCAVC8cU64KtDG6uHc8FcfdI/mDXOqaTv3Ox1LrTcsOAbhHDKqsdoJPA9A3pVLULcy71diCwySOefan2zStMsVuJCZiI1RFLFieNoA5OeOKLh3V2V0ZZUJR1cfMCOxHqMY9a0jFxd0ZTlCcWmY6RurXCqxQn+EcEjgcfXvVrBDMHG0MRznORjpjoKm25nIwOm7IP8qseWrRfMecHqOK1lUOOnh7bMrSBXQKOdvJHYUJ5kE7o5RizElkIK5HHBHGKfNEwCxMRtzlT0AqqMfbWUsq4BwuOWJPT+uaI6qw53i0zat2EkmSeg6g9RVvIdQik7TycmsyDK7AVZMDcMjGRnj/8AXVhpD83PzH09K5ZR1PUp1bR1NSGQOpiJO3cGYfTitWwv5LCVJ4zKICCqgvxjvgevSsCEqGJGRx+FWR8vDHqO/YVzyVmdsJ3XvHuPg3UpVmRomliyN3Qbj7jsa9QuNP099NllCbGCGSbJJJOOhzXzp4a1iWJDL5ZxC23zA33sj5UA9eK9f8O6x9uNtBO4FvKQZcHO5fQ12YeqnGz3PFzHCTUlOLtbexk3/huIWMl5LA6rcPujiGfuDAVT+lc3/wAI5czXr6fEuxFwoCcDdkH/ACP8a9sa+0++1UxSNHttVzGN2NxPcD2xWZ4Zit9NjvLm7CJJO/mR+Y2W2kkD6dAfxqp0ISe+hz08yqQg3KOull67fhuc9pPghhBDa+WsEO0SySvzgnG5fy55rh/HRgsZ7qWxnHl3F00cY4wsSAKW9xk9hzXefETxzb6S4tkthc2wjU3CpKyFlbjGV5GDjn8K8U8Qa19rS3SKJAIYfLyeSxJJJB7f/WrlxDgvcienlaxFaXtq23b+vkem+EjHGLa42/JGBGFYkkvjqffFej3Wpw3FslnaAh2IQu3AUdyPU14b4U1dbDTEYyySSifYgByMHHT/AOtXdeHtU+z6gn2rnY+7JOd468fnWdHEK3KZ5jgXObqb22Nvxhaol7Y2VuVSCMcRk4Csx5Y++KrakY4rOK1tXjEEZIdgeSe36/rVHxRqoa9lu5QsbIQ5Dfwqf5cY/OuVbU2OgaheTN5cgXbCr8fvMZAHoe/4VvKa5mxYXCVJ0oOT2/N/8Ocpq2pXl1r00uxg0BJ8h2+6o4IJ6ZP9RXZz+KLfTFjkS2kkCqqhQcFPTrXJzeUfDcjTXsMk8jI0hBUyNt/g9SAT14qM67bp5sU1qlwiFtnzjbuxkMxx83zH07VyXcL2e59FVoQrJR5dFoek2epzarbNcWolNockZbaQfp61RudGhtL95IZGa4I2sQNwPc/qT0qv4BlWK1jzwpQF0djySOuD610hBiBNzlkkcKjE/wCryc/N71rGPMk2eJU/2eq4Q2/MqWkbRqse5WHrwDj3FW7fTmFhtWJpZmZsBU+6c8isvUYw+oAI8h5DD5iAvb/JNdt4eZIIS07yhCxIAwRz6d63jCL6HJiasqcFNdTznVvD80On3aCEETdWlB+U5yMfiKy9O0q4tdqMJFlVfLcAkLz3GeoPrXq+qOt3ch5ItsMQzHCOS59X/LpWPdm3aVhOqpNICzBm4UdwPTjFDhFO6NqOY1Jw5ZIzdL0KbUEE7zsEt1ICq24H3zXQTWVpNYLGD5MiHa+FyTVvR5oQgELKtuw4J/ma0ZbZXhDW6nzB0ZlwSPpVtaHmV8XN1LS0tt/wTzfxNohkdYnIfY2S4HTj0rm9U0cQWjAMhODwe+f516lfaXPNummkWMDqW7n2rkPEGmg3EUbFTGrAsWyd1JwTWp7GCxzaUebY80utFvrbygsUku8fMEwcZPH14/D61v2GnXqW0MX2eQvgfM55GPbpiuvslUXAl5UIwTYPw612V/YI9hHNbj5yOcgZ5rJYaNm0dGIzZw5YyjueNaswtbpWvLSSdDlZMAc4Gc/gOe1T6kbbdFLbQDOzk5z8p789T7Vo+IIZEkLToSSCxWM46d//AK1crf3Iae3htCCrgKQGwc9MZ7EgdK46tNRujuh+9imjGnka1uGlhcM6MSDt4zn0qnrN5BqA85IRbSpHn5Wz5mfT3H4Zqz5MgkeJlIK5DDHTHGKzrjTp5ULQQuyqeijkY7UU2k9Qrxb1Ri+Y0dyrqcMpBBFe4/De8EfhWxknO0yySGIjvggKf0+leIXsTLIAAcnjGOhr0T4fagwjitJJN7wupt4sfeY9fwzyfbNdbklZnmRg5c0Geu2tkZ7/AFCSJfMii5DAYzk8Z/nVK5hhleCKSDLM/wAoHG5h6Vc0vVhYWr2e5Zbm4YSTOg5Ynk/4fStHTDa31wmoBG+xwOVVv4mI6hR33Nnp2FapKWhwSnOk3KS0W33fqzz7x7o6XseyBwTuwHIGEI4zjuevFcfYWxW7mtZBubzGO9c5fgbj9c8e1e2XulSXEbytGqB2OCTksDzgeuK881HS/LuLc27ZlWYhZG5JOOScdc1x4im079ztwteNRcr1scJqfhxVWOKKHzlGeQPmIPTPuD7+1c14o8HwQXCSaaswgdR+7c73Rsc5IAHJ5AHavZLPRlCYmffJu2Fz94irNxpw+6iKcf3xSpYitS2McThadf4j5WgvgJ0aRkRWGPlHAGeRW3bNGzLvkEak/M4XdwPbv+FcduKZ24I75Fa1nfKzoCxDdW4G0Y9K+jr0eqPlsHjnH3ZmxI6gE/d6EnGBRFMpynJD8Z9D6VDPcBizYCsoDbQMLgnoBUV7H5EccrrsjmG5WyCRyRkgdOlcqhfQ9GWIs7roT/ahb3eGYoAoIZT0OeOnSlt5mLkM4Y5OGzknPPPqaqvI0NxGkyK5xlCOhGefr9KlgQQzYD/LnAB9emMU3FWCNWTlbzL0VyQhtfMZYt3mhe27GM/lxV7Ty1zcrbopd2YIAi7sseBx684rGdnEu59qx9Qyjv0wa0oZCPmjLRyphgycEHPtWFRaHdQqalmS3LjaV2SocFXBByDjHPSqepRzzSvfybpHQojsfl2DgKB7Y4AHQAVoxPcX7qP9bcTOTgEbnIGScepH5/WoNVuYkitJLUSLcxgrMJtro3UKUGP7pwQc8jI9BNJtSszbEKMocyEf5rjZ9qa6SLEUUjZXCjnABPABJpCoyMYOR0qvp7LKG2gDA+ZM8k+1ajzPIYYmEMXlqVDJGAT3+Y/xHnr6VM3ZlUUpRViODIbk7QB07Z+lTByx6854Jp1xFLbiRoTL9nlAVm5CyYwfbPPNVkOWBx05IxWOj1Oi7jobMM7NGsbTMIlYvgc4bHXHrxjNdp4d8QFCjLMxlUgbduOp9Tx/XPSvPEk4Ugc+tWzOjcpHsGANmSe3XPuefxrJXg7o6uaNRcsj2PQvFcY1C4lmMbeWgjLYG4k5yAR06Y/OsfxT4yeee3iWby3dR5cu7KAE8Z9QMD8ORXnUt1JLMZ7hw5kAEkP3QwAwpOPfmq8m0LhSDjgepqnVk1YyWGpqXPbU2NQ1q6v03G7GZWAnt1DAtgkq5OMEZLcZ644pxtNtp5zI53gbCAMEYO7PfsKyNNuJvsU1sSptmbdgKA2f97Gce1bdhPIbFo5C3lAFVVicL06c8dP6VzVro78K7rTqQW77ZBA7n7OXBbAyxUHOB+v1712Fr4nilmilmhW3S1XICtnI6AAfXGfpXFKxaXA4HUNirEEE0zOIYzJtBdgnPyjr7/lUdTplCM17yNfWte1DVo2S7dPLJICov3h23HvgDp05q3rl/HPpVtDbyvcJGElkLEJtyf4e+7AIGBwKwr+CSym8i5wkvJZSDkcDGcj3/Sn2kct86bY0cwKMAIBlQeh7E89+oqlKSvcpRgrKNkkRWN7boblriyiuPOyFLkho+ex7fXGeKksJbXymsrmBWaZxtuBgtGfoe1UzGypvRGCB9uSOnfb9as293LE6MgQmNNiggY6gknjnJHf9KalrqaQTbs9zr7C7SPWbmKzlV28vcVDYChVycep6D6n8tvStd+2xPb3W9LyPLHd0Rg3H8q4bQYCRdzSXK2sIlTlCACwOcYwcAhjitPwytvJ4hvLqRJBYysVWUsd2CfTPTI/pwK6Ivmt5nHiMPDlbl0S/r/gHZ6bdATRvKFRpD0cjDHt16966S/16zQhIowgiUfdzkH1NYWpNDaWbGUpI5HyKP4vSuYvZALczuS0E524BxycYB/Wtua3uniyoQrtTlsd1beI0AV4FErt0JGePUVYnsru/nDyogAO9c8g9xXEeGLoXFz9mgV/IZgqswwTjnj617PoccRdcHJiQD8a6KVPna1PPxk44T3oIxNH0iWWR/OJjKHc4PTPb/Gte+uInhO19204Ld60tSUm2dYtxkfAwvU/Ws2HRnjgZmkYyNycdq0qUWm1HWx5H1hVn7So7dkVbS1m1KUFifs6cAn+99O9cl48i+yhkjbc64G4jPNemRCKwsQc4RFzz1NeP+O9V8+6lIwWHQDOTRWhGnBX3OvLak61duPwow2vDDd2MEWTtcFnAwcZ6H35r1hdRiXTViBypXdg8sB6fia8t8KyNulF7GhaQADcMnHWuytpfKyUxz36kY7VzU6lte562OpRqcqtscz4ohNtazT3hVjguVA5+g/KvNXkw4ZHK+YerDB55z/KvS9cRr65ZZ2OGBBP19PeuSvtKa1lg8oJ8rgMuOx6f1/KuHEtylotD2cDUUI8snqZOm+Zb3IuIhhU++WU4IyOR79sfSuoka3t9PmuGG04zjdyue341EbRAsyeZuRhyx5Jz0HsKpxWDSSpFM5Z8gqu7jHQHb6ZrDVLRGtRxq67HB69G1xObhY9vIIGO1WfCeow6drNrcSIzBQwYFc84wCB6jmuy8Q2f9kv/AKpHJG4egJGOPzrhbuIxmKdEPmbm3Y5BXjH41rTm7cjVrGDir+0jsz1F9UYWt3NDIstw6/JsGCgPUnj/ADxXTeHrt4YobaWRC6ptTcciJT958euOK8dg1Qy2ZhWQBHILr7jt7duK7nSZ2itFIlXzQo81l5A9AT+XFTGvOEryFiMPGVPQ9RmvIZlkdjItpBCUh3HksRgHn6Vg6JDA+rnzANwT5cjOwEcnFc1HqbSOHuGLxIQSMkZHoPSuh0i/zbytsEZmOc9WZuwHoo/WuiFeNV6dDypYWVCDS6lzWdLltJfN2L5Ms5G7PIJHGfw59qrx2hYAPyQO461svLDcXUSTPlUxyWzjjk4/vE1ctZLZnEh8vYieWoY44z1/GtfZpu5yfWJwglJan56sBjnGfegcYPH1qR0ZTyCD6GmdQB6e9fTHxpdgvm3IHAIz8zk9RRdXBLSxyAAgcHOcjtn1qiPlI6g5p8blCcgMp4OaydNXujZVpWs2WlieG6WK6ViyFSFDBsBhkEdR3Face1g438gHAbrjtn1FYsYtwspl8wv8vlhMbc553d+mcY71oNIIrRX+0BpCGXaBhkxjac9CDk/lWdWF9jpw9blNkRERbBt5HY4H5GrdrcJ5yv8AZ02qQTAzEA4xkHvg9+e9UrGY3EAdMPtAzt/h7f4VctmeK2mXYBHIVR3KZIK5IUH9cdeK8+S3TPfpSWkobD5yhnmAhSNXbcIs52Z52jPUAYxmoLhElQEJ8w/DmnSjCowGGHcUm8OoBx0xioXdG71XKxlpiOVxtwrc7s9D71pxsDIMKE9QOcVRVFA3qfmHXBzT4PLBfzDJyCVCY+92/D1pTXMXSk6ehtTXTNF5JaQqOQN3AI46fnVaJMMVZcEgMOaS2JCqh3FWwDjrU8sarOSsgZWTcgblsZIAbHAOBmuW3Lojvd5+8xoBGQDweoPSpowQhkDqhQYHOCc+n60xWKtnoVNPLlid2BnPHrUs0joOtZ/szs3lo5YEfvF3enOPXjrTI8yuGYfKT+dQTSbRyQRnOSQPzq3ANqow+6Opz1+lJq2oLV26I0LFBCpJXnGR+dO89lZupVug7A+v0qZAZFIGOexqlJIfuIMDBGevSuZe83c9F+5FWFklzISqNjO1sVc0i5WDVbZ7geZBu2spJHB9xziqK7ogUZSATkjuOKRgElUMwCkZq7diG31N3X7jOqTARbJFJjIYlicHqSepwR9PeorW8ltbWaKNjHHMByPr1B9azAYy0reZk5HcYBx/hVq3hka0lnUAxwBdxJ5GegFRJdjaGnoS3EiDAjm3owBeNODkE8t64zkHvmmNK6SKYwUYIFbafvEjB575qvAplmGULHoAOTTHcRjlhtOCMcn/APVRboWqjWprQWr3TiGNiU2kbgoDEDBOee2PyFbemTW9vcvYwXCi1WISI0jAEnOee3QZ/KuZt9Se2ilSNtjuMHBwe3I96uaNc2SPbC5dvItyZzEwBXzP4cEc9skfStKbtuOq/aR0PUQh1ewicwtGTGAhkGGIx6dq828TtcW2rG3vN7WxYCI5KDacc59R6j+td7pviSK43OzbVQcY6EZwefX2rD1rT18WvG8BDpEMq7cDB6jjqDW8le2p5dJSptqasvyNLwhCYW8ycl1iCkFT3zzn2r0XR9VaO4M77jbO4AQYJH/1hXn+k6TcWtk1xKQEUHDtJ8xA4wM9f/rVa8L3j39yyxybI1ULCgO1gc9+Oc9O2Ca6oytsebiaUaqbZ7Zbny7ZBknIwCeTVrrVWFdyoD/AOPT/APXVgcdRXr0Hp5HxNXfzKmqKn2Ry4JC8gCvC/GqySX3mKQCOmBgYJ717B4jvWW3ZVwqcjJ6k+1eL+JL9JXIKlQr7A+c5bIx/OvJx04ybaPqeH6Mo+8xuiWU95IEg+e/MyrGrDqPUHPT/APXXTeJr5NB8q2MbqY0UT+YwznucjtVPQL618O2keo3LKWfJRAM7nGQDn0rgvFfieXW725lb+JgWJHBH09sVxqSjT1ep7DjOvXtb3F+Z2S6rFfLFNs/dEkKwOA2O9ZXiYGUMtoxVsqCMc8nuRXJ6beynQZkZ0RIn2ozHAweoFdB/aMgmSztfIaaVQ/zrwOh/M561hV9/Q6YwUHePQbohu1tJTMpUySj524wM4z/n0rprfT4bi+hlKANGCVYH7wHf6VkaTaTXz6h5oV08+KJecjjLH+n5V0kMwSe4LbVljtBtxzj5gAT3xgnJ7mqp09NSa1Vu/Lv/AMMYfjKRLhIlEZe5fPCjhQOAevbn/Jrg7qGRMmWMoORgjFeuJpjXujyXCxCRnXeuTzsHGfbnOBXIeK7O5TRYU8oxhVB3MNp2jqwH5VnWpyT5+5phq8OX2a6OxyWmWtncz+WI3MgwC0TYIJ4zjofpUeoyz6UxhBke1YndkFOh/iHrj9KiV7u0tpLmxZ45FzyOgGOoz1P+NMhlubaKdnnmbzV35dR8zZ+X5vTrx7VCV3rqi5OcZe6dNoV7BqaQW8e1Wj/eEocDHb612ksrJGuxjuHU85A9j2ryHT9SfT71Wh2Qq53SEDcDjqDgZHOfz74rvNN8QxXkQf8AdFBw+0EGL6E/eHvgUQh7KTfRnJWm29TWOqXcO4qzPCxH3jkD2NbVrrCPEI423FeTtP8AX09q8415LmSfdZMywkFmYvkN7fSm6RcxwW5Lyu7E/N3Ge+D6VusQkRUpQnG5g+L/AIWTsslzbQTLKTygGV+ma8/vPBV7br+8WRGzjaY24/Hoa+6Dp3mAeZKc55woBI9M06TR7KWIxyQxuh4+ZRnnrXfDFzgrJnxs4UpO8kfn1d6Ne27EGGQqvOdprMaNg3IIPvxX3hrPw20q+EnltJCGzlYwNv5GvHvH/wAG2hcyaeWuE6AMoVh7Z7100swd7SRg8JGXwM+bSpBx3FWLK7mtGZoG2llZCSoPysMEc+orpvEHhG602Rw0EsZU4KuOlc1LbshbIwBnPtXdTrQqq6ZzTpzpvVFyyuQszPkRF8H92MYP0rZQyNtBYKSufmBA4HWuTKkex61ahvZllDyOzcY5OeKzqUebVHXQxbpq0jp0YlOc49B29xUgHQjDY4rFt9RVmVWbDEgEtk4Hr6n8K0opAZXRWDhGxvU8MO3B6fjXJOm47nr0cZCpoi2qAgA5HcD0p23cQT98kdKgUlWAJIPpnOBUyNge5GetYtM7YVIyNCOVnQBiMxghfx559ajjc+YST2qtFIUcc9Rx7U6Bi7MfTisuS1zp9reyNJpGcLvOQq7V9gO360Nyo5HtxVdGw2D09qnBXOC2Qf0rJqx0xlcm0m6vNL1C31HTpmgu7WQPFOFDbGIOOGBHrwRSwTIItoUFQMEZORTba5mghlSELmcbASASo749Djj6E+tQyRgKgaNkZUwSO5z+npx6UP3tGNPkd4mmhzjaWyuNx9OfSldCZGK5GB8wB5NZqTSRFvnIUjBJoe5UyY5b0IPT14xzWXs3fQ3+sK2pouf3ZckqV7jnms24lJkODgEYzU7zF4MgE45471CFRgHIJzn8vWqgrbk1ZudlEdBb4m2yZ2spbK87vQdf8/pWrbuGAjLHao+Rc/ngVluMfMiEc8exrQj065u1R4oyRgkN0B46A1NRp7sujL2d+VFiaXygqgg8c/SslpJbycJHuHO1Bux+Gegz+tWbieCRdwSQAIqsXfPzY5xgDAJ6A/mam8PRbDOk0iKJY9ynyxIWU9SM8fXNEIqGrKr1nK3YzGHyvkEr1HbBrUtGtFjLzzSKCcbFGSwx1z7GsWXh3MRwA20ZPB/CpBPmRBKo+UYJHrWjjdEUsQqcro7672anJa2enyIgeLcSWwJCOoAA6/yrW0e8XRrFVKsbpj5bLncxPXbxx078CuE0y8a1YvDIUK/MrKcFcd1Pbr+tdPd3Fslq89vdkXaxhQ0o5dM8jHTPX3rFy1v1O+UfaJR6HXw3MN9AgnLRvt4UEcj+79fetXw1bTRX8H2W33RjDtLKMKcckD3AOcDPHNeY6VfzG+LSzNHmMorEbtm4jG3+XavQ4J0gWzig1BpURSZGOSrNgA8N3xjn2rtwj5tWeRmNCdKPKup7HZXkM0ayx3scikneODtPoPb3ov8AVIIi0Ic+f/dAPpnJ9K84i1SLT7SIKkcZiUSBmLBiM9PfkdauS6qrWUk018GnZ97QxoWVRjg7icng8eld0qrUeWJ8usuXNzSH67evJbO4DSKAcADBI9h615driw3FibiZituxwN6EEN1/Dnj/APXXUyeJovKfIIRDyeTjvWF4i1e11iz+zWcAcqRJheuP89c9q8uu1Z3Z9Jg4yotJLQ5FddntbFrHInt1zsDD/Vnnp+dYVmfNmXz5Ci5+Z2yce5q28AklYLxknr2pxt1AEWA3TBTnP0rj51ax63s2ncgvNHvDAsyJI0bOcIgJIx3q1oNxfBXURqyxLtMkpAEX+93x14rp9JupZEhivUjhhROHAw2Oxx0rzzX9TkmuryO3ldbSWUuYwcA44yfWt6LU3Y4683BNnSQ+LPskxtrKbcgd5GuWXG5yMD5fQDIH506HWrzUrgQNO3+luis2cEovQfTv9a8+RmLHHU12vg+eLTZftE7AYHLNzv8Abnoo6+5xV1oJasnC127qx76L8W0MPkK7qYkiESn7xA+Vc+gHJ+lcr41ln1htsJWRkhEaxISQSGwFHsTn8Oa52PWZGCzMUjsmLYmDFC2ehx0weh6iuk8JRXX2N7p5I2mmZiZBjEEeen+9jr+FL2iqrlOdUVh5e06nn2v6TcaXDcPPsVDIIsLkqyMSCwJz3Bx34rnNUvnaOJQAMOR5bg49ia9M8S61pfiDU/7PtZrOKG0kSQxu+zzGUYSNc8EnkcnuT9fNNSs727u5/s8BXEjPAi4O4bsH6gZxwO+TUqlFNNbHYq8qkHdWZkwSPudWGTnOVOHxnt/npV1nnteSJVnHSRRjI9MdCKq20FzDIzzKYwuVJdS3I6+/pVi6eUwTTMu6MbU3j5dpPQYJz6VcleVkZxXuXkbFvrzSW4t5F8mMIAGBHoM9xzz0FSnXLRHKx7ygAwQODx1x1rno4z9jj3whyWxkEjcAM7fyqpNDMjO0KFF3YKtnKnripVGEmYTi469D7IiW/ic/ZpY5oBjIm+VvoCOD+NWU1NEYpcxyWzD/AJ6r8v4MOCPyq6EHolNdEJwwyD61Tab1Pkr33FhlWRA8brIp5DBsj86bqK+ZZyhIy77SVAGSfp71STS7aHBsle05yTAdoP1HT9KnD3EcYHyzlTg87Tj+WaXLbVCsr3RxM/gmTWYJX1qMLv4SEuH2LjuQOvt2rybx18IbmEtLYQmRe4ByB9a+lDcAFVkDpuH8Qx+vSldQ4AOCD2xkVSqyi7mjm38SPg/UPCbwSskweFx2dTisbUNAurRQ2VkQj7yc/pX3F4m8D6br8TeZGkMx6ui4J+teYar8FLrczWF1HKBwFbg11Qxs1uzN0KU1pofLT28ifeGKWJ54c+VK6qwwRk8ivoa8+Duv5xLbJIuPlIYEisG5+E2oRuRPYSp6MozXQsfFr3kZ/VJLWDPIIL+dPvgOMY6c1pQ6nbsqb98TD1X+tehp8KLqVniWQK6ruIkUjmsjV/hjrWnx7zarLEWAEkbAjPp7UOtRn5G9P6xS2dzmoL+1OC0yHn7rccD3q5ZSxvLs8+FQx+V2cBc+hPaqGqeFtR05nF1aSw465Xp+NYsto8TY98AiqVKnP4ZG8cdVp/FE7Z43SJJCMxOSFcdCfTPrSBuoJ4rk9L1a90p2EDhonx5kEo3RuPcf4V0MGsaTeodwm0+fP3X/AHkR/Ecj9a56mHnDpdeX+R30Mxp1N9GXUcg7tzAj0/nVqeRnKrGC21OjMWI7k5qlsdI1kjZJYjnDxsGHv06fjUJlKS45GR+lYcl3c7/arcnL/NncMAcA0sYItmmV4sF/L2bxvzjO7b12+/TPFQZLDhl47dsVWYgSgg456AYq1EiU2tS/G7MyoAS2fzp5uCq7VB29MntVeHbJcRh5BFGzAM7AkLz1PtTrlTHI6BlkXJxIvQj1FJxVy1NpFjd5ZUh+cAA4rag1R5RBbErCFwFZiTjqTkDqCe1cwr59Bkk81OLgiRFCgHnnPJFZzpcxpCvYvTsu91DEjdnBPSoYHVIZAzMDuIVdxGM9eKrFt+XY53Dj2FSNGcZ42evrTUbKw3Nyd0iWCEPC5A56cmkmlZWCnaSVB6g8Y4/Gmo7x8Lyp547VW1afKoIkCscDrndzzRGPNKwpTUIXXQ2YJYxCqo+cjcwK9D6e4+ta9nNFcedLOkpA+ZhAMAHpj2Brk7OVggRl5xnNa+n3Dw3CrGQpDAjdjAP48enWspws9T0MJildX2Ov0gwR6YPskhhvZZRlj8wiAyQpHpjvmvT4LnSoNMs7m41G0i1CS3WH7PbWxCswyA7HPf8AiP8AhXh1wLiaIwwI7vITuUDnjr9OM9etbenX8mlQxwapLG4CB4xnIxj0H8Q6f41VKpbUyzKKryvFnb3jRo1x9tuGuGmAcfZpMgH0wRk1k2moWkUIjMq7jnavds9B15rlNY8RRS28qohjLLtUhwcevfI6muZe+UBHiMqXCDapDdFwQfrzWsqjb93Y4Y02tZOx22pXMMkZjMkXAO9ixCdcEMex44FN8MsbSApEFkEgLDc247VHGSPT+tcDC7KmF3BOM9wf8/1rbsbye1tisbsqY5UHAP1rnrJtHbQtqakgYzygHeVy2U5GO5+lO8qW08i6keJQMSIquNxH9DVXw7eTi8mnjtvOGACCenuM4BPtWn4nSWBImlEYhfPlgHJK8Hkdq5nSkjt9tz6FzT7p9UN1K6oECnZGh3EHHT1IxXA67biDUbm3GAsbkDBz+teleHYG0XTLy7NxsMsZEisgIXjIx74615dqEgkuHZHLhiTuPUg11Uaahr3PPxMk7pbIitQN5JUccYrXtysl1CDtSMfNljwT7+1ZccMqW/nDacY+UnnB4FW7G5DAAYDZ4PaqqK+qIoPl916Ho9rL/wASmNhEkf7tkVcfLnk5rJ0/xvJbWFjZXYea0gMpkgVQvmHACHf145J49KypdXZbBLX5mHBy3Zv/ANVYOoS4uy8SrhjuxjgZ5Fc9CDUmbVVFR17nX+H77TlsNUvb6K4TU5LpXiW2PJO7KonoPX8D2rotK1y3sxJf6lbi7kv2DROBtEUa/IEHHy5JHzHHPNeRPI8lwplZvnfex75PcCuphe71BXu7iYB40WCEqQuWJAGRznAbrx9a6W3Ts0ZUo+0umaGu2c1rPqqzWU0TrIGeH5pCjFchDIAQWyRkcVRl0GWK1uJboRFrYKsm2Ug72PK568Z+nFdt4Q8NpbQ3N2sUU39n7hGMsBcyY++/PbkDA/nVXW0S+0n7JBDJJbxyefNP3JJGdueT68HngVnOP2l1Nfa3lyPX+v6+8yNT8O26PGoLpKDlRGzYxgc/z5x2rOudER0T+zRlwSJGaQ7RzwOvX6V3fiTTzazC4uNskgh/fRoxOzjID+px2FHhSxjbRLYPGY5CC20fwgnpWPsqkZcqYnUi48257kLraASgOBxknr+FR+c7SYC8ckEUpQA8nkj1phZUwF5bI6dc1vdHxiROhbg7lzinhueT9SKgVu4HT09afHnuwJ65AxigVifAI2np6dqiNt3iZoyT1U9vpTlZQCee3FSA5YYIwOvFInVEDyTwAGRGmUdTH1/LvU0FxHKcI434zsJwQPpTxgA5P4VDJDFIR5saMRyDjkfjU2TDR7loElT03ds+tZtlFdyOzX8aqOcfPuJ/DoPwqyFK5KSspx9akDHHPPoRT2QK8b2ILvTbW6CtJEm5ejAc1n3ejwyQiIIvynIB55rZSTP16H2pGA6c465FTdocakonHf8ACPNdCRJ40k3DGJBuBrifGnwct9XR30+OC0uVGQoGEc/WvaVQLkkU8AHBqlNrUqWIv0PhXxR4H1HQ7lob62eNuxK8H6HvXIzWDp25/Kv0I1nSLHWLVrfUreOeJh91hyPoe1eOeLPglbzs8miz7Scnypen5+lddLGyjpIXLCptoz5btDNBcgxMVJPQV01nMt63luVgvCcBGwqSfRux9jxXQeJPh5qmhzE3lpKqKc+Yoyp/GmeJfBOo6UkT39o0UUyCWIsPldWGQQf6VpUrQqanZhXOkrX+Rh3drcWM7wXcMkMw6xyKVJ/+t9KgkjJOc/LjOPSrFteXdh+6uFN1aEANDMd2B6of4T6EdP0rRuIIJdNgfTzFcR7d8joMTR5ONsi+3ryPftUOTjuehCop6MxUfbggkEdMUxiwYMSueoqaRGRijKQTzg8HmqtxCzRk+nOT2q42Y5tpaEiszku2NhI+WpJ53K75Pn2rgBuwqrIWhSNWUEugYbSDgHp06fTqKrXDBofmd8AYXB7irULszdWy0NKK5EmGJGD6Cteykglidbk7TjEbDohz1YdxjPSubtyYrZN6ndjkgVowPgbsjJHQ1lUprodNCs+pp3cTQySRoySqhxvQ5Dj1B9KqzRA4Oc8dfSrFvLujKt29uTQ6L/D0NYJtaM7HFSV0NtkEalQM5HBqUyS2kyzIWEqEEMByCKbECoIYfnUrsswO/GSeAKlvXUuK92yH/wBpO0sksEk0SyrsbbITnp1P1qC4mJTy8gqrZABzj1/pUMgVDwODyQDUBZR9OwqlBbozdRpWY5pCOvzYHAznFQq5kJIB4GeKfn5uOnfNSQuqK3TceRWmxjfmerH2TkSbVyWxxjnNbel/YblhbzMy3EmQrk4RTxjHqTz1/WnxeNJLazWG20nSoHwQ88ERR5B/tHP+HetHRLnwY+g39zrBum8QPMJIUQlYUUYyMD15Pc9Md6fsFN7h9ZdONrfcbrwpodjGY4G3PyqqCWkzxwO9JeaQ89vNcXEhjdAQImUMQT0x+NcPe+K7+a9DQzMYEyFWQZyO2T1rXh8VWzxAytMr7fmVB+Y689OlaOnTasKFaqtUbVt5kXgpnkVoZGVysTdWXnk/XNedhAxUkEjpmtbVfEk2pxbJFVIgfuKevpz6dOKxkl5Hr1rKStouhrzN6z6mlbxmaZURWyWCrjufSo3sRPIzWx2OMt04q9p8tqsY+adJ1Kl5VGVTPbHrxx9T6VcZEt5ysasgJ4L8MQexHtXG6ji9DthSVRanMi5kDGKUcg9+v4Uqy9VJyhOc9xXRPa296/lSRqGbneeMcdc1h6hZNps4laMzW4zuGcHHrmtYVIzdtmY1aM6Wrd0JbqY5Q0WQMEZB9ev44rShuDmFAFVVIJKHGQMYJ9/8ayrWbeQM7s+nANakcQWBgFBYjqe9Kr5l0HfWOxo6rrtzeSkW9zc2tkg27Ufk4GM8cZrV8D67JY2sK6k8UlshQQBo9zArjjjqOwz0rmXtt6KgK7i3I749a3bZLawsZJkjVZtoKGXnhuy4P0qI1eTYqdJPdHYeNPE/2jSba2hgjiMjEyRgfPIzNyWNdjoGiRQ+HrW4nPkM+ANxOMY7flXnHhjQJbm+jv8AVXzJnO1lzs9gM12Wqa7cXvl25wYYRhQDx6ZreM+ZuUvkcdWk7KnSdurPTTctIh2pkjp/9aq6PKwzJwfQHOabHhgMsoUHr1NWUC5GF5AyKNEfLkiu4++eAemKkSQjdkYz3z+lIBkA7QPpzT2XkBj0zWbYh6sWGc889qecjoe3b+tV3YIx5OMYx7VLHLC3DOoyMZNArEjSOVxkY9QKZtIBLH3B9ajeZFOAMj27ikEvzbmJ69BRqFibzFQ5Y4B96kV9wBOOfSq4YsMYBHX3FPRiOMcHOTQJos/eHI4NICc8Hr2PNMjkGATwPenq4JGOCe1SyWrCrIRwy49+op8cgbp0BxTWIGcnHHNRsYgScAd8jvU8vYVkyK+N00yJbRhk/jLS7APoACSR1qcAFueR6mowxbIRvwIpIycktwD170nfsVbSwtzDHcxNHMiOjcMrDINc3d+JPDunQjw9r6syQJtKywb49g+5z64wPXiumDgnGQT71naj4f0zU5vOvrOGWXaF3MOcDpWlKtKk7xGuV6TPKPEXh34Zasss9p4g/s04yUZWKj6Kwz+RrxvW9Fs9OvnbTNespTExMcySMhx6jI4r6ybwf4ePLaRaMfXbXJeM/hLousWzSafCthdjkGP7j+2O1ae25ntb0/qx0UqyjpzN+p83zapeG2ihuZbK5hjBCElS3XpkdRVd1sbgHy3NtKTnB+ZD9O/XvzVvxh4D1XQp3F3asEHRwpKsPY1w9zZyRNkgg9u1dNKlCXwux0SxU4bxOhlsZgpdE3rnBeL5gD6H/wCvWew+YZUlVHasuDVL20bIkZgOx4P51sQ67a3wAuztl6ZkAH/jw/rWzpVIdLryKhiaVXS9n5hboNijjefvYNaMEMLwShmzIBlXz3zyCP6+1NgtYZHVvMXywfvLyCO/Ipr2qm4P2GSR+vyyDBPPH6VhKSk9ztiuXdEu14iyuCrDqKd53SqLzTRSNFNGyuvUHrT/ADAw/WlydzSNVdDSjcvnA/ClIbrzj9Kz4JyGx3q2Jiw5Ocms5RaN41FJDXY5yT81VZmwccc1ZYHPA/Cq06njANXAyqXsV/MbcAAfrTwr9UyPwqe3gZ2xtJrZtbFzFJL5MhiRghZFJXdjO0t0Bx27051FEVHDyqHNyuwyCDupiTYzuP0OatamAZSVBUdADzj61kSM3K87vStoJSRyVW6crGghDYIIJ6Cl83G3tjvWYsxGSMjtUsdwSpJY7RVOmZxrrY0hIT1q9pkMl3cRwQFQ7Z+ZzhUHdiewA5NYgnBX5up9DW/pcj29vLEFCXDsD5ij51A42A+/U4rGcVFanVRnzy0PQ5f7Ctp9Gtntb46Tar+7RFRJLyYgFpDkgnJxgkYwMDpzFBe2tvZXbapazT3ty7BJZLfy0Gei5IBA6dPc1y76vdandLc6tcmVkZDvKLkbcAdPQdq7HRdHfxEov9VWdbGXlC8pMghRt2Wyedx/zxXJOPtG0z1Yy5YLU5VCzEgyKVLZVg3DAd19elWZ2UwNHKylCNrKwxtPp/KtTUdIRv7Q1GSVFwzMm4BCwAGAo45GRXNmSRYEmYMqyNlefTp+GRXO4anYp2jqZep6ZJpwWa2dZIGwwVWyVFRWl8GUdOa6eBgfKaQlsHJC8bh+FZ+s6KjyPNYFI36spyB0zz/KtoV1L3an3nFUw0qfv0du3+QWdyit8mF5PuK25bqzlt4o2YOyHIkdemOQff6d64KK6KsY5cxyL1U9qeLg5HJ496uWFu7mSxkWrM9Gj8TNDBsmlY55JQYK+o681iTa3c+a7JcFgT+H5c1za3IZc5OfX0zUbzMq/Kw2569OamOGs9SliIR2PsgOCQCQpA7cZqwsoUL8xCdcnrWfGCxwRngkkdvrUqqCF3Yz/OtWj5OxpQSCQnDoij+JztB+lQz3RZiEAbjGRVbYoG7GPxpmVUgHn6d6my6BYmVyTuZufc5FP2gpnIAPvUAZduGKgHknvipVKglcYBxgegpsLFhV2DlSSBUgUFhzzzyOlRRONpP1A461IhOMnls4AzUNiJPm27Rx7560biuBngdc96kXa2VAAPcHqPamO0aHcSM+oqbiJDtZuT2704bl5BP4VTe4AUA+o2/Wka/2H5snjn5elNpj5W9iwzHBDE89CaYGCkEMc981Re9Z2GU4JwBTTdkSYVQFPGM/nSsWoMtNcYdhgYHOTUkU5JxnLY4wapS7SVXLgn5gD3+nr/jTQ0omC5DBhtGBgYpWK5E0bAcc9fTilBcBcAy+pB5X3rPhuAdqE8ZOPetGH5vmHUcUmjKceUesqnvg+lLI7Jbysil2CkgAZyfSmsFO3dg+hpqZQkK3B7Mf1o5TOyMuCzk1OCRdXtyyEDassaDr6Y/LmuD8XfBzRtX3yWrGyuCOiqCn5f4V6j53TcQD0pysGXKkEdPTmnzNPQ09pJM+N/GHwn13SGl/0U3MSEHzIPmyD0rza/0ua1kKvGykcHIx/PpX6IOiN1ChT1wa5DxR4C0PXebyyDSf89I/lauuljJR3E1Cp0sz4SglubJw1vK8RHZeh9iO9asHiQ523tspI43x8fpXvnir4Af6PJNo12WkIz5Mi/kMivC/Ffg/UfD14YNRt3if3GAfp613RrUa+ktxw9vQ1pSujTtr+0voxsYTKnVCdsgHpSS24jlZYpBL0OBnj2riXt5YW3fOrA8HoRWxp+uDaItRDHaMJOgyR7MO/wBetTPCuOtN3R10sfGb5ays+/T/AIBtICSRnmr0IwACR171SikW4QywSrKOpKnP+TT1mKjk1yyTeh6dOSWptwwbtuNo3HAJ7V0ej+FLC8mWO+1Exzkr+7jTJ64PX2rj7W92Yz82OcVc/tDzFzIQSTn3P+fWuZqcWejCdKcddz1ST4VzyazO16iaHosEQbCYeUoB95gCfnYg96wtVtLfULKCHQrMxW1uzYaWTaF9TjqxPBLHnt0rAt/FGqpBJBBqMqxyDD8/e9BWzoWo6fHNHFZ211d3s7YZZGCnB6sz9Aue2Onc0TfO7LQqkpR1cr+mi/P9TH1LwWI7BbiS98udl3+W6dfQAdRnpzXF6jo1xaAiaFgMZ+Xkf/Wr2bWvD+qS6lJdXdu81yqhjCi/KinhTjrj09fYVma7ZXFoggkR1Rhh2k4yck8/nUKvVpO/Ql4SjXjo9WeJTQ7c5YjnvTNoHGR+B716dfeH7e4t/NMJjJ4wejZ6cVw2q+FLuz8y4sEeREOZI15wPWvQoYynV0bszxcXl1Wh70VzIz0bZKpK/KDn8a01vNxLr8vrxtHpWYGDwjbyeg+vpTGL20qo4AfOGJ5GK2lBSOeFV09tjdjlMpKZJCjnHIA9a7mx8Sb3gikEqQJGqtIr5+70AXOAOg9uTzXm9hMcOEZnJ6lehHrWnBdHcUU4xwfb2rjrUb6Hp4aumrs76C6OpzXEt9F50KwOxVcnyFGWG0nuSBkj1pvisQJZxpseO4ZUc73wIVI4jC/TvXIrqLlZokVVWXaGbkHA/h+h7j2FdJ4OtEv9Ue81BHnggA2xt8+9ipxn2GM/lXN7Nrc9FVYy22Oj0Xw3J9hiedSJFIYNg5HHTn2yfyp89l5V7ciePdGYiVYdjxjj25/OvVI7Pz4Ft0dUdj5srs3QY7+hrzvxxd+XAVjUFicZA+8P6VNWgoq5FHFyqy5UeP8AiWxNwplhJSZc7XHf2PrXGpqEyPtYnjgjPNen65PAbOCBUIlVQSW44I4rzDWYvLvHdTgNyfQH/Ir0sBLnjySR4Odw5Je2p6Pr/mXbXUCwALHg/hV9bgNGCT9MmuUDEY55xVqC6aM+vFd0sOnseLSx04/Efd6yFeGJBI7VYjmG0EKu4njJ4+tYpnYvtB4I71LGNxBYHr+deS4o7DWvXijCCC4WZ8ndtXgfj3qCNmZSHHPpVWMBSNpO0DHWpUPqBtBz9RU2XQET7dwU4wwOeasBj83Oc1TUr/vADvUiSDJycdyMdKTHYtGUBeg6cAjGacudnAwTyPeoFkwoPY1ZEqxkO2RuwPWoYh0M0qKwV/LV+WAHX8aqly7bSDtHTnFWi6eTvB+UHGcc1mm4Q5znPoPShXY0kSSvsOBnnrjvTV3cMOExnrTGcA4bBHTOKjVgXGBhgev/ANaizNokoLZO5gPbPX0xS7AcMCFz19qhZwcnk4fkn1p7SBfkhJU8biRkAc9vwpWHew9w5xljkcDPYZoSRw+CVxyCPT/GpUDNAAWPoeBTxCNpbOMY/Dip6j5lbUVHEsJVJCm4g898dKtJM0YTOcEfN2yaqKAhyoy3qODU8UykFn3Fv4VxkH8aqzMpWZbDDHO4HrjtijO7knnpx61X+0MTjoemPSkdwN3cDp75p8rMrFhXIJJOfT3NKZRknrIe+cVREu5whBH65qRX+YMRvPf6UNXHYvCY+it/n9aPtKkEEkMONrcfr3qqr5Yc9OfrUkn3AR0x39KlxQrIsLJk8g/Q1x3xM0H+39K8mKDfddQ6xhm/M8YroZZghYoxBHPHQ4prSvuwNhXBPOePamotDj7rujxa++BNreWKut0Yr0r8wK5XNeOeMvhbrnh+V3ktTJbjnzYhkfiOor7LW5JZhtBB6HOeaiMkMw2yqmTwVYEg1vTxFSmVJRn8aufnyyz2c2Y2eJx3U4q7Z69MjhboCSLuQMMPf3r6M+JXwlXxJqwudAa2t9zbZI2BUZ9RxXg3jnwVf+FL0Q3vlOrZw6NkH8K9OnWp10lNanO41aD5qT0/roW4Zo8LJG++N/usDVi2k3pIVdQV9c5bnHH0rirO+ezXCKeWO/nhlx0x2PXmtm3uhDLEUcmOQblzms6mGcTuoY9StfTudUIv3g8h9/GQxGD+Iycc/wBK6zwfc/Y5rqCaKDypELFpm2/OCNpB7kdlPf1NcZDdYlYWz4GflZl5wPXrVxHeRlllcsW5B9+f19686pFnuUZxa0PoDR7y9MpndLyO1mhUTXMilpW9GVWG5R7nOOKxfFcdlqmmm7jWe1tIFyZZfvOc5+bPbivPdM8VahZW8qW91dTmSM70lkOxQOeOct07n8K7LRvErahYQ3mqRC7eSQxpC7EI8mOF4HCdCRx2FZSldcrWgRi4T50c9LGsFtC73DPM2JSg5RUI+VR39P6Vs6cy/aFW4iXE4wrR5KMwXkexp0+l/YrwjV5UjkkdLl5UXciKOFRQBnJJPOMAVav2t457OG3BLtIrjaMbcc5PrXn1qdtzvdVVI27nlXxJ8N/2Dc/2npkZ+wzcyR55RvUVwl1eRMhKPgMvHHU+9fS+swQXumy29ygZZVKOCP1r5m8VaQ+jatLBnKbjtIPpXvZfVVR+ynuvy/4B8xmdKVFe0hs9/wDP5kUGotBIwQkKQAWzityzlxbBkQ5x1OfmPrj+tcehO4Gul0q9RgpAOBxz2ruxFKyukcGCxD57SZ0GnSMAowfm44HXPrXofg27gsZ9sJ33BjzK235QxPAH0Ax75rze0mJKsMjGcetX4b941xGxQEYODgkV5NWMr3ifS0KkeWzZ7tf+Lo7PR5LdCjSTcMRwfcDJ5J6fSvOvEXiEzRxkfvJGGPnH3QOMVycmou0S/M21cjBOcZ9Kz7m8+Uk5A/nUeznUfvF89Kim1uSX12TkZxyeBXKbxdXcoblWXbzVjUr/AOUgHLNVGwBWWMHnIyea9ShS9nFs+ax+M9vUUVsVWDRsyMCCDg80oJ3Hrn6VPfqPtDNjOevvVUngDOBXfF3VzxZq0mj/2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Bullous lesions and hemorrhagic necrosis of the hand and forearm were caused by Vibrio Vulnificus in this immunocompromised patient.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Rolando E Saenz, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_54_10084=[""].join("\n");
var outline_f9_54_10084=null;
var title_f9_54_10085="Short axis LV mass";
var content_f9_54_10085=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F61196&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F61196&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Short axis views for estimating left ventricular mass",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 375px; height: 350px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    These short axis echocardiographic images&nbsp;have been hand digitized to demonstrate the method for outlining the epicardium (left) and the endocardium (right). These measurements are performed in both diastole and systole; since mass changes only 10 to 20 percent during the cardiac cycle (presumably due to myocardial blood volume) obtaining both systolic and diastolic mass estimates&nbsp;can serve as an internal check on accuracy.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_54_10085=[""].join("\n");
var outline_f9_54_10085=null;
var title_f9_54_10086="Budesonide and formoterol: Patient drug information";
var content_f9_54_10086=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Budesonide and formoterol: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/21/8536?source=see_link\">",
"     see \"Budesonide and formoterol: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?42/39/43638?source=see_link\">",
"     see \"Budesonide and formoterol: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F3071871\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Symbicort&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F142769\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Symbicort&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10026099\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700842",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       When changing from an oral steroid to a breathed in one, there may be very bad and sometimes deadly side effects. Signs like weakness, feeling tired, dizziness, upset stomach, throwing up, not thinking clearly, or low blood sugar may happen. Call your doctor right away if you have any of these signs. If you have a bad injury, have surgery, or any type of infection, you may need extra doses of oral steroids. These extra steroids will help your body deal with these stresses. Carry a warning card saying that there may be times when you may need extra steroids.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700378",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In patients with asthma, long-acting puffers (inhalers) raised asthma-related deaths. Talk with the doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700454",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug comes with an extra patient fact sheet called a Medication Guide. Read it with care. Read it again each time this drug is refilled.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10026101\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691417",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to open the airways in lung diseases where spasm may cause breathing problems.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691790",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat COPD (chronic obstructive pulmonary disease).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691736",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat asthma. It may take 2 weeks to see the full effect.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10026100\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to budesonide, formoterol, or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701052",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are having a breathing attack.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701034",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to milk, talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10026105\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697613",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with your doctor before getting any vaccines. Use with this drug may either raise the chance of an infection or make the vaccine not work as well.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697780",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wear disease medical alert ID (identification).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696945",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not use this drug to treat an asthma attack.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697197",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood sugar (diabetes), talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697133",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have a fast heartbeat, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697225",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have glaucoma, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697258",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have heart disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697265",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood pressure, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697038",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are being treated for any infection, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697166",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an overactive thyroid, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697340",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have seizures, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697564",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Limit your use of caffeine (for example, tea, coffee, cola) and chocolate. Use with this drug may cause nervousness, shakiness, and a fast heartbeat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696668",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid grapefruit and grapefruit juice.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10026106\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698243",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Mouth irritation or sores. Using a soft toothbrush or cotton swabs and rinsing the mouth may help. Do not use mouth rinses that have alcohol in them.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698371",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Throat irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698340",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sinus irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698257",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Nose stuffiness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698390",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Weak bones with long-term use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697932",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Cataracts or glaucoma with long-term use.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10026108\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699077",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of infection. These include a fever of 100.5&deg;F (38&deg;C) or higher, chills, very bad sore throat, ear or sinus pain, cough, more sputum or change in color of sputum, pain with passing urine, mouth sores, wound that will not heal, or anal itching or pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698659",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired, weak, or touchy; trembling; having a fast heartbeat, confusion, sweating, or dizziness if you missed a dose or recently stopped this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699102",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are not able to get the breathing attack under control.",
"       <b>",
"        Get help right away.",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698996",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Peak flow measurement low.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698964",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Call your doctor right away if your normal dose does not work as well or if you need to use your inhaler more often.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698623",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Chest pain or pressure or a fast heartbeat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699112",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very nervous and excitable.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698691",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have been exposed to chickenpox or measles and have not had chickenpox or measles or had a chickenpox or measles vaccine.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10026103\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695186",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are using more than 1 type of puffer (inhaler), ask your doctor which puffer to use first.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695532",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Prepare puffer (inhaler) before first use or when puffer has not been used for more than 7 days. Spray 2 test sprays into the air.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694896",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       For breathing in only.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Shake well before use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695599",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Rinse out mouth after each use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694582",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your puffer (inhaler) use checked with your doctor at each visit. Read and follow facts on how to use the puffer. Make sure you use the puffer the right way.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10026104\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696583",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696485",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not use 2 doses or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10026109\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699344",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature. Throw away any part not used 3 months after taking out of foil package.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699262",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Protect from heat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10026110\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11589 Version 36.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-122.72.76.133-1401E7A8BA-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_54_10086=[""].join("\n");
var outline_f9_54_10086=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3071871\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F142769\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026099\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026101\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026100\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026105\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026106\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026108\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026103\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026104\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026109\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026110\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?8/21/8536?source=related_link\">",
"      Budesonide and formoterol: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?42/39/43638?source=related_link\">",
"      Budesonide and formoterol: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f9_54_10087="Stroke-related pulmonary complications and abnormal respiratory patterns";
var content_f9_54_10087=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Stroke-related pulmonary complications and abnormal respiratory patterns",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/54/10087/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/54/10087/contributors\">",
"     Julio A Chalela, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/54/10087/contributors\">",
"     Teresa L Jacobs, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/54/10087/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/54/10087/contributors\">",
"     Jose Biller, MD, FACP, FAAN, FAHA",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/54/10087/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/54/10087/contributors\">",
"     John F Dashe, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?9/54/10087/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 20, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Medical complications of acute ischemic stroke are common and often lead to poor clinical outcomes. The frequency of these complications must be recognized so that preventive strategies and appropriate treatment are employed.",
"   </p>",
"   <p>",
"    The major pulmonary complications of acute stroke will be reviewed here. Other medical complications of acute stroke are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/12/17610?source=see_link\">",
"     \"Medical complications of stroke\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/20/26952?source=see_link\">",
"     \"Cardiac complications of stroke\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PNEUMONIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pneumonia is one of the most common respiratory complications of acute stroke, occurring in about 5 to 9 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10087/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]. The incidence of stroke-related pneumonia appears to be much higher in patients with acute ischemic stroke admitted to a neurologic intensive care unit and in those who require nasogastric tube feeding (21 and 44 percent, respectively) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10087/abstract/4,5\">",
"     4,5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Pneumonia is the most common cause of fever within the first 48 hours of acute stroke, and it is the most common medical complication two to four weeks after a supratentorial ischemic infarction [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10087/abstract/1,6,7\">",
"     1,6,7",
"    </a>",
"    ]. In addition, retrospective data suggest that pneumonia and respiratory illness are the most frequent diagnoses leading to hospital readmission in stroke survivors throughout the first five years after ischemic stroke [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10087/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a prospective study of 412 patients with acute stroke, independent risk factors for in-hospital pneumonia were age &gt;65 years, dysarthria or no speech due to aphasia, severe poststroke disability, cognitive impairment, and an abnormal water swallow test [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10087/abstract/9\">",
"     9",
"    </a>",
"    ]. In an earlier prospective study of 124 patients with acute stroke treated in the intensive care unit, risk factors were mechanical ventilation, abnormal chest radiograph on admission, and dysphagia [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10087/abstract/4\">",
"     4",
"    </a>",
"    ]. In patients requiring nasogastric feeding, independent risk factors for pneumonia were facial palsy and deceased level of consciousness [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10087/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Aspiration is the cause of about 60 percent of post-stroke pneumonia [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10087/abstract/1\">",
"     1",
"    </a>",
"    ]. Aspiration pneumonia refers to the pulmonary consequences resulting from the abnormal entry of fluid, particulate exogenous substances, or endogenous secretions into the lower airways. Most pneumonia arises following the \"aspiration\" of microorganisms from the oral cavity or nasopharynx.",
"   </p>",
"   <p>",
"    Aspiration pneumonia following stroke is usually due to stroke-related dysphagia (ie, impairment of motor and sensory mechanisms involved in deglutition) or to a decreased level of consciousness that results in compromise of the cough reflex and glottic closure. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/12/17610?source=see_link&amp;anchor=H11#H11\">",
"     \"Medical complications of stroke\", section on 'Dysphagia and aspiration'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The dependent pulmonary segments are usually affected in aspiration pneumonia. The most common sites of involvement are the posterior segments of the upper lobes or apical segments of the lower lobes if aspiration occurs while recumbent, and the lower lobes if the patient aspirates while upright or semi-upright. Causative organisms and treatment of aspiration pneumonia are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/18/31017?source=see_link\">",
"     \"Aspiration pneumonia in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with stroke-related pneumonia have a higher mortality and a poorer long-term outcome when compared to patients without pneumonia [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10087/abstract/2,3\">",
"     2,3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Prevention",
"    </span>",
"    &nbsp;&mdash;&nbsp;Measures to prevent aspiration pneumonia in patients with dysphagia include initial nulla per os (NPO) status and subsequent dietary modifications for those who have persistent dysphagia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/38/17000?source=see_link\">",
"     \"Diagnosis and treatment of oropharyngeal dysphagia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Thus, screening on admission for swallowing difficulty is probably the most important measure to prevent pneumonia in patients with acute stroke. Use of a formal screening protocol for dysphagia for all patients admitted with stroke has been associated with a significantly decreased risk of aspiration pneumonia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/12/17610?source=see_link&amp;anchor=H11#H11\">",
"     \"Medical complications of stroke\", section on 'Dysphagia and aspiration'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A number of other interventions (eg, positioning, drugs, oral hygiene, tube feeding, influenza vaccination, pneumococcal vaccination) have been proposed to prevent aspiration in hospitalized and nonhospitalized elderly patients. However, no clinical trials have evaluated the utility of these measures specifically in patients with stroke. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/18/31017?source=see_link\">",
"     \"Aspiration pneumonia in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/7/13433?source=see_link\">",
"     \"Risk factors and prevention of hospital-acquired, ventilator-associated, and healthcare-associated pneumonia in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/12/21705?source=see_link\">",
"     \"Pneumococcal vaccination in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/8/37002?source=see_link\">",
"     \"Seasonal influenza vaccination in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Angiotensin converting enzyme (ACE) inhibitors prevent the breakdown of substance P, an important mediator of the cough reflex, but there is conflicting evidence regarding the utility of ACE inhibitors for preventing pneumonia in patients with stroke. Data from several observational studies suggest that ACE inhibitors significantly lower the risk of aspiration pneumonia in elderly Japanese patients with stroke [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10087/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. However, post-hoc analysis of a multinational randomized controlled trial found that ACE inhibitor use was associated with a statistically nonsignificant reduced risk of pneumonia in patients with a history of stroke or TIA; a subgroup analysis found significant benefit for patients of Asian ethnicity only [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10087/abstract/12\">",
"     12",
"    </a>",
"    ]. In addition, a case-control trial from the Netherlands reported that ACE inhibitor use was not associated with a decreased incidence of pneumonia in a general (mostly white) population [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10087/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     MECHANICAL VENTILATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intubation and mechanical ventilation of patients with ischemic stroke is usually performed secondary to pulmonary edema or for inability to protect the airway because of a decreased level of consciousness from effects of the stroke or seizure. Additional indications include partial airway obstruction, hypoventilation, and aspiration pneumonia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/1/13336?source=see_link\">",
"     \"Overview of mechanical ventilation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/32/26119?source=see_link&amp;anchor=H21#H21\">",
"     \"Physiologic and pathophysiologic consequences of mechanical ventilation\", section on 'Central nervous system'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In a single-center retrospective series of 24 patients with hemispheric ischemic stroke, mechanical ventilation was initiated for bilateral pulmonary edema from heart failure (n = 10), progression to stupor from brain swelling (n = 8), and generalized seizures or status epilepticus (n = 6) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10087/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The morbidity and mortality in patients intubated after acute stroke is very high. In the study just cited, death occurred in 17 of the 24 patients (71 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10087/abstract/14\">",
"     14",
"    </a>",
"    ]. Another retrospective study found that among a group of 74 patients with ischemic stroke receiving mechanical ventilation, 56 (76 percent) were either dead or had severe disability requiring nursing home placement at discharge [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10087/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Intubation is infrequently required in ischemic stroke, but the rate may be more frequent in intracerebral hemorrhage. As an example, intubation rates in one retrospective study for ischemic stroke and intracerebral hemorrhage were 6 and 30 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10087/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     OXYGEN DESATURATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients with acute hemiparetic ischemic and hemorrhagic stroke, oxygen desaturation detected by continuous pulse oximetry is associated with increased age, higher National Institutes of Health Stroke Scale (NIHSS) score, and the presence of dysphagia [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10087/abstract/16\">",
"     16",
"    </a>",
"    ]. Even patients with stroke deemed safe to eat have a greater likelihood of desaturation after completion of a meal than do elderly controls [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10087/abstract/17\">",
"     17",
"    </a>",
"    ]. Patients with a history of cardiac and pulmonary diseases are also at higher risk for desaturation [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10087/abstract/16\">",
"     16",
"    </a>",
"    ]. In these studies, most patients were asymptomatic during periods of desaturation, suggesting that silent desaturation may be more common than previously recognized. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/32/9736?source=see_link\">",
"     \"Pulse oximetry\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     NEUROGENIC PULMONARY EDEMA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neurogenic pulmonary edema (NPE) is reviewed here briefly and discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/43/25271?source=see_link\">",
"     \"Neurogenic pulmonary edema\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    NPE is an increase in interstitial and alveolar fluid that occurs in the setting of an acute central nervous system injury, particularly head trauma, seizures, and subarachnoid hemorrhage (",
"    <a class=\"graphic graphic_table graphicRef57483 \" href=\"UTD.htm?29/45/30427\">",
"     table 1",
"    </a>",
"    ). The alveoli are flooded with proteinaceous, hemorrhagic fluid. Radiographically, it is indistinguishable from hydrostatic pulmonary edema. NPE occurs in only a minority of patients with acute stroke, usually following subarachnoid hemorrhage or uncontrolled seizures [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10087/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The pathophysiology is not clear, but hemodynamic and permeability factors are cited. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/43/25271?source=see_link&amp;anchor=H9#H9\">",
"     \"Neurogenic pulmonary edema\", section on 'Pathogenesis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/43/25271?source=see_link&amp;anchor=H11#H11\">",
"     \"Neurogenic pulmonary edema\", section on 'Mechanisms of edema formation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    NPE most often develops abruptly and progresses quickly after the onset of the neurologic insult. In contrast, aspiration pneumonia usually takes longer to become manifest. However, NPE with delayed onset (hours to days) has been described. Resolution usually occurs within several days. The typical patient with NPE is dyspneic, tachycardic, and hypertensive, with bilateral rales. The chest radiograph reveals bilateral infiltrates that tend to be more interstitial than alveolar, and the cardiac silhouette may appear normal or enlarged. At the time of diagnosis, the cardiac filling pressures are usually normal. In some patients, florid pulmonary edema does not occur, but transient respiratory difficulty and hypoxemia with a normal chest radiograph are evident soon after a stroke. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/43/25271?source=see_link&amp;anchor=H2#H2\">",
"     \"Neurogenic pulmonary edema\", section on 'Clinical presentation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    NPE is a clinical diagnosis based upon the occurrence of pulmonary edema in the appropriate setting and in the absence of a more likely alternative cause. Central to the diagnosis is a strong index of suspicion when pulmonary congestion develops in patients with head trauma (especially with elevated intracranial pressure), seizures, status epilepticus, or subarachnoid hemorrhage. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/43/25271?source=see_link&amp;anchor=H4#H4\">",
"     \"Neurogenic pulmonary edema\", section on 'Diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Most cases of NPE resolve spontaneously and are well tolerated, but the condition can be fatal in severe cases. The management of NPE is largely supportive and directed mainly towards treatment of the underlying neurologic condition. Most patients with NPE are hypoxemic and require supplemental oxygen. Some patients may require mechanical ventilation, which differs from that for other causes of respiratory failure in two ways: permissive hypercapnia and high levels of positive end expiratory pressure should be avoided. A variety of medications have been used to treat patients with NPE, but their efficacy in this setting has not been established. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/43/25271?source=see_link&amp;anchor=H14#H14\">",
"     \"Neurogenic pulmonary edema\", section on 'Treatment'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     ABNORMAL RESPIRATORY PATTERNS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Abnormal respiratory patterns are a common consequence of stroke. Abnormal breathing patterns are recognized in approximately 60 percent of patients with acute neurologic disorders, including acute stroke. In a subset of these patients, underlying cardiac and respiratory abnormalities account for the abnormal breathing pattern [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10087/abstract/19,20\">",
"     19,20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Among the recognized abnormal respiratory patterns (",
"    <a class=\"graphic graphic_figure graphicRef74371 \" href=\"UTD.htm?1/1/1040\">",
"     figure 1",
"    </a>",
"    ) are Cheyne-Stokes breathing, periodic breathing, apneustic breathing, central sleep apnea, ataxic breathing, and failure of automatic breathing (Ondine's curse) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10087/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Abnormal breathing patterns are more common among patients with impaired consciousness, with severe deficits, during sleep, and in patients with medullary infarcts [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10087/abstract/18,20\">",
"     18,20",
"    </a>",
"    ]. Most respiratory patterns do not have prognostic significance or imply involvement of specific areas of the central nervous system [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10087/abstract/18-20\">",
"     18-20",
"    </a>",
"    ]. Only sustained tachypnea with low PaCO2 is associated with poor outcome [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10087/abstract/18\">",
"     18",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/4/40008?source=see_link\">",
"     \"Control of ventilation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/63/22520?source=see_link\">",
"     \"Disorders of ventilatory control\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Cheyne-Stokes respiration",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cheyne-Stokes respiration is characterized by recurrent central apnea alternating with a crescendo-decrescendo pattern of tidal volume. It is the most commonly recognized abnormal respiratory pattern after stroke, but in approximately 90 percent of patients it reflects underlying cardiopulmonary disease [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10087/abstract/20\">",
"     20",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/43/8888?source=see_link\">",
"     \"Cheyne-Stokes breathing and obstructive sleep apnea in heart failure\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Initially believed to be due to bilateral forebrain disease or diffuse bihemispheric disease, Cheyne-Stokes respiration is now known to occur with unilateral hemispheric and brainstem infarcts [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10087/abstract/18,20\">",
"     18,20",
"    </a>",
"    ]. Cheyne-Stokes respiration has little prognostic value [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10087/abstract/18,20\">",
"     18,20",
"    </a>",
"    ]. However, hypocapnia is almost always present and may require treatment to prevent cerebral vasoconstriction and exacerbation of the underlying neurologic condition. Hypoxemia is frequently present due to concomitant heart and lung disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Periodic breathing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Periodic breathing, a variant of Cheyne-Stokes respiration, is characterized by regular, recurrent cycles of changing tidal volumes in which the lowest tidal volume is less than half the maximal tidal volume in that cycle [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10087/abstract/18\">",
"     18",
"    </a>",
"    ]. It is the most frequent abnormal respiratory pattern directly related to stroke rather than underlying systemic disease, occurring in approximately 25 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10087/abstract/18,20\">",
"     18,20",
"    </a>",
"    ]. Periodic breathing may be more common among patients with subarachnoid hemorrhage [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10087/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Ataxic breathing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ataxic breathing is a rare respiratory pattern characterized by an erratic rate and depth of breathing, alternating with interspersed episodes of apnea [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10087/abstract/21\">",
"     21",
"    </a>",
"    ]. It is the only respiratory pattern with true localizing value and is indicative of a medullary lesion. It may occur in patients with neurodegenerative disorders (such as Shy-Drager syndrome) but when developing acutely should always raise suspicion for a medullary stroke.",
"   </p>",
"   <p>",
"    Ataxic breathing is caused by dysfunction of the dorsal respiratory neurons in the medulla that control the rhythmicity of breathing. In one case series of 227 patients, ataxic breathing was found in all 12 patients with medullary strokes [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10087/abstract/18\">",
"     18",
"    </a>",
"    ]. Ataxic breathing is not necessarily associated with poor outcome.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Apneustic breathing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Apneustic breathing is characterized by sustained deep inspiration lasting several seconds followed by a rapid exhalation and a brief post-expiratory phase. Its presence reflects dysfunction of the inspiratory cut-off mechanism localized in the inferomedial posterior region of the pons [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10087/abstract/21\">",
"     21",
"    </a>",
"    ]. The pattern is rarely observed because patients usually have severe bulbar dysfunction and require mechanical ventilation [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10087/abstract/20,21\">",
"     20,21",
"    </a>",
"    ]. Weaning from mechanical ventilation is often difficult, and long-term ventilation via tracheostomy is often necessary.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Gasping",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gasping is an abnormal breathing pattern characterized by an attenuated inspiratory period followed by a disproportionately long period of expiration. Associated abnormal involuntary movements such as platysma contraction and neck hyperextension are common [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10087/abstract/18,21\">",
"     18,21",
"    </a>",
"    ]. Gasping is more commonly seen in medullary strokes but overall has poor localizing value. Respiratory failure almost invariably ensues.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Apnea",
"    </span>",
"    &nbsp;&mdash;&nbsp;Complete apnea following stroke is extremely rare in the absence of brain death, but it may be seen with the development of medullary or high spinal cord lesions [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10087/abstract/21,22\">",
"     21,22",
"    </a>",
"    ]. It has been described rarely after unilateral brainstem infarction [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10087/abstract/22\">",
"     22",
"    </a>",
"    ]. It is diagnosed by determining absent respirations in fully alert patients after stimulation with CO2, in a similar manner to that performed when brain death is suspected [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10087/abstract/22\">",
"     22",
"    </a>",
"    ]. The prognosis for recovery is generally poor.",
"   </p>",
"   <p>",
"    Complete apnea during sleep with normal ventilation during wakefulness has been termed Ondine's curse. It occurs due to an interruption of the brainstem respiratory generators or their spinal projections but with preserved integrity of corticospinal pathways which control the more voluntary aspects of respiratory control. Ondine's curse is generally treated with mechanical ventilation during sleep. In some patients spontaneous improvement may occur [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10087/abstract/19,21\">",
"     19,21",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/63/22520?source=see_link\">",
"     \"Disorders of ventilatory control\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1015755437\">",
"    <span class=\"h2\">",
"     Sleep apnea",
"    </span>",
"    &nbsp;&mdash;&nbsp;The relationship of sleep disordered breathing (including both obstructive sleep apnea and central sleep apnea syndrome) as a possible risk factor for stroke and as a possible complication of stroke is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/39/38518?source=see_link\">",
"     \"Sleep related breathing disorders and stroke\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1015755021\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pneumonia is one of the most common respiratory complications of acute stroke, occurring in about 5 to 7 percent of patients. Stroke-related pneumonia is associated with a higher mortality and a poorer long-term outcome. Risk factors for in-hospital pneumonia include older age, dysarthria, aphasia, stroke severity, cognitive impairment, and an abnormal water swallow test. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Pneumonia'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Intubation and mechanical ventilation of patients with ischemic stroke is usually performed to treat pulmonary edema or for inability to protect the airway. The morbidity and mortality in patients intubated after acute stroke is high. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Mechanical ventilation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Neurogenic pulmonary edema (NPE) is an increase in interstitial and alveolar fluid that occurs in the setting of head trauma, seizures, or stroke, particularly subarachnoid hemorrhage (",
"      <a class=\"graphic graphic_table graphicRef57483 \" href=\"UTD.htm?29/45/30427\">",
"       table 1",
"      </a>",
"      ). NPE most often develops abruptly and progresses quickly after the onset of the neurologic insult. The typical patient with NPE is dyspneic, tachycardic, and hypertensive, with bilateral rales. Most cases of NPE resolve spontaneously and are well tolerated, but the condition can be fatal in severe cases. Treatment of NPE is largely supportive and directed mainly towards treatment of the underlying neurologic condition. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Neurogenic pulmonary edema'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Abnormal breathing patterns are a common consequence of stroke. Among the recognized abnormal respiratory patterns are Cheyne-Stokes breathing, periodic breathing, apneustic breathing, central sleep apnea, ataxic breathing, and failure of automatic breathing (",
"      <a class=\"graphic graphic_figure graphicRef74371 \" href=\"UTD.htm?1/1/1040\">",
"       figure 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Abnormal respiratory patterns'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The relationship of sleep disordered breathing (including both obstructive sleep apnea and central sleep apnea syndrome) as a possible risk factor for stroke and as a possible complication of stroke is discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/39/38518?source=see_link\">",
"       \"Sleep related breathing disorders and stroke\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10087/abstract/1\">",
"      Johnston KC, Li JY, Lyden PD, et al. Medical and neurological complications of ischemic stroke: experience from the RANTTAS trial. RANTTAS Investigators. Stroke 1998; 29:447.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10087/abstract/2\">",
"      Finlayson O, Kapral M, Hall R, et al. Risk factors, inpatient care, and outcomes of pneumonia after ischemic stroke. Neurology 2011; 77:1338.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10087/abstract/3\">",
"      Ingeman A, Andersen G, Hundborg HH, et al. In-hospital medical complications, length of stay, and mortality among stroke unit patients. Stroke 2011; 42:3214.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10087/abstract/4\">",
"      Hilker R, Poetter C, Findeisen N, et al. Nosocomial pneumonia after acute stroke: implications for neurological intensive care medicine. Stroke 2003; 34:975.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10087/abstract/5\">",
"      Dziewas R, Ritter M, Schilling M, et al. Pneumonia in acute stroke patients fed by nasogastric tube. J Neurol Neurosurg Psychiatry 2004; 75:852.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10087/abstract/6\">",
"      Silver FL, Norris JW, Lewis AJ, Hachinski VC. Early mortality following stroke: a prospective review. Stroke 1984; 15:492.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10087/abstract/7\">",
"      Grau AJ, Buggle F, Schnitzler P, et al. Fever and infection early after ischemic stroke. J Neurol Sci 1999; 171:115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10087/abstract/8\">",
"      Bravata DM, Ho SY, Meehan TP, et al. Readmission and death after hospitalization for acute ischemic stroke: 5-year follow-up in the medicare population. Stroke 2007; 38:1899.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10087/abstract/9\">",
"      Sellars C, Bowie L, Bagg J, et al. Risk factors for chest infection in acute stroke: a prospective cohort study. Stroke 2007; 38:2284.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10087/abstract/10\">",
"      Sekizawa K, Matsui T, Nakagawa T, et al. ACE inhibitors and pneumonia. Lancet 1998; 352:1069.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10087/abstract/11\">",
"      Arai T, Sekizawa K, Ohrui T, et al. ACE inhibitors and protection against pneumonia in elderly patients with stroke. Neurology 2005; 64:573.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10087/abstract/12\">",
"      Ohkubo T, Chapman N, Neal B, et al. Effects of an angiotensin-converting enzyme inhibitor-based regimen on pneumonia risk. Am J Respir Crit Care Med 2004; 169:1041.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10087/abstract/13\">",
"      van de Garde EM, Souverein PC, van den Bosch JM, et al. Angiotensin-converting enzyme inhibitor use and pneumonia risk in a general population. Eur Respir J 2006; 27:1217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10087/abstract/14\">",
"      Wijdicks EF, Scott JP. Causes and outcome of mechanical ventilation in patients with hemispheric ischemic stroke. Mayo Clin Proc 1997; 72:210.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10087/abstract/15\">",
"      Gujjar AR, Deibert E, Manno EM, et al. Mechanical ventilation for ischemic stroke and intracerebral hemorrhage: indications, timing, and outcome. Neurology 1998; 51:447.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10087/abstract/16\">",
"      Sulter G, Elting JW, Stewart R, et al. Continuous pulse oximetry in acute hemiparetic stroke. J Neurol Sci 2000; 179:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10087/abstract/17\">",
"      Rowat AM, Wardlaw JM, Dennis MS, Warlow CP. Does feeding alter arterial oxygen saturation in patients with acute stroke? Stroke 2000; 31:2134.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10087/abstract/18\">",
"      North JB, Jennett S. Abnormal breathing patterns associated with acute brain damage. Arch Neurol 1974; 31:338.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10087/abstract/19\">",
"      Bassetti C, Aldrich MS, Quint D. Sleep-disordered breathing in patients with acute supra- and infratentorial strokes. A prospective study of 39 patients. Stroke 1997; 28:1765.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10087/abstract/20\">",
"      Lee MC, Klassen AC, Resch JA. Respiratory pattern disturbances in ischemic cerebral vascular disease. Stroke 1974; 5:612.",
"     </a>",
"    </li>",
"    <li>",
"     Frank, JI. Abnormal breathing patterns. In: Neurocritical Care, Hanley, DF, Einhaupl, KM, Bleck, TP, Diringer, MN (Eds), Springer-Verlag, Heidelberg 1994. p.366.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10087/abstract/22\">",
"      Bogousslavsky J, Khurana R, Deruaz JP, et al. Respiratory failure and unilateral caudal brainstem infarction. Ann Neurol 1990; 28:668.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1098 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-217.117.136.88-CE19846B1C-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_54_10087=[""].join("\n");
var outline_f9_54_10087=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H1015755021\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PNEUMONIA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Prevention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      MECHANICAL VENTILATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      OXYGEN DESATURATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      NEUROGENIC PULMONARY EDEMA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      ABNORMAL RESPIRATORY PATTERNS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Cheyne-Stokes respiration",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Periodic breathing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Ataxic breathing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Apneustic breathing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Gasping",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Apnea",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1015755437\">",
"      Sleep apnea",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1015755021\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEURO/1098\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/1098|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?1/1/1040\" title=\"figure 1\">",
"      Stroke breathing patterns",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/1098|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?29/45/30427\" title=\"table 1\">",
"      Causes of NPE",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/18/31017?source=related_link\">",
"      Aspiration pneumonia in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/20/26952?source=related_link\">",
"      Cardiac complications of stroke",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/43/8888?source=related_link\">",
"      Cheyne-Stokes breathing and obstructive sleep apnea in heart failure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/4/40008?source=related_link\">",
"      Control of ventilation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/38/17000?source=related_link\">",
"      Diagnosis and treatment of oropharyngeal dysphagia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/63/22520?source=related_link\">",
"      Disorders of ventilatory control",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/12/17610?source=related_link\">",
"      Medical complications of stroke",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/43/25271?source=related_link\">",
"      Neurogenic pulmonary edema",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/1/13336?source=related_link\">",
"      Overview of mechanical ventilation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/32/26119?source=related_link\">",
"      Physiologic and pathophysiologic consequences of mechanical ventilation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/12/21705?source=related_link\">",
"      Pneumococcal vaccination in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/32/9736?source=related_link\">",
"      Pulse oximetry",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/7/13433?source=related_link\">",
"      Risk factors and prevention of hospital-acquired, ventilator-associated, and healthcare-associated pneumonia in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/8/37002?source=related_link\">",
"      Seasonal influenza vaccination in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/39/38518?source=related_link\">",
"      Sleep related breathing disorders and stroke",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f9_54_10088="Techniques to reduce blood loss during abdominal or laparoscopic myomectomy";
var content_f9_54_10088=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Techniques to reduce blood loss during abdominal or laparoscopic myomectomy",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/54/10088/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/54/10088/contributors\">",
"     William H Parker, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/54/10088/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/54/10088/contributors\">",
"     Howard T Sharp, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/54/10088/contributors\">",
"     Tommaso Falcone, MD, FRCSC, FACOG",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/54/10088/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/54/10088/contributors\">",
"     Sandy J Falk, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?9/54/10088/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 19, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1389281\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Uterine leiomyomas (myomas or fibroids) are smooth muscle tumors and are the most common type of pelvic tumors in women. Myomectomy is removal of the myomas, while leaving the uterus in place.",
"   </p>",
"   <p>",
"    Myomatous uteri have an increased number of arterioles and venules and myomectomy may involve significant blood loss [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10088/abstract/1\">",
"     1",
"    </a>",
"    ]. However, studies show that the blood loss is no greater than for hysterectomy, when controlled for uterine size [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10088/abstract/2\">",
"     2",
"    </a>",
"    ]. The average volume of blood loss during abdominal myomectomy (performed via laparotomy, also referred to as open myomectomy) is 200 to 800 mL [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10088/abstract/2-4\">",
"     2-4",
"    </a>",
"    ] and for laparoscopic myomectomy is 80 to 250 ml [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10088/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. Surgical hemorrhage may result in anemia, hypovolemia, and coagulation abnormalities.",
"   </p>",
"   <p>",
"    Bleeding can be prevented or decreased with mechanical or pharmacologic methods. Allogeneic blood transfusion can be avoided by using methods of autologous blood transfusion (autologous blood donation, intraoperative and postoperative blood salvage, or acute normovolemic [isovolemic] hemodilution).",
"   </p>",
"   <p>",
"    Techniques to reduce blood loss during abdominal or laparoscopic myomectomy are reviewed here. Preoperative and postoperative care and surgical technique for abdominal or laparoscopic myomectomy are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/3/12346?source=see_link\">",
"     \"Abdominal myomectomy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/48/8970?source=see_link\">",
"     \"Laparoscopic myomectomy and other laparoscopic treatments for uterine leiomyomas (fibroids)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3731788\">",
"    <span class=\"h1\">",
"     VASCULAR ANATOMY OF THE UTERUS AND LEIOMYOMAS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The ascending blood supply of the uterus is from the uterine arteries, which pass through the cardinal ligament at level of the cervicouterine junction. The descending blood supply is from the ovarian arteries, which pass through the infundibulopelvic ligaments (suspensory ligaments of the ovary) and perfuse the ovaries, fallopian tubes, and uterine cornua (",
"    <a class=\"graphic graphic_figure graphicRef54737 \" href=\"UTD.htm?14/55/15222\">",
"     figure 1",
"    </a>",
"    ). The uterine and ovarian vessels anastomose to perfuse the uterus. Arcuate arteries run transversely within the uterine wall and radial arteries penetrate deeply into the myometrium [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10088/abstract/7\">",
"     7",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    The presence of leiomyomas in the uterus distorts normal vascular architecture [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10088/abstract/8\">",
"     8",
"    </a>",
"    ]. Thus, the arcuate arteries may run in any axis, rather than transversely. Thus, either vertical or transverse incisions during myomectomy may transect these vessels. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/3/12346?source=see_link&amp;anchor=H1522049#H1522049\">",
"     \"Abdominal myomectomy\", section on 'Uterine incision'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    It has been the common teaching that there is a vascular pedicle at the base of each myoma, and that ligation of this pedicle will achieve hemostasis during myomectomy. However, a study using vascular corrosion casting and electron microscopy revealed that myomas are surrounded completely by a dense vascular layer supplying the myoma, which is separated from the myometrium by a narrow avascular cleft [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10088/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1389273\">",
"    <span class=\"h1\">",
"     PREOPERATIVE MEASURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several preoperative measures can be taken to reduce the likelihood of postoperative anemia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1389432\">",
"    <span class=\"h2\">",
"     Correction of anemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Iron deficiency anemia associated with menorrhagia or dietary deficiency is the most common cause of anemia in the gynecologic patient population. In women with abnormal uterine bleeding, a common symptom of uterine leiomyomas, laboratory testing for anemia should be part of the diagnostic evaluation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/41/20122?source=see_link&amp;anchor=H7#H7\">",
"     \"Chronic menorrhagia or anovulatory uterine bleeding\", section on 'Evaluation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Preoperative anemia increases likelihood of blood transfusion and also increases the risk of perioperative morbidity and mortality. A systematic review of 20 observational studies confirmed the association between preoperative anemia and blood transfusion [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10088/abstract/10\">",
"     10",
"    </a>",
"    ]. No meta-analysis was performed to quantify the magnitude of this effect, but in one representative study of 212 patients who underwent colorectal surgery, the rate of transfusion was significantly higher in those with a hemoglobin &le;12.5",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    compared with &gt;12",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    (49 versus 19 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10088/abstract/11\">",
"     11",
"    </a>",
"    ]. The effect of preoperative anemia on perioperative morbidity was illustrated in a retrospective study of 1958 patients who underwent noncardiac surgery and declined blood transfusion for religious reasons [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10088/abstract/12\">",
"     12",
"    </a>",
"    ]. A preoperative hemoglobin of &le;10",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    was associated with a three-fold or higher increase in serious perioperative morbidity (cardiac events, respiratory failure, or serious bacterial infection) or mortality.",
"   </p>",
"   <p>",
"    Preoperative anemia may be treated with iron supplementation. Strategies to correct anemia preoperatively are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/18/43305?source=see_link&amp;anchor=H7#H7\">",
"     \"Management of hemorrhage in gynecologic surgery\", section on 'Correction of anemia'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1389439\">",
"    <span class=\"h2\">",
"     GnRH agonists",
"    </span>",
"    &nbsp;&mdash;&nbsp;Preoperative use of gonadotropin releasing hormone (GnRH) agonists provides some short-term benefits for women undergoing myomectomy regarding blood loss and uterine size, but may increase the difficulty of surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10088/abstract/13\">",
"     13",
"    </a>",
"    ]. In the long-term, their use appears to increase the risk of",
"    <span class=\"nowrap\">",
"     persistent/recurrent",
"    </span>",
"    myomas.",
"   </p>",
"   <p>",
"    Preoperatively, GnRH agonists can help correct anemia by temporarily inducing amenorrhea [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10088/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]. However, the clinical impact of these agents is controversial. A meta-analysis of 11 randomized trials compared women planning abdominal myomectomy who were treated with a GnRH agonist for three to four months with those receiving either placebo or no treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10088/abstract/13\">",
"     13",
"    </a>",
"    ]. Preoperative GnRH agonist therapy resulted in a small, but statistically significant, increase in preoperative hemoglobin (1.0",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    higher). A further benefit of treatment with these agents was a reduction in intraoperative blood loss (68 mL less). Ultimately, however, there was no significant decrease in the risk of blood transfusion in women treated with GnRH (14 percent for both treatment groups; OR 0.86, 95% CI 0.26-2.85). This analysis was limited by insufficient statistical power to detect this difference.",
"   </p>",
"   <p>",
"    Another potential benefit of GnRH agonists is reduction in uterine size. This may permit the use of a transverse rather than vertical laparotomy incision or may make a laparoscopic approach possible. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/3/12346?source=see_link&amp;anchor=H623653#H623653\">",
"     \"Abdominal myomectomy\", section on 'Reducing uterine size with GnRH agonists'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/48/8970?source=see_link&amp;anchor=H26569841#H26569841\">",
"     \"Laparoscopic myomectomy and other laparoscopic treatments for uterine leiomyomas (fibroids)\", section on 'GnRH agonists'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There are several important disadvantages of preoperative use of GnRH agonists. These agents make enucleation of fibroids more difficult by obscuring the tissue plane between the myoma and the myometrium [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10088/abstract/16\">",
"     16",
"    </a>",
"    ]. Operative difficulty associated with GnRH agonist pretreatment has been measured in only one randomized trial, which found no difference in difficulty between pretreatment with a",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/11/9398?source=see_link\">",
"     triptorelin",
"    </a>",
"    compared with immediate surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10088/abstract/17\">",
"     17",
"    </a>",
"    ]. In our experience, however, operative difficulty",
"    <strong>",
"     is",
"    </strong>",
"    noticeably increased after pretreatment with these medications.",
"   </p>",
"   <p>",
"    There is concern that pretreatment with GnRH agonists may increase the risk of persistent myomas, because small myomas would shrink in size and would not be palpable during myomectomy. The meta-analysis described above reported a significantly higher rate of post-myomectomy myomas in women treated with GnRH agonists compared with placebo or no treatment (11 of 17 [65 percent] versus 7 of 25 [28 percent]; OR 4.0, 95% CI 1.1-14.7) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10088/abstract/13\">",
"     13",
"    </a>",
"    ]. The sample sizes and number of events in this analysis were small and the follow-up period ranged widely from 6 to 38 months. A subsequent randomized trial (n = 108) that compared eight weeks of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/11/9398?source=see_link\">",
"     triptorelin",
"    </a>",
"    therapy with no treatment had a similar finding (proportion of women with myomas at six-month follow-up: 8 versus 2 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10088/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Most of the data regarding GnRH agonists and myomectomy are for open procedures. The only randomized trial to address this issue in women undergoing laparoscopic myomectomy found that GnRH agonist treatment compared with no treatment resulted in a significant increase in operative duration (45 minutes longer) and no decrease in blood loss [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10088/abstract/18\">",
"     18",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/48/8970?source=see_link&amp;anchor=H1880877#H1880877\">",
"     \"Laparoscopic myomectomy and other laparoscopic treatments for uterine leiomyomas (fibroids)\", section on 'Conversion to laparotomy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    GnRH antagonists are another type of agent that suppresses endogenous GnRH. Their effects are similar to those of GnRH agonists, with the exception that results would be seen sooner, since GnRH is immediately suppressed. However, these agents are not widely used for a preoperative indication, since they are more expensive than GnRH agonists and require a daily injection. There are no high quality data regarding use of GnRH antagonists prior to myomectomy.",
"   </p>",
"   <p>",
"    Treatment with either GnRH agonists or antagonists is accompanied by menopausal symptoms (eg, hot flashes, mood disturbance) that many women find difficult to tolerate.",
"   </p>",
"   <p>",
"    In summary, there is no evidence that use of GnRH agonists prior to myomectomy reduces the risk of blood transfusion and such use may increase operative difficulty and the risk of myoma",
"    <span class=\"nowrap\">",
"     persistence/recurrence.",
"    </span>",
"    The primary advantage of use of these agents is the ability to use a more favorable laparotomy incision or, potentially, to use a laparoscopic approach. We suggest",
"    <strong>",
"     not",
"    </strong>",
"    using GnRH agonist pretreatment for women undergoing open or laparoscopic myomectomy. Use of these agents is a reasonable option in women for whom treatment would allow a transverse rather than a vertical incision or a laparoscopic rather than open myomectomy and who place a high priority on type of surgical incision",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    duration of recovery.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1390136\">",
"    <span class=\"h2\">",
"     Autologous blood donation",
"    </span>",
"    &nbsp;&mdash;&nbsp;A patient who is scheduled for surgery and is not anemic may bank one or more units of her own blood. (See",
"    <a class=\"local\" href=\"#H6862479\">",
"     'Autologous blood donation'",
"    </a>",
"    below.) &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1388946\">",
"    <span class=\"h1\">",
"     INTRAOPERATIVE MEASURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bleeding can be prevented or decreased with mechanical or pharmacologic methods. Unfortunately, none of these interventions has been proven to reduce the rate of blood transfusion. Allogeneic blood transfusion can be avoided by using methods of autologous blood transfusion.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4413351\">",
"    <span class=\"h2\">",
"     Pharmacologic interventions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several pharmacologic agents reduce blood loss during myomectomy, although none has been proven to reduce the risk of blood transfusion. No studies have compared directly between these medications. Surgeons should use the agent with which they are most experienced, barring any individual patient contraindications. The most commonly used agent is vasopressin.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4413358\">",
"    <span class=\"h3\">",
"     Vasopressin and other vasoconstrictors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intramyometrial vasopressin injected into the planned uterine incision site for each fibroid reduces blood loss. Vasopressin acts by constricting the smooth muscle in the walls of capillaries, small arterioles, and venules. Randomized trial data show that blood loss during myomectomy with vasopressin is significantly less than with placebo (299 mL less [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10088/abstract/19\">",
"     19",
"    </a>",
"    ]) and less than or comparable to use of a uterine artery tourniquet [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10088/abstract/20-22\">",
"     20-22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Safe use of vasopressin",
"      </strong>",
"      - Vasopressin use during myomectomy has been associated with rare cases of bradycardia, cardiovascular collapse, and death [",
"      <a class=\"abstract\" href=\"UTD.htm?9/54/10088/abstract/22-26\">",
"       22-26",
"      </a>",
"      ]. Vasopressin use may be contraindicated in women with medical comorbidities (eg, cardiovascular, vascular, or renal disease). The use of vasopressin to decrease blood loss during myomectomy has not been approved by the United States Food and Drug Association.",
"      <br/>",
"      <br/>",
"      Safe use of vasopressin depends upon the surgeon&rsquo;s knowledge of its pharmacodynamics and use of safe practices. Care should be taken to avoid intravascular injection; before injecting, the surgeon should pull back on the plunger of the syringe to check for blood. However, complications may result even if intravascular injection does not occur. The maximal safe dose of vasopressin is not well established. Cardiovascular complications following intramyometrial injection have been reported in isolated cases with total vasopressin doses ranging from 5 to 11 units [",
"      <a class=\"abstract\" href=\"UTD.htm?9/54/10088/abstract/23-25,27,28\">",
"       23-25,27,28",
"      </a>",
"      ]. A classic prospective cohort study found no cardiovascular complication in 13 women undergoing myomectomy who received a maximum of 4 units of intramyometrial vasopressin [",
"      <a class=\"abstract\" href=\"UTD.htm?9/54/10088/abstract/29\">",
"       29",
"      </a>",
"      ]. An upper limit of a cumulative total vasopressin dose per procedure of 4 to 6 units has been proposed [",
"      <a class=\"abstract\" href=\"UTD.htm?9/54/10088/abstract/30\">",
"       30",
"      </a>",
"      ]. Use of a dilute solution helps to limit the total dose. In our practice, we dilute 20 units of vasopressin in 100 ml of saline; 4 to 6 units of vasopressin equals 20 to 30 mL of this solution. The half-life of intramuscular vasopressin is 10 to 20 minutes and the duration of action is two to eight hours.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    There are few data about combining use of vasopressin with other measures. The only randomized trial to address this issue included 105 women who underwent laparoscopic myomectomy and were assigned to one of three groups: vasopressin combined with ligation of the myoma pedicle with a loop of suture, vasopressin alone, or no vasopressin or loop ligation [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10088/abstract/22\">",
"     22",
"    </a>",
"    ]. Blood loss was significantly lower with combined use of",
"    <span class=\"nowrap\">",
"     vasopressin/loop",
"    </span>",
"    ligation compared with vasopressin alone (59 versus 224 mL); both treatment groups had a significantly lower blood loss than the group that was not treated with either vasopressin or loop ligation (no treatment group: 364 mL). Ligation of the myoma pedicle merits further study.",
"   </p>",
"   <p>",
"    Epinephrine is another vasoconstrictor that is effective in reducing blood loss during myomectomy. One randomized trial found that intramyometrial injection of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?33/60/34758?source=see_link\">",
"     bupivacaine",
"    </a>",
"    with epinephrine (50 mL bupivacaine cloridrate 0.25 percent and 0.5 mL of 1",
"    <span class=\"nowrap\">",
"     mg/ml",
"    </span>",
"    epinephrine) reduced blood loss compared with saline (69 mL less) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10088/abstract/27\">",
"     27",
"    </a>",
"    ]. There were no differences in blood pressure or heart rate between groups. Intravascular injection of epinephrine may cause acute cardiovascular adverse events, similar to vasopressin. A disadvantage of epinephrine is that clinical experience during myomectomy is limited, since most gynecologic surgeons use vasopressin in this setting.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4413531\">",
"    <span class=\"h3\">",
"     Uterotonics",
"    </span>",
"    &nbsp;&mdash;&nbsp;Uterotonics have been used during myomectomy. One small randomized trial (n = 25) found that use of vaginal",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/41/662?source=see_link\">",
"     misoprostol",
"    </a>",
"    (400 mcg, one hour before surgery) compared with placebo significantly reduced blood loss (149 mL less) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10088/abstract/31\">",
"     31",
"    </a>",
"    ]; further study of use of this agent during myomectomy is needed.",
"   </p>",
"   <p>",
"    Data from a meta-analysis of two randomized trials including 77 women showed that intravenous",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/0/5125?source=see_link\">",
"     oxytocin",
"    </a>",
"    does",
"    <strong>",
"     not",
"    </strong>",
"    reduce blood loss compared with physiologic serum (mean difference in blood loss -69 mL; 95% -297 to 157) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10088/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4413538\">",
"    <span class=\"h3\">",
"     Other agents",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other agents to reduce blood loss during myomectomy have been investigated, but have not been found to be successful, including:",
"    <a class=\"drug drug_general\" href=\"UTD.htm?13/58/14248?source=see_link\">",
"     tranexamic acid",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10088/abstract/32\">",
"     32",
"    </a>",
"    ] and sodium-2-mercaptoethanesulphonate (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/0/41989?source=see_link\">",
"     mesna",
"    </a>",
"    ; used for chemical dissection) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10088/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Topical hemostatic agents appear to reduce blood loss during myomectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10088/abstract/34\">",
"     34",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/18/43305?source=see_link&amp;anchor=H16#H16\">",
"     \"Management of hemorrhage in gynecologic surgery\", section on 'Topical hemostatic agents'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1388953\">",
"    <span class=\"h2\">",
"     Tourniquets and clamps",
"    </span>",
"    &nbsp;&mdash;&nbsp;Use of tourniquets and clamps that occlude the uterine blood supply reduce blood loss during myomectomy (",
"    <a class=\"graphic graphic_figure graphicRef71118 \" href=\"UTD.htm?16/38/16995\">",
"     figure 2",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H3731788\">",
"     'Vascular anatomy of the uterus and leiomyomas'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    The benefit of use of a uterine artery tourniquet was illustrated in a randomized trial of 28 women [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10088/abstract/35\">",
"     35",
"    </a>",
"    ]. Use of a uterine artery tourniquet compared with no tourniquet resulted in a significant decrease in blood loss (an average of 1870 mL less). There are no high quality data regarding the use of infundibulopelvic ligament clamps.",
"   </p>",
"   <p>",
"    Data conflict regarding whether tourniquet use is as effective as use of vasopressin. Blood loss with use of a uterine artery tourniquet compared with intramyometrial vasopressin was significantly lower in one randomized trial (an average of 225 mL less) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10088/abstract/21\">",
"     21",
"    </a>",
"    ], but was comparable in another trial [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10088/abstract/20\">",
"     20",
"    </a>",
"    ]. There are no data regarding whether the combined use of a vasoconstrictor and tourniquets and clamps decreases blood loss more effectively than either measure alone. In our practice, we use vasopressin in all patients and reserve use of tourniquets and clamps for women with large fibroids.",
"   </p>",
"   <p>",
"    An example of a procedure to apply a tourniquet is as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Palpate the broad ligament just above the level of the internal cervical os to identify a space that is free of vessels and the ureter.",
"     </li>",
"     <li>",
"      Make a 1 cm incision in this clear space bilaterally. &nbsp;",
"     </li>",
"     <li>",
"      Pass the tourniquet (eg, a Penrose drain [or a latex-free tourniquet in a latex-allergic patient]) through the incisions with the ends protruding anteriorly.",
"     </li>",
"     <li>",
"      Pull the tourniquet tight and secure by securing the ends with a Kelley clamp. Take care to avoid enlarging the broad ligament incisions or damaging surrounding structures.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Use of number one suture as a uterine artery tourniquet during laparoscopic myomectomy has been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10088/abstract/35\">",
"     35",
"    </a>",
"    ]. In general, however, it is difficult to secure a tourniquet using laparoscopic instruments.",
"   </p>",
"   <p>",
"    Occlusion of the ovarian arteries is accomplished by placing a tourniquet or atraumatic vascular clamp (eg, bulldog clamp) bilaterally across the infundibulopelvic ligaments. Care must be taken to avoid lacerating the ovarian vessels or compressing the ureter.",
"   </p>",
"   <p>",
"    There are no high quality data regarding the safe duration of tourniquet or clamp use to prevent uterine tissue damage. Some studies refer to releasing the tourniquet every 20 minutes, but outcomes for this practice have not been evaluated [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10088/abstract/21,35\">",
"     21,35",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1388988\">",
"    <span class=\"h2\">",
"     Autologous blood transfusion",
"    </span>",
"    &nbsp;&mdash;&nbsp;Autologous blood transfusion methods include autologous blood donation, intraoperative or postoperative blood salvage, and acute normovolemic (isovolemic) hemodilution. There is no consensus regarding which method is most cost effective and acceptable to patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6862479\">",
"    <span class=\"h3\">",
"     Autologous blood donation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some surgeons advise patients to bank autologous blood, but this should be done only by patients with an appropriate hematocrit and sufficient time before surgery to avoid anemia at the time of surgery. Transfusion of banked autologous blood avoids some, but not all, of the risks that are associated with allogeneic blood transfusion. Transfusion of autologous blood should be restricted to the same indications as for allogeneic blood. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/54/12134?source=see_link&amp;anchor=H3#H3\">",
"     \"Preoperative autologous blood donation\", section on 'Drawbacks'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/54/12134?source=see_link&amp;anchor=H14#H14\">",
"     \"Preoperative autologous blood donation\", section on 'Indications for transfusion'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6862472\">",
"    <span class=\"h3\">",
"     Intraoperative blood salvage",
"    </span>",
"    &nbsp;&mdash;&nbsp;In our practice, in procedures in which significant blood loss (&ge;300 ml) is anticipated, we use intraoperative blood salvage, if necessary. In a study of 91 women who underwent open myomectomy for uterine size greater than 16 weeks, the operative blood loss ranged from 50 to 3000 mL [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10088/abstract/3\">",
"     3",
"    </a>",
"    ]. The Cell Saver&reg; blood salvage was used for the 70 women with a blood loss &ge;300 ml; 7 women received a homologous (non-autologous) blood transfusion in addition to blood salvage. The cost of using a cell-saver compared to donation of autologous blood has not been studied for abdominal myomectomy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2728258\">",
"    <span class=\"h3\">",
"     Normovolemic (isovolemic) hemodilution",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is only one report of normovolemic (isovolemic) hemodilution during myomectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10088/abstract/36\">",
"     36",
"    </a>",
"    ], but we have not used this approach in our practice.",
"   </p>",
"   <p>",
"    Methods of autologous transfusion and their use in gynecologic surgery are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/54/12134?source=see_link\">",
"     \"Preoperative autologous blood donation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/21/10582?source=see_link\">",
"     \"Intraoperative and postoperative blood salvage\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/51/37684?source=see_link\">",
"     \"Acute normovolemic intraoperative hemodilution\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/18/43305?source=see_link&amp;anchor=H8#H8\">",
"     \"Management of hemorrhage in gynecologic surgery\", section on 'Autologous transfusion methods'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1388995\">",
"    <span class=\"h2\">",
"     Other measures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Uterine artery ligation or embolization or internal iliac artery ligation may also be used to avoid hysterectomy when heavy bleeding is anticipated or occurs during myomectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10088/abstract/37,38\">",
"     37,38",
"    </a>",
"    ]. The uterine vessels will recannulate, so future fertility should theoretically be preserved. However, the impact on fertility and obstetric outcomes following uterine artery embolization as a primary procedure is not well established. For this reason, we reserve these techniques for situations in which other measures have failed and additional hemostasis is needed to avoid hysterectomy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/18/43305?source=see_link&amp;anchor=H19#H19\">",
"     \"Management of hemorrhage in gynecologic surgery\", section on 'Internal iliac artery ligation'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/60/22473?source=see_link&amp;anchor=H25#H25\">",
"     \"Uterine leiomyoma (fibroid) embolization\", section on 'Pregnancy after UFE'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3732327\">",
"    <span class=\"h1\">",
"     CLINICAL APPROACH",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is no consensus about the optimal combination of preoperative or intraoperative measures to decrease blood loss or prepare for autologous blood transfusion. Few studies have compared among interventions. Also, most interventions have not been proven to reduce the risk of blood transfusion",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    avoid hysterectomy, the most important outcomes to patients.",
"   </p>",
"   <p>",
"    Our approach is to employ basic methods for all procedures, and then use additional measures when significant blood loss (&ge;300 mL) is anticipated or occurs. Blood loss during myomectomy is correlated with the size and number of myomas, and also with operative duration, (which depends in large part upon the first two factors) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10088/abstract/20\">",
"     20",
"    </a>",
"    ]. During the preoperative evaluation of each patient, we assess the characteristics of the myomas and make our best clinical estimate of the risk of excessive blood loss.",
"   </p>",
"   <p>",
"    In our practice, for all women undergoing myomectomy, we do the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Correct preoperative anemia.",
"     </li>",
"     <li>",
"      Inject vasopressin before each uterine incision.",
"     </li>",
"     <li>",
"      Many surgeons apply a uterine artery tourniquet (for open myomectomy only) and ovarian artery clamps in all patients. In our practice, we reserve the use of tourniquets and clamps for women with large fibroids.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    For women in whom we anticipate significant blood loss (&ge;300 mL), we additionally do the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Prepare for the use of blood salvage.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Preoperative banking of autologous blood is also an option, but should be limited to patients in whom this will not result in anemia at the time of surgery.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1389289\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Women with leiomyomatous uteri have an increased number of uterine arterioles and venules and myomectomy may involve significant blood loss. The average volume of blood loss during abdominal myomectomy is 200 to 800 mL and for laparoscopic myomectomy is 80 to 250 ml. (See",
"      <a class=\"local\" href=\"#H1389281\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest",
"      <strong>",
"       not",
"      </strong>",
"      using GnRH agonist pretreatment for women undergoing abdominal or laparoscopic myomectomy (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). Use of these agents is a reasonable option in women for whom treatment would allow a transverse rather than a vertical laparotomy or a laparoscopic rather than abdominal myomectomy and who place a high priority on type of surgical incision",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      duration of recovery. (See",
"      <a class=\"local\" href=\"#H1389439\">",
"       'GnRH agonists'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      To reduce intraoperative blood loss for women undergoing laparoscopic or abdominal myomectomy:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      We recommend intramyometrial injection of vasopressin before each uterine incision (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H4413358\">",
"       'Vasopressin and other vasoconstrictors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest placement of tourniquets and clamps to occlude the uterine blood supply (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H1388953\">",
"       'Tourniquets and clamps'",
"      </a>",
"      above.)",
"      <br/>",
"      <br/>",
"      These measures may be used in combination, although it is uncertain whether combined use further decreases blood loss.",
"     </li>",
"     <li>",
"      Other agents that appear to reduce blood loss include epinephrine and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?0/41/662?source=see_link\">",
"       misoprostol",
"      </a>",
"      , but further study of these agents is needed. We recommend",
"      <strong>",
"       not",
"      </strong>",
"      using",
"      <a class=\"drug drug_general\" href=\"UTD.htm?5/0/5125?source=see_link\">",
"       oxytocin",
"      </a>",
"      for the purpose of reducing blood loss during myomectomy (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H4413351\">",
"       'Pharmacologic interventions'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In our practice, in procedures in which significant blood loss (&ge;300 ml) occurs, we use intraoperative blood salvage. Preoperative banking of autologous blood is also an option, but should be limited to patients in whom this will not result in anemia at the time of surgery. (See",
"      <a class=\"local\" href=\"#H1390136\">",
"       'Autologous blood donation'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10088/abstract/1\">",
"      Sampson, JA. The blood supply of uterine myomata. Surg Gynecol Obstet 1912; 14:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10088/abstract/2\">",
"      Iverson RE Jr, Chelmow D, Strohbehn K, et al. Relative morbidity of abdominal hysterectomy and myomectomy for management of uterine leiomyomas. Obstet Gynecol 1996; 88:415.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10088/abstract/3\">",
"      West S, Ruiz R, Parker WH. Abdominal myomectomy in women with very large uterine size. Fertil Steril 2006; 85:36.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10088/abstract/4\">",
"      Sawin SW, Pilevsky ND, Berlin JA, Barnhart KT. Comparability of perioperative morbidity between abdominal myomectomy and hysterectomy for women with uterine leiomyomas. Am J Obstet Gynecol 2000; 183:1448.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10088/abstract/5\">",
"      Paul GP, Naik SA, Madhu KN, Thomas T. Complications of laparoscopic myomectomy: A single surgeon's series of 1001 cases. Aust N Z J Obstet Gynaecol 2010; 50:385.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10088/abstract/6\">",
"      Sinha R, Hegde A, Mahajan C, et al. Laparoscopic myomectomy: do size, number, and location of the myomas form limiting factors for laparoscopic myomectomy? J Minim Invasive Gynecol 2008; 15:292.",
"     </a>",
"    </li>",
"    <li>",
"     Falcone, T, Drake, RL, Hurd, WH. Surgical anatomy of the abdomen and pelvis. In: Clinical Reproductive Medicine and Surgery, Falcone, T, Hurd, WH (Eds), Mosby Elsevier, Philadelphia 2007. p.123.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10088/abstract/8\">",
"      Discepola F, Valenti DA, Reinhold C, Tulandi T. Analysis of arterial blood vessels surrounding the myoma: relevance to myomectomy. Obstet Gynecol 2007; 110:1301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10088/abstract/9\">",
"      Walocha JA, Litwin JA, Miodoski AJ. Vascular system of intramural leiomyomata revealed by corrosion casting and scanning electron microscopy. Hum Reprod 2003; 18:1088.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10088/abstract/10\">",
"      Shander A, Knight K, Thurer R, et al. Prevalence and outcomes of anemia in surgery: a systematic review of the literature. Am J Med 2004; 116 Suppl 7A:58S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10088/abstract/11\">",
"      Benoist S, Panis Y, Pannegeon V, et al. Predictive factors for perioperative blood transfusions in rectal resection for cancer: A multivariate analysis of a group of 212 patients. Surgery 2001; 129:433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10088/abstract/12\">",
"      Carson JL, Duff A, Poses RM, et al. Effect of anaemia and cardiovascular disease on surgical mortality and morbidity. Lancet 1996; 348:1055.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10088/abstract/13\">",
"      Lethaby A, Vollenhoven B, Sowter M. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids. Cochrane Database Syst Rev 2001; :CD000547.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10088/abstract/14\">",
"      Muneyyirci-Delale O, Richard-Davis G, Morris T, Armstrong J. Goserelin acetate 10.8 mg plus iron versus iron monotherapy prior to surgery in premenopausal women with iron-deficiency anemia due to uterine leiomyomas: results from a Phase III, randomized, multicenter, double-blind, controlled trial. Clin Ther 2007; 29:1682.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10088/abstract/15\">",
"      Stovall TG, Muneyyirci-Delale O, Summitt RL Jr, Scialli AR. GnRH agonist and iron versus placebo and iron in the anemic patient before surgery for leiomyomas: a randomized controlled trial. Leuprolide Acetate Study Group. Obstet Gynecol 1995; 86:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10088/abstract/16\">",
"      Deligdisch L, Hirschmann S, Altchek A. Pathologic changes in gonadotropin releasing hormone agonist analogue treated uterine leiomyomata. Fertil Steril 1997; 67:837.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10088/abstract/17\">",
"      Vercellini P, Tresp&igrave;di L, Zaina B, et al. Gonadotropin-releasing hormone agonist treatment before abdominal myomectomy: a controlled trial. Fertil Steril 2003; 79:1390.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10088/abstract/18\">",
"      Campo S, Garcea N. Laparoscopic myomectomy in premenopausal women with and without preoperative treatment using gonadotrophin-releasing hormone analogues. Hum Reprod 1999; 14:44.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10088/abstract/19\">",
"      Kongnyuy EJ, Wiysonge CS. Interventions to reduce haemorrhage during myomectomy for fibroids. Cochrane Database Syst Rev 2011; :CD005355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10088/abstract/20\">",
"      Ginsburg ES, Benson CB, Garfield JM, et al. The effect of operative technique and uterine size on blood loss during myomectomy: a prospective randomized study. Fertil Steril 1993; 60:956.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10088/abstract/21\">",
"      Fletcher H, Frederick J, Hardie M, Simeon D. A randomized comparison of vasopressin and tourniquet as hemostatic agents during myomectomy. Obstet Gynecol 1996; 87:1014.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10088/abstract/22\">",
"      Zhao F, Jiao Y, Guo Z, et al. Evaluation of loop ligation of larger myoma pseudocapsule combined with vasopressin on laparoscopic myomectomy. Fertil Steril 2011; 95:762.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10088/abstract/23\">",
"      Nezhat F, Admon D, Nezhat CH, et al. Life-threatening hypotension after vasopressin injection during operative laparoscopy, followed by uneventful repeat laparoscopy. J Am Assoc Gynecol Laparosc 1994; 2:83.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10088/abstract/24\">",
"      Hobo R, Netsu S, Koyasu Y, Tsutsumi O. Bradycardia and cardiac arrest caused by intramyometrial injection of vasopressin during a laparoscopically assisted myomectomy. Obstet Gynecol 2009; 113:484.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10088/abstract/25\">",
"      Tulandi T, B&eacute;ique F, Kimia M. Pulmonary edema: a complication of local injection of vasopressin at laparoscopy. Fertil Steril 1996; 66:478.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10088/abstract/26\">",
"      Lurie S, Mamet Y. Transient myocardial ischemia may occur following subendometrial vasopressin infiltration. Eur J Obstet Gynecol Reprod Biol 2000; 91:87.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10088/abstract/27\">",
"      Zullo F, Palomba S, Corea D, et al. Bupivacaine plus epinephrine for laparoscopic myomectomy: a randomized placebo-controlled trial. Obstet Gynecol 2004; 104:243.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10088/abstract/28\">",
"      Hung MH, Wang YM, Chia YY, et al. Intramyometrial injection of vasopressin causes bradycardia and cardiac arrest--report of two cases. Acta Anaesthesiol Taiwan 2006; 44:243.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10088/abstract/29\">",
"      DILLON TF, MARBURY BE, BONSNES RW, et al. Vasopressin as a hemostatic in gynecologic surgery; a preliminary report. Obstet Gynecol 1958; 11:363.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10088/abstract/30\">",
"      Frishman G. Vasopressin: if some is good, is more better? Obstet Gynecol 2009; 113:476.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10088/abstract/31\">",
"      Celik H, Sapmaz E. Use of a single preoperative dose of misoprostol is efficacious for patients who undergo abdominal myomectomy. Fertil Steril 2003; 79:1207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10088/abstract/32\">",
"      Caglar GS, Tasci Y, Kayikcioglu F, Haberal A. Intravenous tranexamic acid use in myomectomy: a prospective randomized double-blind placebo controlled study. Eur J Obstet Gynecol Reprod Biol 2008; 137:227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10088/abstract/33\">",
"      Benassi L, Lopopolo G, Pazzoni F, et al. Chemically assisted dissection of tissues: an interesting support in abdominal myomectomy. J Am Coll Surg 2000; 191:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10088/abstract/34\">",
"      Raga F, Sanz-Cortes M, Bonilla F, et al. Reducing blood loss at myomectomy with use of a gelatin-thrombin matrix hemostatic sealant. Fertil Steril 2009; 92:356.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10088/abstract/35\">",
"      Taylor A, Sharma M, Tsirkas P, et al. Reducing blood loss at open myomectomy using triple tourniquets: a randomised controlled trial. BJOG 2005; 112:340.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10088/abstract/36\">",
"      Nussbaum W, deCastro N, Campbell FW. Perioperative challenges in the care of the Jehovah's Witness: a case report. AANA J 1994; 62:160.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10088/abstract/37\">",
"      Helal AS, Abdel-Hady el-S, Refaie E, et al. Preliminary uterine artery ligation versus pericervical mechanical tourniquet in reducing hemorrhage during abdominal myomectomy. Int J Gynaecol Obstet 2010; 108:233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10088/abstract/38\">",
"      Dumousset E, Chabrot P, Rabischong B, et al. Preoperative uterine artery embolization (PUAE) before uterine fibroid myomectomy. Cardiovasc Intervent Radiol 2008; 31:514.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 15798 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-200.131.240.2-0CE6B713CC-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_54_10088=[""].join("\n");
var outline_f9_54_10088=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H1389289\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1389281\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3731788\">",
"      VASCULAR ANATOMY OF THE UTERUS AND LEIOMYOMAS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1389273\">",
"      PREOPERATIVE MEASURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1389432\">",
"      Correction of anemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1389439\">",
"      GnRH agonists",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1390136\">",
"      Autologous blood donation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1388946\">",
"      INTRAOPERATIVE MEASURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4413351\">",
"      Pharmacologic interventions",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4413358\">",
"      - Vasopressin and other vasoconstrictors",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4413531\">",
"      - Uterotonics",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4413538\">",
"      - Other agents",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1388953\">",
"      Tourniquets and clamps",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1388988\">",
"      Autologous blood transfusion",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6862479\">",
"      - Autologous blood donation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6862472\">",
"      - Intraoperative blood salvage",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2728258\">",
"      - Normovolemic (isovolemic) hemodilution",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1388995\">",
"      Other measures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3732327\">",
"      CLINICAL APPROACH",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1389289\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"OBGYN/15798\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/15798|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?14/55/15222\" title=\"figure 1\">",
"      Uterine blood supply",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?16/38/16995\" title=\"figure 2\">",
"      Myomectomy tourniquet and clamps",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/3/12346?source=related_link\">",
"      Abdominal myomectomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/51/37684?source=related_link\">",
"      Acute normovolemic intraoperative hemodilution",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/41/20122?source=related_link\">",
"      Chronic menorrhagia or anovulatory uterine bleeding",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/21/10582?source=related_link\">",
"      Intraoperative and postoperative blood salvage",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/48/8970?source=related_link\">",
"      Laparoscopic myomectomy and other laparoscopic treatments for uterine leiomyomas (fibroids)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/18/43305?source=related_link\">",
"      Management of hemorrhage in gynecologic surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/54/12134?source=related_link\">",
"      Preoperative autologous blood donation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/60/22473?source=related_link\">",
"      Uterine leiomyoma (fibroid) embolization",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f9_54_10089="Chapter 11B: Regulation of renal hydrogen excretion";
var content_f9_54_10089=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Chapter 11B: Regulation of renal hydrogen excretion",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/54/10089/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/54/10089/contributors\">",
"     Burton D Rose, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/54/10089/contributors\">",
"     Theodore W Post, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/54/10089/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/54/10089/contributors\">",
"     Burton D Rose, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/54/10089/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/54/10089/contributors\">",
"     Theodore W Post, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?9/54/10089/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 15, 2000.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The preceding section discussed how the kidney excretes H+ ions. In this section, we will review the factors that determine exactly how much H+ is excreted. The extracellular pH (which is most often measured clinically on a specimen of arterial blood) is the major physiologic regulator of this process, as it allows acid excretion to vary with day-to-day changes in the dietary acid load. In addition, the rate of H+ secretion also can be influenced by the effective circulating volume, aldosterone, the plasma K+ concentration, and other less important factors such as parathyroid hormone.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EXTRACELLULAR PH",
"    </span>",
"    &nbsp;&mdash;&nbsp;Net acid excretion tends to vary inversely with the extracellular pH. Acidemia, for example, is characterized by a fall in extracellular pH (or rise in H+ concentration) and is associated with an increase in both proximal and distal acidification [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10089/abstract/1-4\">",
"     1-4",
"    </a>",
"    ]. This is manifested in the proximal tubule by three changes:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Enhanced luminal Na+-H+ exchange [",
"      <a class=\"abstract\" href=\"UTD.htm?9/54/10089/abstract/1,2,5\">",
"       1,2,5",
"      </a>",
"      ], a response that may be mediated both by binding of excess intracellular H+ ions to a modifier site on the exchanger [",
"      <a class=\"abstract\" href=\"UTD.htm?9/54/10089/abstract/1\">",
"       1",
"      </a>",
"      ] and by the synthesis of new exchangers, as evidenced by a rise in mRNA for the Na+-H+ antiporter [",
"      <a class=\"abstract\" href=\"UTD.htm?9/54/10089/abstract/6\">",
"       6",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Increased activity of the Na:3HCO3- cotransporter in the basolateral membrane, thereby allowing HCO3- formed within the cell to be returned to the systemic circulation [",
"      <a class=\"abstract\" href=\"UTD.htm?9/54/10089/abstract/2,5,7\">",
"       2,5,7",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Increased NH4+ production from glutamine&nbsp;[",
"      <a class=\"abstract\" href=\"UTD.htm?9/54/10089/abstract/8\">",
"       8",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In the collecting tubules, on the other hand, the increase in acidification appears to involve the insertion of preformed cytoplasmic H+-ATPase pumps into the luminal membrane of the acid-secreting cells [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10089/abstract/9-11\">",
"     9-11",
"    </a>",
"    ], particularly those in the outer medullary collecting duct [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10089/abstract/11\">",
"     11",
"    </a>",
"    ]. The ensuing reduction in the tubular fluid pH in these segments will promote the diffusion of interstitial NH3 into the lumen, where it will be trapped as NH4+ (",
"    <a class=\"graphic graphic_figure graphicRef70913 \" href=\"UTD.htm?16/18/16686\">",
"     figure 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10089/abstract/12\">",
"     12",
"    </a>",
"    ]. The net effect of this increase in acid excretion is enhanced generation of HCO3- by the tubules. Return of this HCO3- to the systemic circulation will then raise the extracellular pH toward normal.",
"   </p>",
"   <p>",
"    The extracellular pH is thought to affect net acid excretion in part by parallel, although lesser, alterations in the renal tubular cell pH [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10089/abstract/13,14\">",
"     13,14",
"    </a>",
"    ]. The importance of this local effect, which is independent of other circulating factors, has been demonstrated in experiments with cultured renal proximal tubule cells. Lowering the pH of the bathing medium in this setting leads to a significant increase in the activity of the luminal Na+-H+ exchanger [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10089/abstract/15\">",
"     15",
"    </a>",
"    ]. This effect is thought to be mediated by activation of",
"    <strong>",
"     pH-sensitive proteins",
"    </strong>",
"    &nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10089/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The mechanism by which the intracellular pH changes varies with the cause of the acid-base disorder. An elevation in the PCO2, for example, will lower the pH of the extracellular fluid; this will induce a similar and rapid acidification in the cells, because CO2 can freely cross cell membranes.",
"   </p>",
"   <p>",
"    The effect of alterations in the plasma HCO3- concentration is less direct, since transcellular diffusion of this anion is limited by the lipid bilayer of the cell membrane. However, the carrier-mediated HCO3- exit steps in the basolateral membrane of the proximal tubule (Na+-3HCO3- cotransport) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10089/abstract/13,14\">",
"     13,14",
"    </a>",
"    ] and the distal nephron (Cl--HCO3- exchange) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10089/abstract/17\">",
"     17",
"    </a>",
"    ] are affected by the transmembrane HCO3- gradient. For example, lowering the extracellular pH by reducing the HCO3- concentration will make this gradient more favorable, thereby promoting HCO3- exit from the cell and reducing the cell pH (",
"    <a class=\"graphic graphic_figure graphicRef72181 \" href=\"UTD.htm?5/62/6125\">",
"     figure 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10089/abstract/13,14\">",
"     13,14",
"    </a>",
"    ]. The ensuing increase in acid excretion then raises both the systemic and the intracellular pH toward normal; thus, it may actually be the intracellular pH that is primarily being regulated [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10089/abstract/17,18\">",
"     17,18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These adaptive changes in cell pH are determined by the extracellular pH itself, not by the HCO3- concentration or PCO2 alone. Thus, there is no alteration in the cell pH if both the HCO3- concentration and PCO2 are lowered or raised to a similar degree, so that the extracellular pH remains constant [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10089/abstract/13\">",
"     13",
"    </a>",
"    ]. In this setting, there is also no change in net acid excretion [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10089/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Metabolic acidosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Metabolic acidosis is characterized by acidemia that is due to a fall in the plasma HCO3- concentration. Net acid excretion is appropriately and often dramatically increased in this disorder, beginning within one day and reaching its maximum in 5 to 6 days (",
"    <a class=\"graphic graphic_figure graphicRef80366 \" href=\"UTD.htm?7/46/7917\">",
"     figure 3",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10089/abstract/12,19,20\">",
"     12,19,20",
"    </a>",
"    ]. This response is mostly due to enhanced NH4+ excretion which is mediated both by increased proximal NH4+ secretion [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10089/abstract/8,12\">",
"     8,12",
"    </a>",
"    ] and by increased distal hydrogen secretion [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10089/abstract/10,11\">",
"     10,11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In comparison, titratable acid excretion is generally limited by the amount of phosphate in the urine, which is modestly increased by an acidemia-induced inhibition of proximal phosphate reabsorption [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10089/abstract/21\">",
"     21",
"    </a>",
"    ]. An exception to this rule occurs in diabetic ketoacidosis, where urinary ketone anions (particularly &szlig;-hydroxybutyrate) can act as titratable acids. In this setting, net acid excretion can exceed 500",
"    <span class=\"nowrap\">",
"     meq/day",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10089/abstract/22,23\">",
"     22,23",
"    </a>",
"    ], resulting in the generation of an equivalent quantity of HCO3- ions in the extracellular fluid.",
"   </p>",
"   <p>",
"    The relationship between cell pH and net acid excretion can also be understood in terms of the steady state. Suppose a normal subject increases acid generation by going on a high protein diet. Over a period of days, net acid excretion will rise until it meets the new level of acid production. At this time, the patient is back in a new steady state, but the plasma HCO3- concentration must have fallen to provide the signal (lower cell pH) for the higher level of acid excretion. This process is reasonably efficient. As shown in this figure (",
"    <a class=\"graphic graphic_figure graphicRef80366 \" href=\"UTD.htm?7/46/7917\">",
"     figure 3",
"    </a>",
"    ), for example, lowering the plasma HCO3- concentration by 4 to 5",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"    leads to a fourfold increase in NH4+ excretion.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Metabolic alkalosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Metabolic alkalosis, on the other hand, is characterized by an alkaline extracellular pH that results from an elevation in the plasma HCO3- concentration. The normal response to a HCO3- load is to excrete the excess HCO3- in the urine, both by diminishing its rate of reabsorption and by HCO3- secretion in the cortical collecting tubule [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10089/abstract/24-26\">",
"     24-26",
"    </a>",
"    ]. As described above, the latter process occurs in a subpopulation of cortical intercalated cell that are able, in the presence of an elevated pH, to insert H+-ATPase pumps into the basolateral rather than the luminal membrane (",
"    <a class=\"graphic graphic_figure graphicRef62465 \" href=\"UTD.htm?17/31/17917\">",
"     figure 4",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10089/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This protective bicarbonaturic response is extremely efficient. As an example, the administration of as much as 1000 meq of NaHCO3 per day to normal subjects induces only a minor elevation in the plasma HCO3- concentration, as virtually all of the excess HCO3- is excreted in the urine [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10089/abstract/27\">",
"     27",
"    </a>",
"    ]. Thus, maintenance of metabolic alkalosis requires the presence of a defect in HCO3- excretion that is most often due to effective volume and chloride depletion (see below).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Respiratory acidosis and alkalosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Disturbances in alveolar ventilation induce changes in CO2 elimination and, consequently, in the PCO2. Primary hyperventilation, for example, enhances CO2 loss, resulting in a fall in the PCO2 (hypocapnia) and a rise in pH that is called respiratory alkalosis. Primary hypoventilation, on the other hand, impairs CO2 elimination, producing an elevation in the PCO2 (hypercapnia) and a reduction in pH that is called respiratory acidosis. Although correction of either of these conditions requires the restoration of normal alveolar ventilation, the kidney can minimize the changes in arterial pH by varying H+ excretion and HCO3- reabsorption.",
"   </p>",
"   <p>",
"    From the Henderson-Hasselbalch equation, the extracellular pH is a function of the",
"    <span class=\"nowrap\">",
"     HCO3-/PCO2",
"    </span>",
"    ratio. Thus, the pH may remain near normal in respiratory acid-base disorders if the PCO2 and HCO3-concentration change in the same direction and to a similar degree. Consequently, an elevation in the plasma HCO3- concentration is an appropriate response to hypercapnia, and a reduction in the plasma HCO3- concentration is an appropriate response to hypocapnia.",
"   </p>",
"   <p>",
"    These changes occur because the PCO2, via its effect on intracellular pH, is an important determinant of H+ secretion and HCO3- reabsorption (",
"    <a class=\"graphic graphic_figure graphicRef75228 \" href=\"UTD.htm?1/23/1405\">",
"     figure 5",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10089/abstract/3,4,9\">",
"     3,4,9",
"    </a>",
"    ]. With chronic respiratory acidosis, for example, there is an increase in net acid excretion (primarily as NH4+), resulting in the generation of new HCO3- ions in the plasma [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10089/abstract/28\">",
"     28",
"    </a>",
"    ]. The net effect in the steady state (which is achieved within 5 to 6 days) is that the rise is PCO2 is partially offset by an increase in the plasma HCO3- concentration that averages 3.5",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"    for every 10 mmHg elevation in the PCO2 [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10089/abstract/29\">",
"     29",
"    </a>",
"    ].A review of the renal and extrarenal compensations that occur in respiratory acid-base disturbances can be found elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/41/27288?source=see_link\">",
"     \"Simple and mixed acid-base disorders\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The renal response is reversed in chronic respiratory alkalosis. In this setting, the concurrent rise in intracellular pH diminishes H+ secretion, resulting in HCO3- loss in the urine and decreased NH4+ excretion [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10089/abstract/30,31\">",
"     30,31",
"    </a>",
"    ]. These changes are manifested by a fall in the plasma HCO3- concentration that averages 5",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"    for every 10 mmHg decline in the PCO2 [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10089/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Chronic metabolic acidosis versus chronic respiratory acidosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although chronic metabolic and respiratory acid-base disturbances can produce similar changes in extracellular pH, there are major differences in the renal response that illustrate the role of the intracellular pH in determining the degree of acidification that occurs [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10089/abstract/32,33\">",
"     32,33",
"    </a>",
"    ]. In chronic metabolic acidosis, for example, the daily acid load must be increased to sustain the acidemia (as with chronic diarrhea). Consequently, net acid and NH4+ excretion are persistently above normal (",
"    <a class=\"graphic graphic_figure graphicRef61554 \" href=\"UTD.htm?8/17/8477\">",
"     figure 6",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The same response is seen in acute respiratory acidosis, as new HCO3- ions must be generated to produce the compensatory rise in the plasma HCO3- concentration [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10089/abstract/3,28\">",
"     3,28",
"    </a>",
"    ]. In the new steady state, however, the pH will be partially corrected but the daily acid load generated from protein metabolism will be normal (assuming that there is no change in dietary intake). As a result, there is no necessity for increased NH4+ excretion, which returns to a level similar to that in controls (",
"    <a class=\"graphic graphic_figure graphicRef61554 \" href=\"UTD.htm?8/17/8477\">",
"     figure 6",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10089/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    To summarize, net acid and NH4+ excretion are enhanced in chronic metabolic but not respiratory acidosis, despite a similar degree of acidemia in both conditions. This seemingly paradoxical finding may be explained by differences in proximal tubular cell pH [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10089/abstract/33,34\">",
"     33,34",
"    </a>",
"    ]. Both metabolic and respiratory acidosis will produce a similar effect at the basolateral membrane: lowering the cell pH by HCO3- exit down a more favorable gradient in metabolic acidosis, and by CO2 entry in respiratory acidosis [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10089/abstract/13,14\">",
"     13,14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The responses are quite different, however, at the luminal membrane. The plasma HCO3- concentration and therefore the filtered HCO3- load are reduced in metabolic acidosis. As a result, less HCO3- is reabsorbed in the proximal tubule by Na+-H+ exchange. In comparison, the plasma HCO3- concentration and filtered HCO3- load are elevated in chronic respiratory acidosis. This increase in the tubular fluid HCO3- concentration allows more HCO3- to be reabsorbed [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10089/abstract/35\">",
"     35",
"    </a>",
"    ]. It is important to remember that proximal acidification is limited by the transcellular Na+ gradient that provides the energy for the Na+-H+ antiporter. When more buffer (as HCO3-) is present, more H+ secretion can occur without an excessive reduction in tubular fluid pH [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10089/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The net effect of this increase in H+ extrusion from the cell is that the proximal tubular cell pH returns toward normal in chronic respiratory acidosis&dagger; [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10089/abstract/33,34\">",
"     33,34",
"    </a>",
"    ]. As a result, there is now no stimulus to increase proximal NH4+ secretion, in comparison to chronic metabolic acidosis where the cell pH is persistently reduced [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10089/abstract/34\">",
"     34",
"    </a>",
"    ]. Similar factors may explain why mRNA expression for the Na+-H+ exchanger is increased in metabolic acidosis, but unchanged in chronic respiratory acidosis [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10089/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    &nbsp;&dagger; It seems likely that distal acidification is similar in metabolic and respiratory acidosis [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10089/abstract/4\">",
"     4",
"    </a>",
"    ], since the confounding effect of increased HCO3- reabsorption is primarily limited to the proximal tubule. However, this preservation of distal function in chronic respiratory acidosis does not lead to a significant increase in net acid excretion, since virtually all of the urinary NH4+ is produced proximally [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10089/abstract/8,36\">",
"     8,36",
"    </a>",
"    ]. Therefore, the absence of an elevation in proximal NH4+ production in this disorder [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10089/abstract/32\">",
"     32",
"    </a>",
"    ] limits the degree to which distal H+ secretion can enhance net acid excretion.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     EFFECTIVE CIRCULATING VOLUME",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bicarbonate reabsorption can be influenced by the effective circulating volume, with the most important effect being an increase in HCO3- reabsorptive capacity with volume depletion [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10089/abstract/35,37,38\">",
"     35,37,38",
"    </a>",
"    ]. As shown in this figure (",
"    <a class=\"graphic graphic_figure graphicRef80338 \" href=\"UTD.htm?25/50/26413\">",
"     figure 7",
"    </a>",
"    ), for example, raising the plasma HCO3- concentration by infusing NaHCO3 leads to a plateau in HCO3- reabsorption at a level of about 26",
"    <span class=\"nowrap\">",
"     meq/L.",
"    </span>",
"    This is a proper response, since it allows virtually all of the filtered HCO3- to be reabsorbed as long as the plasma HCO3- concentration is within the normal range. Once the latter exceeds 26",
"    <span class=\"nowrap\">",
"     meq/L,",
"    </span>",
"    however, inappropriate HCO3- retention is prevented by excretion of the excess HCO3- in the urine.",
"   </p>",
"   <p>",
"    In contrast, if hypovolemia is induced by the prior administration of a diuretic, then net HCO3- reabsorption continues to increase, even at a level above 35",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"    (",
"    <a class=\"graphic graphic_figure graphicRef80338 \" href=\"UTD.htm?25/50/26413\">",
"     figure 7",
"    </a>",
"    ). This effect can be demonstrated in normals simply by the ingestion of a low salt diet (10",
"    <span class=\"nowrap\">",
"     meq/day),",
"    </span>",
"    which is sufficient to increase HCO3- reabsorptive capacity by 4",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"    even though the subject is clinically euvolemic [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10089/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The relationship between volume depletion and HCO3- transport becomes clinically important in patients with metabolic alkalosis, in whom the inability to excrete the excess HCO3- prevents the spontaneous restoration of acid-base balance [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10089/abstract/40\">",
"     40",
"    </a>",
"    ]. In this setting, the attempt to maintain volume, by preventing further Na+ loss as NaHCO3, occurs at the expense of the systemic pH. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/28/10692?source=see_link\">",
"     \"Pathogenesis of metabolic alkalosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    At least four factors may contribute to this effect on HCO3- excretion: (1) a reduction in glomerular filtration rate; (2) activation of the renin-angiotensin-aldosterone system; (3) hypochloremia; and (4) concurrent hypokalemia due to urinary or gastrointestinal losses (see below) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10089/abstract/37,40-42\">",
"     37,40-42",
"    </a>",
"    ]. A decline in GFR, for example, may play a permissive role in selected patients. It is not likely to be of primary importance, however, since the rise in the plasma HCO3- concentration results in a filtered load of HCO3- that is often not diminished. Furthermore, many patients maintain a GFR that is relatively normal; in this setting, increased tubular reabsorption must be responsible for the absence of HCO3- excretion [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10089/abstract/40,42\">",
"     40,42",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Renin-angiotensin-aldosterone system",
"    </span>",
"    &nbsp;&mdash;&nbsp;The hypovolemia-induced increase in renin release can enhance net H+ secretion and therefore HCO3- reabsorption in several ways. Angiotensin II, acting in the early proximal tubule, is a potent stimulator of HCO3- transport, by increasing the activity of both the luminal Na+-H+ antiporter and the basolateral Na+-3HCO3- cotransporter [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10089/abstract/43,44\">",
"     43,44",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, the physiologic significance of this response on acid-base balance is uncertain. Angiotensin II does increase HCO3- reabsorption in the early proximal tubule, but the ensuing decrease in delivery out of this segment may result in an equivalent delivery-dependent reduction in HCO3- transport in the late proximal tubule [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10089/abstract/45,46\">",
"     45,46",
"    </a>",
"    ]. Thus, there may be a net neutral effect on HCO3- handling, as the major function of the proximal action of angiotensin II is to increase NaCl and water reabsorption, thereby appropriately expanding the extracellular volume&dagger; [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10089/abstract/45\">",
"     45",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Aldosterone, on the other hand, may play a more important role by stimulating the Na+-independent H+-ATPase pump throughout the distal nephron, including the intercalated cells in the cortical collecting tubule, and the cells in the outer and inner medullary collecting tubule&dagger; [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10089/abstract/47-52\">",
"     47-52",
"    </a>",
"    ]. Aldosterone also increases the activity of the second step in distal acidification, promoting HCO3- extrusion from the cell into the peritubular capillary via the basolateral Cl--HCO3- exchanger [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10089/abstract/17,50\">",
"     17,50",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    &nbsp;&dagger;This ability of aldosterone to increase urinary H+ loss can promote the development of metabolic alkalosis in disorders of primary mineralocorticoid excess, such as primary aldosteronism. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/1/37911?source=see_link\">",
"     \"Clinical features of primary aldosteronism\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition, aldosterone can indirectly increase net H+ secretion by its ability to stimulate Na+ transport in a different cell population, the principal cells in the cortical collecting tubule (",
"    <a class=\"graphic graphic_figure graphicRef60693 \" href=\"UTD.htm?12/31/12797\">",
"     figure 8",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10089/abstract/37,53,54\">",
"     37,53,54",
"    </a>",
"    ]. The reabsorption of cationic Na+ ions creates a lumen-negative potential difference; this electrical gradient then promotes H+ accumulation in the lumen by minimizing the degree of back-diffusion.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Chloride depletion",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypochloremia is a common concomitant of metabolic alkalosis, since both H+ and Cl- ions are lost in most patients, such as those with vomiting or diuretic therapy. This reduction in the filtered Cl- concentration can enhance H+ secretion and HCO3- reabsorption through both Na+-dependent and Na+-independent factors. It has been proposed, for example, that the effect of hypochloremia is related to the high level of Na+ reabsorption seen in volume depletion, often leading to a urine Na+ concentration below 5 to 10",
"    <span class=\"nowrap\">",
"     meq/L.",
"    </span>",
"    If, as in normal subjects, the filtrate Na+ concentration is 145",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"    and the filtrate Cl- concentration is 115",
"    <span class=\"nowrap\">",
"     meq/L,",
"    </span>",
"    then only 115",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"    of Na+ can be reabsorbed with Cl-. Since Cl- is the only quantitatively important reabsorbable anion in the filtrate, further Na+ reabsorption must be accompanied by H+ or K+ secretion to maintain electroneutrality. These secretory processes, which primarily occur in the collecting tubules, become more important in the presence of hypochloremia, since less of the filtered Na+ can be reabsorbed with Cl-. The net effect is enhanced H+ secretion, increased HCO3- reabsorption, and persistence of the metabolic alkalosis.",
"   </p>",
"   <p>",
"    The importance of both volume status and the reabsorbability of the anion can be illustrated by the response to an infusion of Na2SO4 (SO42- being a poorly reabsorbed anion). When given to a euvolemic subject, Na2SO4 will be rapidly excreted in the urine. In a volume-depleted subject, however, the Na+ will be retained (in part under the influence of aldosterone) and, since SO42- cannot be reabsorbed, H+ and K+ secretion must be increased (",
"    <a class=\"graphic graphic_figure graphicRef73828 \" href=\"UTD.htm?42/60/43980\">",
"     figure 9",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10089/abstract/55\">",
"     55",
"    </a>",
"    ]. In contrast, the administration of NaCl in this setting results in both Na+ and Cl- reabsorption without affecting H+ and K+ secretion.",
"   </p>",
"   <p>",
"    The reabsorbability of the anion creates a paradoxical situation in patients with hypovolemia and metabolic alkalosis in that the administration of acid will not necessarily correct the alkalemia. If, for example, HNO3 is given (NO3- being relatively nonreabsorbable), it will be buffered by extracellular HCO3-:",
"   </p>",
"   <p>",
"    &nbsp; &nbsp;HNO3 &nbsp;+ &nbsp;NaHCO3 &nbsp; &nbsp;&mdash;&gt; &nbsp; &nbsp; NaNO3 &nbsp;+ &nbsp;H2CO3 &nbsp; &nbsp;&mdash;&gt; &nbsp; &nbsp;CO2 &nbsp;+ &nbsp;H2O",
"   </p>",
"   <p>",
"    As the NaNO3 is presented to the cortical collecting tubule, Na+ will be retained and H+ excretion enhanced. This is similar to the fate of Na2SO4, with the net effect being the excretion of the administered HNO3 as NH4NO3 [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10089/abstract/56\">",
"     56",
"    </a>",
"    ]. As a result, the arterial pH will be unchanged, since an acid urine is excreted despite the presence of systemic alkalemia.",
"   </p>",
"   <p>",
"    If, in comparison, acid is given as HCl, buffering by NaHCO3 will lead to the generation of NaCl. When this reaches the cortical collecting tubule, the Na+ will be reabsorbed with Cl- and not exchanged for H+. Therefore, the administered H+ will be retained and the alkalemia will be corrected.",
"   </p>",
"   <p>",
"    Rather than giving HCl, the alkalemia can be reversed more easily by promoting HCO3- excretion in the urine. This can be achieved by expanding the effective circulating volume with NaCl, eventually allowing the excess HCO3- to be excreted as NaHCO3. In comparison, the administration of Na+ with a different, nonreabsorbable anion, such as SO42-, will be ineffective. Thus, the correction of metabolic alkalosis in a volume-depleted (Na+-avid) subject requires the administration of the only reabsorbable anion Cl-, either as NaCl, HCl, or, if hypokalemia is present, KCl. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/14/14568?source=see_link\">",
"     \"Treatment of metabolic alkalosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The importance of Cl- may also be related to direct effects on acid-base handling that are independent of Na+ [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10089/abstract/41,57\">",
"     41,57",
"    </a>",
"    ]. In particular, both HCO3- secretion by the type B intercalated cells in the cortical collecting tubule and H+ secretion in the distal nephron can be affected by the local Cl- concentration:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      HCO3- secretion into the lumen in the type B intercalated cells appears to be mediated by a Cl--HCO3- exchanger in the luminal membrane, the energy for which is provided by the favorable inward gradient for Cl- (",
"      <a class=\"graphic graphic_figure graphicRef62465 \" href=\"UTD.htm?17/31/17917\">",
"       figure 4",
"      </a>",
"      )&nbsp;[",
"      <a class=\"abstract\" href=\"UTD.htm?9/54/10089/abstract/25,26\">",
"       25,26",
"      </a>",
"      ]. Lowering the tubular fluid Cl- concentration will diminish this gradient, minimizing the ability to secrete HCO3-.",
"     </li>",
"     <li>",
"      With H+ secretion by the H+-ATPase pump, Cl- appears to be passively cosecreted to maintain electroneutrality [",
"      <a class=\"abstract\" href=\"UTD.htm?9/54/10089/abstract/58\">",
"       58",
"      </a>",
"      ]. The gradient for Cl- secretion and therefore the ability to secrete H+ may be enhanced when the tubular fluid Cl- concentration is reduced [",
"      <a class=\"abstract\" href=\"UTD.htm?9/54/10089/abstract/57\">",
"       57",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Both diminished HCO3- secretion and enhanced H+ secretion will contribute to maintenance of the high plasma HCO3- concentration and persistence of the alkalemia.",
"   </p>",
"   <p>",
"    In summary, the effects of hypochloremia on net HCO3- reabsorption are most prominent in the collecting tubules. Thus, the appropriate HCO3- diuresis induced by fluid and chloride repletion is mostly mediated by decreased net distal HCO3- reabsorption (which probably includes a component of HCO3- secretion) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10089/abstract/59\">",
"     59",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     PLASMA POTASSIUM CONCENTRATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Potassium is another potential influence on renal H+ secretion, as a reciprocal relationship has been demonstrated between the plasma K+ concentration and HCO3- reabsorption (",
"    <a class=\"graphic graphic_figure graphicRef76787 \" href=\"UTD.htm?1/17/1309\">",
"     figure 10",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10089/abstract/60-62\">",
"     60-62",
"    </a>",
"    ]. The major proposed mechanism for this relationship is that alterations in K+ balance lead to transcellular cation shifts that affect the intracellular H+ concentration (",
"    <a class=\"graphic graphic_figure graphicRef67451 \" href=\"UTD.htm?31/46/32492\">",
"     figure 11",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    As an example, gastrointestinal or urinary K+ losses lead to a reduction in the plasma K+ concentration. As a result, intracellular K+ moves into the extracellular fluid (through K+ channels in the cell membrane) down a favorable concentration gradient to replete the extracellular stores. To maintain electroneutrality, H+ (and Na+) enter the cell [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10089/abstract/63\">",
"     63",
"    </a>",
"    ], resulting in an intracellular acidosis [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10089/abstract/34,64,65\">",
"     34,64,65",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This increase in H+ concentration in the renal tubular cells may account for the enhanced H+ secretion, HCO3- reabsorption, and NH4+ excretion observed with K+ depletion [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10089/abstract/60,65,66\">",
"     60,65,66",
"    </a>",
"    ]. In the proximal tubule, for example, hypokalemia is associated with increased activity of both the luminal Na+-H+ antiporter and the basolateral Na+-3HCO3- cotransporter that are required for the elevations in H+ secretion and HCO3- reabsorption [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10089/abstract/67\">",
"     67",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These changes are reversed with a rise in the plasma K+ concentration, as K+ moves into and H+ out of cells [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10089/abstract/68\">",
"     68",
"    </a>",
"    ]. The ensuing intracellular alkalosis may then account for the associated reductions in HCO3- reabsorption and NH4+ excretion [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10089/abstract/60,65,66\">",
"     60,65,66",
"    </a>",
"    ]",
"   </p>",
"   <p>",
"    Factors other than these transcellular shifts also may contribute to the potassium-induced changes in urinary acidification. As an example, hyperkalemia reduces NH4+ excretion in rats; there is, however, no change in NH4+ delivery out of the proximal tubule, suggesting that segments distal to the proximal tubule must be involved [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10089/abstract/69\">",
"     69",
"    </a>",
"    ]. There are at least 2 mechanisms by which distal K+ and H+ handling might be related.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Medullary recycling of NH4+ is initiated by substitution of NH4+ for K+ on the Na+-K+-2Cl- carrier in the luminal membrane of the thick ascending limb (",
"      <a class=\"graphic graphic_figure graphicRef69352 \" href=\"UTD.htm?2/32/2574\">",
"       figure 12",
"      </a>",
"      )&nbsp;[",
"      <a class=\"abstract\" href=\"UTD.htm?9/54/10089/abstract/70\">",
"       70",
"      </a>",
"      ]. Increased luminal K+ in hyperkalemia could competitively inhibit this process, thereby limiting ammonia accumulation in the medullary interstitium, subsequent secretion into the medullary collecting tubule, and total urinary NH4+ excretion [",
"      <a class=\"abstract\" href=\"UTD.htm?9/54/10089/abstract/69,71\">",
"       69,71",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      H+ secretion in the distal nephron is mediated in part by an electroneutral H+-K+-ATPase that also actively reabsorbs K+ [",
"      <a class=\"abstract\" href=\"UTD.htm?9/54/10089/abstract/72-74\">",
"       72-74",
"      </a>",
"      ]. Active K+ reabsorption by this pump appears to be stimulated by hypokalemia [",
"      <a class=\"abstract\" href=\"UTD.htm?9/54/10089/abstract/74-77\">",
"       74-77",
"      </a>",
"      ], an effect that could in part explain the concurrent increase in H+ secretion. The net result is that hypokalemia and aldosterone, which stimulate the H+-K+-ATPase and H+-ATPase pumps, respectively, can have a potentiating effect on distal hydrogen secretion and therefore on the development and maintenance of metabolic alkalosis [",
"      <a class=\"abstract\" href=\"UTD.htm?9/54/10089/abstract/78\">",
"       78",
"      </a>",
"      ]. This synergism has potential clinical importance, since many of the causes of metabolic alkalosis (such as diuretic therapy, vomiting, and primary hyperaldosteronism) are associated with both a reduction in the plasma K+ concentration and increased aldosterone release. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?8/22/8551?source=see_link\">",
"       \"Causes of metabolic alkalosis\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In summary, hypokalemia tends to increase net acid excretion, which promotes the development of metabolic alkalosis. Hyperkalemia, via opposite mechanisms, reduces net acid excretion which, by causing H+ retention, favors the development of metabolic acidosis. In some patients with hyperkalemia due to hypoaldosteronism, for example, the associated metabolic acidosis can be corrected solely by lowering the plasma K+ concentration [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10089/abstract/66\">",
"     66",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     PARATHYROID HORMONE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Parathyroid hormone (PTH) diminishes proximal HCO3- reabsorption by reducing the activity of Na+-H+ exchanger in the luminal membrane [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10089/abstract/79,80\">",
"     79,80",
"    </a>",
"    ] and the Na+-3HCO3- cotransporter in the basolateral membrane [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10089/abstract/81\">",
"     81",
"    </a>",
"    ]. However, the extra HCO3- delivered out of the proximal tubule is mostly picked up in the loop of Henle and more distal segments. Although there may be a slight increase in HCO3- excretion, this is generally counteracted by enhanced excretion of phosphate which can increase net acid excretion by buffering secreted H+ ions [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10089/abstract/82\">",
"     82",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This response may be physiologically important, since an acid load stimulates PTH secretion. PTH then minimizes the change in extracellular pH both by promoting bone buffering and by increasing acid and phosphate excretion in the urine [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10089/abstract/82,83\">",
"     82,83",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The effect of a chronic excess of PTH on acid-base balance is less clear. Patients with primary hyperparathyroidism, who are also hypercalcemic, tend to have a metabolic acidosis [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10089/abstract/84\">",
"     84",
"    </a>",
"    ]. However, the chronic, continuous administration of PTH to normal humans increases net acid excretion and produces a small elevation, not reduction, in the plasma HCO3- concentration [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10089/abstract/85\">",
"     85",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This discussion is continued elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/11/28852?source=see_link\">",
"     \"Chapter 11C: Effect of arterial pH on ventilation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    (From Rose, BD, Post, TW. Clinical Physiology of Acid-Base and Electrolyte Disorders, 5th ed, McGraw-Hill, New York, 2001.)",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/1\">",
"      Aronson PS, Nee J, Suhm MA. Modifier role of internal H+ in activating the Na+-H+ exchanger in renal microvillus membrane vesicles. Nature 1982; 299:161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/2\">",
"      Akiba T, Rocco VK, Warnock DG. Parallel adaptation of the rabbit renal cortical sodium/proton antiporter and sodium/bicarbonate cotransporter in metabolic acidosis and alkalosis. J Clin Invest 1987; 80:308.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/3\">",
"      Sasaki S, Berry CA, Rector FC Jr. Effect of luminal and peritubular HCO3(-) concentrations and PCO2 on HCO3(-) reabsorption in rabbit proximal convoluted tubules perfused in vitro. J Clin Invest 1982; 70:639.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/4\">",
"      Tannen RL, Hamid B. Adaptive changes in renal acidification in response to chronic respiratory acidosis. Am J Physiol 1985; 248:F492.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/5\">",
"      Preisig PA, Alpern RJ. Chronic metabolic acidosis causes an adaptation in the apical membrane Na/H antiporter and basolateral membrane Na(HCO3)3 symporter in the rat proximal convoluted tubule. J Clin Invest 1988; 82:1445.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/6\">",
"      Krapf R, Pearce D, Lynch C, et al. Expression of rat renal Na/H antiporter mRNA levels in response to respiratory and metabolic acidosis. J Clin Invest 1991; 87:747.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/7\">",
"      Soleimani M, Lesoine GA, Bergman JA, McKinney TD. A pH modifier site regulates activity of the Na+:HCO3- cotransporter in basolateral membranes of kidney proximal tubules. J Clin Invest 1991; 88:1135.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/8\">",
"      Good DW, Burg MB. Ammonia production by individual segments of the rat nephron. J Clin Invest 1984; 73:602.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/9\">",
"      Verlander JW, Madsen KM, Tisher CC. Effect of acute respiratory acidosis on two populations of intercalated cells in rat cortical collecting duct. Am J Physiol 1987; 253:F1142.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/10\">",
"      Bastani B, Purcell H, Hemken P, et al. Expression and distribution of renal vacuolar proton-translocating adenosine triphosphatase in response to chronic acid and alkali loads in the rat. J Clin Invest 1991; 88:126.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/11\">",
"      Khadouri C, Marsy S, Barlet-Bas C, et al. Effect of metabolic acidosis and alkalosis on NEM-sensitive ATPase in rat nephron segments. Am J Physiol 1992; 262:F583.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/12\">",
"      Tizianello A, Deferrari G, Garibotto G, et al. Renal ammoniagenesis in an early stage of metabolic acidosis in man. J Clin Invest 1982; 69:240.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/13\">",
"      Krapf R, Berry CA, Alpern RJ, Rector FC Jr. Regulation of cell pH by ambient bicarbonate, carbon dioxide tension, and pH in the rabbit proximal convoluted tubule. J Clin Invest 1988; 81:381.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/14\">",
"      Alpern RJ, Chambers M. Cell pH in the rat proximal convoluted tubule. Regulation by luminal and peritubular pH and sodium concentration. J Clin Invest 1986; 78:502.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/15\">",
"      Horie S, Moe O, Tejedor A, Alpern RJ. Preincubation in acid medium increases Na/H antiporter activity in cultured renal proximal tubule cells. Proc Natl Acad Sci U S A 1990; 87:4742.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/16\">",
"      Alpern RJ. Trade-offs in the adaptation to acidosis. Kidney Int 1995; 47:1205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/17\">",
"      Weiner ID, Hamm LL. Regulation of intracellular pH in the rabbit cortical collecting tubule. J Clin Invest 1990; 85:274.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/18\">",
"      Kikeri D, Azar S, Sun A, et al. Na(+)-H+ antiporter and Na(+)-(HCO3-)n symporter regulate intracellular pH in mouse medullary thick limbs of Henle. Am J Physiol 1990; 258:F445.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/19\">",
"      Hamm LL, Simon EE. Roles and mechanisms of urinary buffer excretion. Am J Physiol 1987; 253:F595.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/20\">",
"      Kraut JA, Wish JB, Sweet SJ, et al. Failure of increased sodium avidity to facilitate renal acid excretion in dogs fed sulfuric acid. Kidney Int 1981; 20:50.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/21\">",
"      Busch A, Waldegger S, Herzer T, et al. Electrophysiological analysis of Na+/Pi cotransport mediated by a transporter cloned from rat kidney and expressed in Xenopus oocytes. Proc Natl Acad Sci U S A 1994; 91:8205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/22\">",
"      CLARKE E, EVANS BM, MACINTYRE I, MILNE MD. Acidosis in experimental electrolyte depletion. Clin Sci (Lond) 1955; 14:421.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/23\">",
"      Owen OE, Licht JH, Sapir DG. Renal function and effects of partial rehydration during diabetic ketoacidosis. Diabetes 1981; 30:510.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/24\">",
"      Lombard WE, Kokko JP, Jacobson HR. Bicarbonate transport in cortical and outer medullary collecting tubules. Am J Physiol 1983; 244:F289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/25\">",
"      Star RA, Burg MB, Knepper MA. Bicarbonate secretion and chloride absorption by rabbit cortical collecting ducts. Role of chloride/bicarbonate exchange. J Clin Invest 1985; 76:1123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/26\">",
"      Schuster VL. Cortical collecting duct bicarbonate secretion. Kidney Int Suppl 1991; 33:S47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/27\">",
"      VAN GOIDSENHOVEN GM, GRAY OV, PRICE AV, SANDERSON PH. The effect of prolonged administration of large doses of sodium bicarbonate in man. Clin Sci (Lond) 1954; 13:383.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/28\">",
"      POLAK A, HAYNIE GD, HAYS RM, SCHWARTZ WB. Effects of chronic hypercapnia on electrolyte and acid-base equilibrium. I. Adaptation. J Clin Invest 1961; 40:1223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/29\">",
"      Brasseur L, De Coninck JD. The \"carbon dioxide response curve\" for chronic hypercapnia in man. N Engl J Med 1966; 275:117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/30\">",
"      Gennari FJ, Goldstein MB, Schwartz WB. The nature of the renal adaptation to chronic hypocapnia. J Clin Invest 1972; 51:1722.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/31\">",
"      Gougoux A, Kaehny WD, Cohen JJ. Renal adaptation to chronic hypocapnia: dietary constraints in achieving H+ retention. Am J Physiol 1975; 229:1330.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/32\">",
"      Rodriguez-Nichols F, Laughrey E, Tannen RL. Response of renal NH3 production to chronic respiratory acidosis. Am J Physiol 1984; 247:F896.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/33\">",
"      Trivedi B, Tannen RL. Effect of respiratory acidosis on intracellular pH of the proximal tubule. Am J Physiol 1986; 250:F1039.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/34\">",
"      Adam WR, Koretsky AP, Weiner MW. 31P-NMR in vivo measurement of renal intracellular pH: effects of acidosis and K+ depletion in rats. Am J Physiol 1986; 251:F904.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/35\">",
"      Cogan MG, Alpern RJ. Regulation of proximal bicarbonate reabsorption. Am J Physiol 1984; 247:F387.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/36\">",
"      Buerkert J, Martin D, Trigg D. Segmental analysis of the renal tubule in buffer production and net acid formation. Am J Physiol 1983; 244:F442.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/37\">",
"      Sabatini S, Kurtzman NA. The maintenance of metabolic alkalosis: factors which decrease bicarbonate excretion. Kidney Int 1984; 25:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/38\">",
"      Slatopolsky E, Hoffsten P, Purkerson M, Bricker NS. On the influence of extracellular fluid volume expansion and of uremia on bicarbonate reabsorption in man. J Clin Invest 1970; 49:988.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/39\">",
"      Cogan MG, Carneiro AV, Tatsuno J, et al. Normal diet NaCl variation can affect the renal set-point for plasma pH-(HCO3-) maintenance. J Am Soc Nephrol 1990; 1:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/40\">",
"      Harrington JT. Metabolic alkalosis. Kidney Int 1984; 26:88.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/41\">",
"      Galla JH, Gifford JD, Luke RG, Rome L. Adaptations to chloride-depletion alkalosis. Am J Physiol 1991; 261:R771.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/42\">",
"      Wesson DE. Augmented bicarbonate reabsorption by both the proximal and distal nephron maintains chloride-deplete metabolic alkalosis in rats. J Clin Invest 1989; 84:1460.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/43\">",
"      Liu FY, Cogan MG. Role of protein kinase C in proximal bicarbonate absorption and angiotensin signaling. Am J Physiol 1990; 258:F927.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/44\">",
"      Geibel J, Giebisch G, Boron WF. Angiotensin II stimulates both Na(+)-H+ exchange and Na+/HCO3- cotransport in the rabbit proximal tubule. Proc Natl Acad Sci U S A 1990; 87:7917.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/45\">",
"      Cogan MG. Angiotensin II: a powerful controller of sodium transport in the early proximal tubule. Hypertension 1990; 15:451.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/46\">",
"      Liu FY, Cogan MG. Role of angiotensin II in glomerulotubular balance. Am J Physiol 1990; 259:F72.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/47\">",
"      Wall SM, Sands JM, Flessner MF, et al. Net acid transport by isolated perfused inner medullary collecting ducts. Am J Physiol 1990; 258:F75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/48\">",
"      Stone DK, Seldin DW, Kokko JP, Jacobson HR. Mineralocorticoid modulation of rabbit medullary collecting duct acidification. A sodium-independent effect. J Clin Invest 1983; 72:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/49\">",
"      Garg LC, Narang N. Effects of aldosterone on NEM-sensitive ATPase in rabbit nephron segments. Kidney Int 1988; 34:13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/50\">",
"      Hays SR. Mineralocorticoid modulation of apical and basolateral membrane H+/OH-/HCO3- transport processes in the rabbit inner stripe of outer medullary collecting duct. J Clin Invest 1992; 90:180.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/51\">",
"      Khadouri C, Marsy S, Barlet-Bas C, Doucet A. Short-term effect of aldosterone on NEM-sensitive ATPase in rat collecting tubule. Am J Physiol 1989; 257:F177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/52\">",
"      Higashihara E, Carter NW, Pucacco L, Kokko JP. Aldosterone effects on papillary collecting duct pH profile of the rat. Am J Physiol 1984; 246:F725.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/53\">",
"      Batlle DC. Segmental characterization of defects in collecting tubule acidification. Kidney Int 1986; 30:546.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/54\">",
"      Harrington JT, Hulter HN, Cohen JJ, Madias NE. Mineralocorticoid-stimulated renal acidification: the critical role of dietary sodium. Kidney Int 1986; 30:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/55\">",
"      SCHWARTZ WB, JENSON RL, RELMAN AS. Acidification of the urine and increased ammonium excretion without change in acid-base equilibrium: sodium reabsorption as a stimulus to the acidifying process. J Clin Invest 1955; 34:673.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/56\">",
"      Tannen RL, Bleich HL, Schwartz WB. The renal response to acid loads in metabolic alkalosis; an assessment of the mechanisms regulating acid excretion. J Clin Invest 1966; 45:562.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/57\">",
"      Galla JH, Bonduris DN, Luke RG. Effects of chloride and extracellular fluid volume on bicarbonate reabsorption along the nephron in metabolic alkalosis in the rat. Reassessment of the classical hypothesis of the pathogenesis of metabolic alkalosis. J Clin Invest 1987; 80:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/58\">",
"      Stone DK, Xie XS. Proton translocating ATPases: issues in structure and function. Kidney Int 1988; 33:767.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/59\">",
"      Wesson DE. Depressed distal tubule acidification corrects chloride-deplete alkalosis in rats. Am J Physiol 1990; 259:F636.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/60\">",
"      FULLER GR, MACLEOD MB, PITTS RF. Influence of administration of potassium salts on the renal tubular reabsorption of bicarbonate. Am J Physiol 1955; 182:111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/61\">",
"      Capasso G, Kinne R, Malnic G, Giebisch G. Renal bicarbonate reabsorption in the rat. I. Effects of hypokalemia and carbonic anhydrase. J Clin Invest 1986; 78:1558.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/62\">",
"      Capasso G, Jaeger P, Giebisch G, et al. Renal bicarbonate reabsorption in the rat. II. Distal tubule load dependence and effect of hypokalemia. J Clin Invest 1987; 80:409.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/63\">",
"      COOKE RE, SEGAR WE, CHEEK DB, et al. The extrarenal correction of alkalosis associated with potassium deficiency. J Clin Invest 1952; 31:798.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/64\">",
"      Adler S, Zett B, Anderson B. The effect of acute potassium depletion on muscle cell pH in vitro. Kidney Int 1972; 2:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/65\">",
"      Jaeger P, Karlmark B, Giebisch G. Ammonium transport in rat cortical tubule: relationship to potassium metabolism. Am J Physiol 1983; 245:F593.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/66\">",
"      Szylman P, Better OS, Chaimowitz C, Rosler A. Role of hyperkalemia in the metabolic acidosis of isolated hypoaldosteronism. N Engl J Med 1976; 294:361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/67\">",
"      Soleimani M, Bergman JA, Hosford MA, McKinney TD. Potassium depletion increases luminal Na+/H+ exchange and basolateral Na+:CO3=:HCO3- cotransport in rat renal cortex. J Clin Invest 1990; 86:1076.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/68\">",
"      Altenberg GA, Aristimu&ntilde;o PC, Amorena CE, Taquini AC. Amiloride prevents the metabolic acidosis of a KCl load in nephrectomized rats. Clin Sci (Lond) 1989; 76:649.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/69\">",
"      DuBose TD Jr, Good DW. Effects of chronic hyperkalemia on renal production and proximal tubule transport of ammonium in rats. Am J Physiol 1991; 260:F680.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/70\">",
"      Garvin JL, Burg MB, Knepper MA. Active NH4+ absorption by the thick ascending limb. Am J Physiol 1988; 255:F57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/71\">",
"      DuBose TD Jr, Good DW. Chronic hyperkalemia impairs ammonium transport and accumulation in the inner medulla of the rat. J Clin Invest 1992; 90:1443.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/72\">",
"      Armitage FE, Wingo CS. Luminal acidification in K-replete OMCDi: contributions of H-K-ATPase and bafilomycin-A1-sensitive H-ATPase. Am J Physiol 1994; 267:F450.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/73\">",
"      Garg LC. Respective roles of H-ATPase and H-K-ATPase in ion transport in the kidney. J Am Soc Nephrol 1991; 2:949.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/74\">",
"      Cheval L, Barlet-Bas C, Khadouri C, et al. K(+)-ATPase-mediated Rb+ transport in rat collecting tubule: modulation during K+ deprivation. Am J Physiol 1991; 260:F800.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/75\">",
"      Wingo CS. Active proton secretion and potassium absorption in the rabbit outer medullary collecting duct. Functional evidence for proton-potassium-activated adenosine triphosphatase. J Clin Invest 1989; 84:361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/76\">",
"      Doucet A, Marsy S. Characterization of K-ATPase activity in distal nephron: stimulation by potassium depletion. Am J Physiol 1987; 253:F418.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/77\">",
"      Codina J, Delmas-Mata JT, DuBose TD Jr. Expression of HKalpha2 protein is increased selectively in renal medulla by chronic hypokalemia. Am J Physiol 1998; 275:F433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/78\">",
"      Eiam-Ong S, Kurtzman NA, Sabatini S. Regulation of collecting tubule adenosine triphosphatases by aldosterone and potassium. J Clin Invest 1993; 91:2385.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/79\">",
"      Sasaki S, Marumo F. Mechanisms of inhibition of proximal acidification by PTH. Am J Physiol 1991; 260:F833.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/80\">",
"      Fan L, Wiederkehr MR, Collazo R, et al. Dual mechanisms of regulation of Na/H exchanger NHE-3 by parathyroid hormone in rat kidney. J Biol Chem 1999; 274:11289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/81\">",
"      Ruiz OS, Qiu YY, Wang LJ, Arruda JA. Regulation of the renal Na-HCO3 cotransporter: V. mechanism of the inhibitory effect of parathyroid hormone. Kidney Int 1996; 49:396.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/82\">",
"      Bichara M, Mercier O, Borensztein P, Paillard M. Acute metabolic acidosis enhances circulating parathyroid hormone, which contributes to the renal response against acidosis in the rat. J Clin Invest 1990; 86:430.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/83\">",
"      Arruda JA, Alla V, Rubinstein H, et al. Parathyroid hormone and extrarenal acid buffering. Am J Physiol 1980; 239:F533.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/84\">",
"      Coe FL. Magnitude of metabolic acidosis in primary hyperparathyroidism. Arch Intern Med 1974; 134:262.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10089/abstract/85\">",
"      Hulter HN, Peterson JC. Acid-base homeostasis during chronic PTH excess in humans. Kidney Int 1985; 28:187.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7257 Version 3.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-200.167.4.114-3ADB073D65-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_54_10089=[""].join("\n");
var outline_f9_54_10089=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EXTRACELLULAR PH",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Metabolic acidosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Metabolic alkalosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Respiratory acidosis and alkalosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Chronic metabolic acidosis versus chronic respiratory acidosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      EFFECTIVE CIRCULATING VOLUME",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Renin-angiotensin-aldosterone system",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Chloride depletion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      PLASMA POTASSIUM CONCENTRATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      PARATHYROID HORMONE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEPH/7257\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEPH/7257|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?16/18/16686\" title=\"figure 1\">",
"      NH4 excretion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?5/62/6125\" title=\"figure 2\">",
"      Regulation of proximal pH",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?7/46/7917\" title=\"figure 3\">",
"      Acid load and NH4 excretion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?17/31/17917\" title=\"figure 4\">",
"      Distal HCO3 secretion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?1/23/1405\" title=\"figure 5\">",
"      PCO2 and HCO3 reabsorption",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?8/17/8477\" title=\"figure 6\">",
"      NH4 excretion in acidosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?25/50/26413\" title=\"figure 7\">",
"      TmHCO3 without volume expansion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?12/31/12797\" title=\"figure 8\">",
"      Collecting tubule transport",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?42/60/43980\" title=\"figure 9\">",
"      Effect of SO4 on H and K",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?1/17/1309\" title=\"figure 10\">",
"      Plasma K and HCO3 reabsorption",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?31/46/32492\" title=\"figure 11\">",
"      Potassium and cation shifts",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?2/32/2574\" title=\"figure 12\">",
"      Mechanism of NH4 recycling",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/22/8551?source=related_link\">",
"      Causes of metabolic alkalosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/11/28852?source=related_link\">",
"      Chapter 11C: Effect of arterial pH on ventilation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/1/37911?source=related_link\">",
"      Clinical features of primary aldosteronism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/28/10692?source=related_link\">",
"      Pathogenesis of metabolic alkalosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/41/27288?source=related_link\">",
"      Simple and mixed acid-base disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/14/14568?source=related_link\">",
"      Treatment of metabolic alkalosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f9_54_10090="Pruritus: Etiology and patient evaluation";
var content_f9_54_10090=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Pruritus: Etiology and patient evaluation",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/54/10090/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/54/10090/contributors\">",
"     Sara B Fazio, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/54/10090/contributors\">",
"     Gil Yosipovitch, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/54/10090/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/54/10090/contributors\">",
"     Robert P Dellavalle, MD, PhD, MSPH",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/54/10090/contributors\">",
"     Jeffrey Callen, MD, FACP, FAAD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/54/10090/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/54/10090/contributors\">",
"     Abena O Ofori, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?9/54/10090/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 15, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H690753\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pruritus (itch) is a common symptom, rather than a specific disease entity, that occurs in a diverse range of skin diseases and may appear as a prominent feature of extracutaneous disorders such as systemic, neurologic, and psychiatric diseases (",
"    <a class=\"graphic graphic_table graphicRef74678 \" href=\"UTD.htm?2/21/2397\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The pathogenesis and etiology of pruritus, as well as the evaluation of the patient with pruritus, will be reviewed here. The treatment of pruritus is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/58/6058?source=see_link\">",
"     \"Pruritus: Overview of management\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H690760\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pruritus is a common symptom that is experienced by all human beings at some point during the course of life. The frequent occurrence of pruritus is supported by the results of epidemiologic studies. In a large cross-sectional study (n = 11,730), chronic pruritus (pruritus persisting for more than six weeks) was reported in approximately 16 percent of German workers [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10090/abstract/1\">",
"     1",
"    </a>",
"    ]. A separate study of almost 19,000 adults in Norway found that the prevalence of pruritus in the general population was approximately 8 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10090/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H690767\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although the neurologic pathways that lead to itch are not fully understood, it is generally accepted that transmission of signals along unmyelinated, histamine-sensitive peripheral C-nerve fibers (distinct from the C-nerve fibers that transmit pain) is involved. These fibers represent a minority (up to 5 percent) of C-nerve fibers in the body and are characterized by a slow conduction velocity and extensive terminal branching [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10090/abstract/3\">",
"     3",
"    </a>",
"    ]. Nonhistamine nerve fibers may also participate in the transmission of itch [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10090/abstract/4-8\">",
"     4-8",
"    </a>",
"    ], possibly accounting for the poor response of many types of itch to oral antihistamines.",
"   </p>",
"   <p>",
"    Signal transmission in nerves may be stimulated by the action of a variety of neural mediators on sensory nerve endings in the epidermis, dermal-epidermal junction, and other sites. Mediators that have been identified as potential peripheral or central contributors to pruritus include histamine, proteases, cathepsins, gastrin releasing peptide, opioids, substance P, nerve growth factor, interleukins, and prostaglandins [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10090/abstract/9-11\">",
"     9-11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The itch-transmitting primary afferent C neurons synapse with secondary transmission neurons that cross over to the contralateral spinothalamic tract and ascend to the thalamus. The itch stimulus then travels to the cerebral cortex, where multiple sites in the brain are activated, including those involved in sensory function, motor function, and emotion [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10090/abstract/6,12,13\">",
"     6,12,13",
"    </a>",
"    ]. This suggests that there is no single area primarily responsible for processing this stimulus, a factor that may contribute to the multidimensional psychological and physical aspects of pruritus.",
"   </p>",
"   <p>",
"    Both scratching and rubbing skin inhibit the sensation of pruritus by stimulating inhibitory local circuits in the spinal cord and brain [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10090/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]; scratching also stimulates pain receptors, which inhibits the sensation of itch. The inhibitory interneurons can be activated by both peripheral and central stimuli, and they release endogenous opiates [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10090/abstract/5\">",
"     5",
"    </a>",
"    ]. Additionally, central sensitization for itching may occur in patients with chronic pruritus such that noxious stimuli are perceived as itch rather than pain [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10090/abstract/12,16\">",
"     12,16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H690774\">",
"    <span class=\"h1\">",
"     CLASSIFICATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute pruritus is defined as pruritus lasting less than six weeks; the term chronic pruritus refers to symptoms of longer duration [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10090/abstract/17\">",
"     17",
"    </a>",
"    ]. Chronic pruritus is often difficult to manage and can be debilitating; therapies that provide transient relief usually do not address the underlying causes of chronic pruritus.",
"   </p>",
"   <p>",
"    A two tier classification system for pruritus has been proposed by a panel of experts from the International Forum for the Study of Itch [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10090/abstract/17\">",
"     17",
"    </a>",
"    ]. The first tier allows the classification of pruritus when the diagnosis is unknown. The clinical presentation of pruritus is divided into three groups:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Group I &ndash;",
"      </strong>",
"      Pruritus on diseased (inflamed) skin",
"     </li>",
"     <li>",
"      <strong>",
"       Group II &ndash;",
"      </strong>",
"      Pruritus on non-diseased (noninflamed skin)",
"     </li>",
"     <li>",
"      <strong>",
"       Group III &ndash;",
"      </strong>",
"      Pruritus presenting with severe chronic secondary scratch lesions",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A skin biopsy may be useful for the evaluation of patients in Group I, as it may assist in identifying a primary skin disease. Skin biopsy generally is not useful in patients in the latter two groups.",
"   </p>",
"   <p>",
"    When the origin of pruritus is known, pruritus can be divided into the following categories:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Dermatologic &ndash;",
"      </strong>",
"      This group contains pruritus resulting from primary skin disorders. Examples include xerosis, atopic dermatitis, psoriasis, cutaneous infections, and cutaneous T-cell lymphoma. This group accounts for almost all disorders in group I.",
"     </li>",
"     <li>",
"      <strong>",
"       Systemic &ndash;",
"      </strong>",
"      Systemic causes of pruritus consist of disorders that affect other organ systems, such as chronic renal failure, liver disease, hematologic or lymphoproliferative disorders, and malignancy. Drug induced pruritus is also included in this category.",
"     </li>",
"     <li>",
"      <strong>",
"       Neurologic &ndash;",
"      </strong>",
"      This group includes pruritus related to disorders of the peripheral or central nervous system. Examples include notalgia paresthetica, brachioradial pruritus, and multiple sclerosis.",
"     </li>",
"     <li>",
"      <strong>",
"       Psychogenic &ndash;",
"      </strong>",
"      Examples of psychiatric disorders in which patients may complain of pruritus include depression, anxiety, psychogenic excoriation, and delusional parasitosis.",
"     </li>",
"     <li>",
"      <strong>",
"       Mixed &ndash;",
"      </strong>",
"      Pruritus attributed to more than one cause is placed in this category.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H690781\">",
"    <span class=\"h1\">",
"     ETIOLOGY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H690788\">",
"    <span class=\"h2\">",
"     Dermatologic disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;Numerous dermatologic disorders present with pruritus, most of which are characterized by the presence of visible skin inflammation. Examples of some of the disorders that may present with pruritus are provided below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H690795\">",
"    <span class=\"h3\">",
"     Xerosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;In older adults, the most common cause of pruritus in the absence of an obvious skin eruption is xerosis, or dry skin [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10090/abstract/18\">",
"     18",
"    </a>",
"    ]. Most commonly seen in the winter, it is characterized by itching in areas of dry, scaly skin (",
"    <a class=\"graphic graphic_picture graphicRef67366 \" href=\"UTD.htm?16/23/16759\">",
"     picture 1",
"    </a>",
"    ). Symptoms often occur on the lower extremities. Severe xerosis may also precipitate the development of pruritic eczematous dermatitis.",
"   </p>",
"   <p>",
"    Factors associated with xerosis include advanced age, frequent bathing, and ambient high temperatures with relatively low humidity, such as the environment produced by home heating in the winter [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10090/abstract/19\">",
"     19",
"    </a>",
"    ]. The cornerstone of therapy is maintaining adequate skin moisture with topical emollients. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/58/6058?source=see_link&amp;anchor=H8354494#H8354494\">",
"     \"Pruritus: Overview of management\", section on 'Xerosis (dry skin)'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H690802\">",
"    <span class=\"h3\">",
"     Atopic dermatitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pruritus is the hallmark symptom of atopic dermatitis and has a significant impact on sleep and quality of life [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10090/abstract/20\">",
"     20",
"    </a>",
"    ]. Allokinesis, a phenomenon in which a normally innocuous stimulus induces itch, is a prominent feature in this disorder. Sweating, sudden changes in temperature, clothing changes, and direct contact with wool can lead to intense pruritus. A vicious itch-scratch cycle, in which injury to the skin from scratching stimulates pruritus, can also occur in patients with atopic dermatitis.",
"   </p>",
"   <p>",
"    The diagnosis of atopic dermatitis is predominantly clinical (",
"    <a class=\"graphic graphic_table graphicRef57187 \" href=\"UTD.htm?40/34/41516\">",
"     table 2",
"    </a>",
"    ). Pruritus, chronic and recurring dermatitis, a positive family history of allergic disease, and an early age of onset of symptoms suggest the diagnosis (",
"    <a class=\"graphic graphic_picture graphicRef52163 \" href=\"UTD.htm?27/57/28575\">",
"     picture 2",
"    </a>",
"    ). Other physical findings that may occur in association with atopic dermatitis include xerosis, infraorbital skin folds (Dennie-Morgan lines), periorbital darkening, hyperlinear palms (accentuation of fine palmar skin lines), and keratosis pilaris (follicular accentuation that is usually present on the extensor surfaces of the upper arms). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/40/42631?source=see_link\">",
"     \"Epidemiology, clinical manifestations, and diagnosis of atopic dermatitis (eczema)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H690809\">",
"    <span class=\"h3\">",
"     Contact dermatitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Contact dermatitis refers to any dermatitis arising from direct skin exposure to a substance. The dermatitis may be allergic or irritant-induced. In allergic contact dermatitis (",
"    <a class=\"graphic graphic_picture graphicRef71913 \" href=\"UTD.htm?33/61/34782\">",
"     picture 3",
"    </a>",
"    ), the trigger induces an immune response, while in irritant contact dermatitis (",
"    <a class=\"graphic graphic_picture graphicRef71834 \" href=\"UTD.htm?41/28/42432\">",
"     picture 4",
"    </a>",
"    ), the trigger itself directly damages the skin. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/42/11943?source=see_link\">",
"     \"Clinical features and diagnosis of allergic contact dermatitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/20/29001?source=see_link\">",
"     \"Irritant contact dermatitis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H690816\">",
"    <span class=\"h3\">",
"     Urticaria",
"    </span>",
"    &nbsp;&mdash;&nbsp;Urticaria, or hives, is a common disorder that affects up to 25 percent of the population at some point during the course of life [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10090/abstract/21\">",
"     21",
"    </a>",
"    ]. The usual urticarial lesion is an intensely pruritic, circumscribed, raised, and erythematous eruption with central pallor. Individual lesions may enlarge or coalesce with other lesions, and typically disappear over a few hours (",
"    <a class=\"graphic graphic_picture graphicRef72519 graphicRef81678 \" href=\"UTD.htm?11/7/11380\">",
"     picture 5A-B",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Acute urticaria may be allergic in nature, while chronic urticaria (ie, regular outbreaks of hives occurring for more than six weeks) is rarely caused by allergy to an external substance [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10090/abstract/22\">",
"     22",
"    </a>",
"    ]. Urticaria may also occur in the setting of multiple systemic disorders. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/24/21898?source=see_link&amp;anchor=H30#H30\">",
"     \"New onset urticaria\", section on 'Systemic disorders that may include urticaria'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H690823\">",
"    <span class=\"h3\">",
"     Dermatophytosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Superficial fungal infections due to dermatophytes (tinea infections) are common causes of localized pruritus. Tinea cruris typically presents with bilateral, half-moon shaped lesions starting in the inguinal folds and extending to the upper thighs (",
"    <a class=\"graphic graphic_picture graphicRef56684 \" href=\"UTD.htm?6/8/6276\">",
"     picture 6",
"    </a>",
"    ). Central clearing is often apparent. Predisposing factors include warm temperatures, prolonged exposure to moisture, obesity, and tight-fitting clothing [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10090/abstract/23\">",
"     23",
"    </a>",
"    ]. Tinea pedis (athlete's foot) presents as a whitish maceration between the digits of the feet, or as dry, scaly skin or localized blisters (",
"    <a class=\"graphic graphic_picture graphicRef76067 graphicRef54214 \" href=\"UTD.htm?4/10/4263\">",
"     picture 7A-B",
"    </a>",
"    ). Tinea capitis, which most commonly occurs in children, can be associated with scalp pruritus (",
"    <a class=\"graphic graphic_picture graphicRef86628 \" href=\"UTD.htm?9/47/9976\">",
"     picture 8",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/58/7082?source=see_link\">",
"     \"Dermatophyte (tinea) infections\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H690830\">",
"    <span class=\"h3\">",
"     Lichen simplex chronicus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lichen simplex chronicus is not a primary skin disorder. Rather, the lichenified plaques (thickened skin with accentuated skin markings) and excoriations of lichen simplex chronicus result from excessive scratching (",
"    <a class=\"graphic graphic_picture graphicRef73843 \" href=\"UTD.htm?5/57/6035\">",
"     picture 9",
"    </a>",
"    ). Lesions only occur in skin sites accessible to scratching.",
"   </p>",
"   <p>",
"    Patients typically complain of intense pruritus in the affected areas. Common sites of involvement include the scalp, neck, extensor forearms, scrotum, and lower legs.",
"   </p>",
"   <p>",
"    Lichen simplex chronicus is commonly noted in adult forms of atopic dermatitis and can also be noted in patients with neuropathic pruritus, such as in brachioradial pruritus and diabetic neuropathy. Psychological factors, such as depression, also may contribute to lichen simplex chronicus [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10090/abstract/24\">",
"     24",
"    </a>",
"    ]. Breaking the cycle of scratching is the central goal of treatment. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/58/6058?source=see_link\">",
"     \"Pruritus: Overview of management\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H690837\">",
"    <span class=\"h3\">",
"     Psoriasis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pruritus is reported in approximately 80 percent of patients with psoriasis [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10090/abstract/25\">",
"     25",
"    </a>",
"    ]. There tends to be a cyclical quality to the symptoms, with the majority of pruritus occurring at night. Furthermore, pruritus is not restricted to the area of the psoriatic plaque, often being generalized and poorly responsive to antipruritics [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10090/abstract/26\">",
"     26",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/62/27625?source=see_link\">",
"     \"Epidemiology, clinical manifestations, and diagnosis of psoriasis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H690844\">",
"    <span class=\"h3\">",
"     Scabies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Scabies (from the Latin for \"scratching\") is caused by the mite Sarcoptes scabiei, which lays its eggs in the epidermal layer of human skin. The outstanding clinical feature of scabies is intense itching. It is often severe and usually worse in the evening and night. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/2/28712?source=see_link\">",
"     \"Scabies\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The essential lesion is a small, erythematous, nondescript papule, often excoriated and tipped with hemorrhagic crusts (",
"    <a class=\"graphic graphic_picture graphicRef51161 graphicRef53894 \" href=\"UTD.htm?43/25/44438\">",
"     picture 10A-B",
"    </a>",
"    ). It is not a dramatic lesion and is not always easy to see. More striking, when present, is the burrow. Pathognomonic when correctly identified, the burrow is a thin, grayish, reddish, or brownish line some 2 to 15 mm long (",
"    <a class=\"graphic graphic_picture graphicRef53715 \" href=\"UTD.htm?28/26/29091\">",
"     picture 11",
"    </a>",
"    ). Burrows are often absent, however, or obscured by eczematization or secondary infection.",
"   </p>",
"   <p>",
"    Lesions are most common in intertriginous areas such as the neck, axillae, genitals, and finger webs. Involvement of the face and scalp may occur in young children, but is uncommon in adults.",
"   </p>",
"   <p>",
"    Pruritus in scabies is due to a delayed hypersensitivity response to the mite proteins. Itch can continue for several weeks after the mites are eradicated [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10090/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H690851\">",
"    <span class=\"h3\">",
"     Pediculosis corporis and pubis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Also known as \"body lice\" and \"pubic lice,\" these infestations are marked by itching caused by a delayed hypersensitivity reaction to the saliva of the louse (",
"    <a class=\"graphic graphic_picture graphicRef73592 graphicRef55191 \" href=\"UTD.htm?17/10/17578\">",
"     picture 12A-B",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10090/abstract/23\">",
"     23",
"    </a>",
"    ]. Diagnosis is made by appearance, although a magnifying lens is often necessary in order to see the eggs or lice. Pediculosis corporis typically occurs in patients with poor hygienic practices, unlike pediculosis pubis, which is primarily a sexually transmitted disease [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10090/abstract/23\">",
"     23",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/49/24339?source=see_link\">",
"     \"Pediculosis corporis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/30/1511?source=see_link\">",
"     \"Pediculosis pubis and pediculosis ciliaris\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H690858\">",
"    <span class=\"h3\">",
"     Allergies",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the absence of urticaria, atopic dermatitis, or contact dermatitis, allergies are a rare cause of pruritus (apart from localized pruritus of mucous membranes).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H690865\">",
"    <span class=\"h2\">",
"     Systemic disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pruritus caused by systemic disease typically presents without a primary skin eruption. Secondary skin lesions related to scratching and rubbing, such as lichenified plaques, excoriations, and prurigo nodules, are often present. There are a number of systemic diseases, including malignancy, that should be considered when a patient presents with generalized pruritus without any dermatologic manifestations (",
"    <a class=\"graphic graphic_table graphicRef74678 \" href=\"UTD.htm?2/21/2397\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H690872\">",
"    <span class=\"h3\">",
"     Renal disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Uremic pruritus remains one of the most frustrating, common, and potentially disabling symptoms in patients with end-stage renal disease. The disorder is common among dialysis patients. Patients typically complain of pruritus, which is often generalized but may be most prominent on the back [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10090/abstract/28-30\">",
"     28-30",
"    </a>",
"    ]. Many patients experience a worsening of symptoms in the evening and night. Pruritus may also be exacerbated during and at the conclusion of dialysis [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10090/abstract/28,31\">",
"     28,31",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/49/6937?source=see_link\">",
"     \"Uremic pruritus\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A number of factors may contribute to uremic pruritus in individual patients, but a specific general etiology has not been identified. Pruritus in renal disease is often very difficult to treat and may be associated with a poor prognosis [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10090/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H690879\">",
"    <span class=\"h3\">",
"     Cholestasis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cholestatic pruritus, which occurs due to the impaired secretion of bile, is a common symptom seen in certain forms of liver disease. It is typically generalized and often begins with an acral distribution involving the palms and soles, areas that are uncommon sites for pruritus in other systemic diseases. Symptoms later become more generalized [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10090/abstract/33\">",
"     33",
"    </a>",
"    ]. Associated conditions include: primary biliary cirrhosis, pruritus gravidarum (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/32/4617?source=see_link\">",
"     \"Intrahepatic cholestasis of pregnancy\"",
"    </a>",
"    ), sclerosing cholangitis, viral hepatitis, drug-induced cholestasis, as well as cases of obstructive jaundice. Pruritus is the presenting symptom of primary biliary cirrhosis in 50 percent of patients and occurs at some point in almost 100 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10090/abstract/34\">",
"     34",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/42/41641?source=see_link\">",
"     \"Clinical manifestations, diagnosis, and natural history of primary biliary cirrhosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The mechanism of cholestatic pruritus has not been clearly elucidated. Patients with cholestatic pruritus have elevated plasma opioid levels, which conceivably could contribute to itch [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10090/abstract/33\">",
"     33",
"    </a>",
"    ]. In addition, the enzyme autotaxin and its substrate lysophosphatidic acid have been proposed as potential mediators in cholestatic itch [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10090/abstract/33,35\">",
"     33,35",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/19/23863?source=see_link\">",
"     \"Pruritus associated with cholestasis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H690886\">",
"    <span class=\"h3\">",
"     Malignancy",
"    </span>",
"    &nbsp;&mdash;&nbsp;While generalized pruritus may be the presenting sign of hematologic malignancies, the association is not as strong in solid tumors. Pruritus occasionally presents years before the malignancy becomes clinically detectable. Pruritus may also occur as a feature of paraneoplastic skin diseases, such as eruptive seborrheic keratosis, malignant acanthosis nigricans, dermatomyositis, erythroderma, and transient acantholytic dermatosis (Grover disease) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10090/abstract/36\">",
"     36",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/18/21802?source=see_link&amp;anchor=H3208461#H3208461\">",
"     \"Cutaneous manifestations of internal malignancy\", section on 'Sign of Leser-Trelat'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/18/21802?source=see_link&amp;anchor=H9#H9\">",
"     \"Cutaneous manifestations of internal malignancy\", section on 'Acanthosis nigricans'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/4/27722?source=see_link\">",
"     \"Clinical manifestations and diagnosis of adult dermatomyositis and polymyositis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/41/31381?source=see_link\">",
"     \"Grover's disease (transient and persistent acantholytic dermatosis)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The most common malignancies associated with pruritus include Hodgkin lymphoma, non-Hodgkin lymphoma, mycosis fungoides, polycythemia vera, leukemias, plasma cell dyscrasias, and gastric carcinoid tumors. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/18/21802?source=see_link\">",
"     \"Cutaneous manifestations of internal malignancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Hodgkin lymphoma &mdash;",
"      </strong>",
"      Itching as a primary symptom is commonly seen in patients with Hodgkin lymphoma, developing in approximately 30 percent of cases [",
"      <a class=\"abstract\" href=\"UTD.htm?9/54/10090/abstract/37\">",
"       37",
"      </a>",
"      ]. In some patients, pruritus precedes the clinical presentation of lymphoma by up to five years and therefore can be regarded as a paraneoplastic sign [",
"      <a class=\"abstract\" href=\"UTD.htm?9/54/10090/abstract/34,36\">",
"       34,36",
"      </a>",
"      ]. Itching is often located on the lower extremities and is occasionally accompanied with ichthyosiform skin changes. Pruritus related to Hodgkin lymphoma is often more severe in older patients and patients with more advanced disease. Symptoms may be aggravated at night [",
"      <a class=\"abstract\" href=\"UTD.htm?9/54/10090/abstract/33,36\">",
"       33,36",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?0/35/568?source=see_link\">",
"       \"Clinical presentation and patterns of disease distribution in classical Hodgkin lymphoma in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Polycythemia vera &mdash;",
"      </strong>",
"      Polycythemia vera commonly presents with water-induced itching (aquagenic pruritus), occurring in up to 30 percent of cases [",
"      <a class=\"abstract\" href=\"UTD.htm?9/54/10090/abstract/38\">",
"       38",
"      </a>",
"      ]. Patients frequently complain of intractable pruritus within minutes after having a bath. As with other malignancies, symptoms may precede disease presentation by several years [",
"      <a class=\"abstract\" href=\"UTD.htm?9/54/10090/abstract/39\">",
"       39",
"      </a>",
"      ]. Aquagenic pruritus has also been associated with other diseases including myelodysplastic disorders and T cell lymphomas. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?9/32/9738?source=see_link\">",
"       \"Diagnostic approach to the patient with suspected polycythemia vera\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Mycosis fungoides &mdash;",
"      </strong>",
"      Pruritus is a frequent manifestation of mycosis fungoides (cutaneous T cell lymphoma), although it is typically not present in the absence of cutaneous findings [",
"      <a class=\"abstract\" href=\"UTD.htm?9/54/10090/abstract/40\">",
"       40",
"      </a>",
"      ]. The erythrodermic form of mycosis fungoides and S&eacute;zary syndrome are extremely pruritic. There are case reports of pruritus preceding the onset of skin findings by several years [",
"      <a class=\"abstract\" href=\"UTD.htm?9/54/10090/abstract/41\">",
"       41",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/32/4618?source=see_link\">",
"       \"Clinical manifestations, pathologic features, and diagnosis of mycosis fungoides\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Other hematologic malignancies &mdash;",
"      </strong>",
"      Patients with non-Hodgkin lymphoma may present with pruritus, but there are limited epidemiologic data on the prevalence of this symptom. Other hematologic malignancies linked to chronic pruritus include leukemia, most commonly chronic lymphocytic leukemia, as well as multiple myeloma and mastocytosis [",
"      <a class=\"abstract\" href=\"UTD.htm?9/54/10090/abstract/34,36\">",
"       34,36",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/61/27610?source=see_link\">",
"       \"Clinical presentation and diagnosis of non-Hodgkin lymphoma\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?24/6/24680?source=see_link\">",
"       \"Epidemiology and clinical manifestations of chronic lymphocytic leukemia\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/1/6170?source=see_link\">",
"       \"Clinical manifestations, pathogenesis, and classification of mastocytosis (cutaneous and systemic)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/13/35034?source=see_link\">",
"       \"Clinical features, laboratory manifestations, and diagnosis of multiple myeloma\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Gastric carcinoid &mdash;",
"      </strong>",
"      In contrast to the usually nonpruritic intermittent cutaneous flushing associated with intestinal carcinoids, the intermittent \"histamine\" flush associated with atypical gastric carcinoids tends to be pruritic. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?8/63/9206?source=see_link&amp;anchor=H16#H16\">",
"       \"Clinical features of the carcinoid syndrome\", section on 'Gastric carcinoid variant syndrome'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H690893\">",
"    <span class=\"h3\">",
"     Thyroid disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;Generalized pruritus is seen commonly in patients with thyrotoxicosis, particularly in cases of Graves' disease [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10090/abstract/34,37\">",
"     34,37",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/60/14279?source=see_link\">",
"     \"Overview of the clinical manifestations of hyperthyroidism in adults\"",
"    </a>",
"    .) Possible mechanisms include reduction of the itch threshold mediated by vasodilation, as well as activation of kinin pathways secondary to an increased metabolic rate. Hypothyroidism is less frequently associated with itch and is associated with skin xerosis [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10090/abstract/34\">",
"     34",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/10/14503?source=see_link\">",
"     \"Clinical manifestations of hypothyroidism\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H690900\">",
"    <span class=\"h3\">",
"     Diabetes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Generalized itching does not appear to occur at increased frequency in diabetic patients [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10090/abstract/42\">",
"     42",
"    </a>",
"    ]. However, pruritus due to other disorders in diabetic patients, including dermatophyte infections, xerosis, diabetic neuropathy, or Candida infections (such as may occur in the anogenital region), may occur [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10090/abstract/34\">",
"     34",
"    </a>",
"    ]. In particular, diabetic neuropathy may account for otherwise unexplained pruritus localized to the lower extremities, scalp, or trunk [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10090/abstract/43,44\">",
"     43,44",
"    </a>",
"    ]. Pruritus vulvae has been associated with poorly controlled diabetes. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/13/5336?source=see_link\">",
"     \"Dermatitis of the vulva\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H690907\">",
"    <span class=\"h3\">",
"     HIV",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pruritus is associated with several primary skin disorders that are common in human immunodeficiency virus (HIV)&ndash;infected individuals (eg, scabies, seborrheic dermatitis, psoriasis, xerosis). It may also be associated with systemic disease in patients with HIV infection (eg, lymphoma, chronic renal disease, or hepatic disease) or may present as a manifestation of early HIV infection [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10090/abstract/45\">",
"     45",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Eosinophilic folliculitis is an intensely pruritic condition associated with advanced HIV disease. It is characterized by a perifollicular papular eruption that involves the upper trunk, limbs, and face (",
"    <a class=\"graphic graphic_picture graphicRef87125 \" href=\"UTD.htm?19/37/20053\">",
"     picture 13",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10090/abstract/46\">",
"     46",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/50/24359?source=see_link\">",
"     \"HIV-associated eosinophilic folliculitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other causes of itch in HIV infection individuals are insect bite hypersensitivity reactions; pruritic papular eruption of HIV infection; and itch associated with xerosis, lichenoid dermatitis, or exacerbations of seborrheic dermatitis and psoriasis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H693620\">",
"    <span class=\"h3\">",
"     Connective tissue diseases",
"    </span>",
"    &nbsp;&mdash;&nbsp;Itch is a common symptom of dermatomyositis and occasionally occurs in patients with systemic sclerosis (scleroderma) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10090/abstract/47-49\">",
"     47-49",
"    </a>",
"    ]. Patients with dermatomyositis frequently experience intense pruritus that impairs their ability to sleep and affects their quality of life. Most often patients with cutaneous lupus erythematosus have little or no itching. Therefore, the presence of severe pruritus in a patient with presumed lupus erythematosus should result in a careful reassessment of the diagnosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/9/15513?source=see_link&amp;anchor=H28087755#H28087755\">",
"     \"Initial management of cutaneous dermatomyositis\", section on 'Quality of life'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/34/29224?source=see_link\">",
"     \"Overview of the clinical manifestations of systemic sclerosis (scleroderma) in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H690914\">",
"    <span class=\"h3\">",
"     Medication",
"    </span>",
"    &nbsp;&mdash;&nbsp;The mechanisms through which drugs induce itch vary. As examples, pruritus may result from drug-induced skin dryness, such as may occur with systemic retinoid therapy, or as an associated feature of drug-induced phototoxicity, such as may follow",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/41/2714?source=see_link\">",
"     doxycycline",
"    </a>",
"    therapy.",
"   </p>",
"   <p>",
"    In addition, pruritus without an associated skin eruption is a side effect of numerous medications. Pruritus frequently accompanies the use of opiates, particularly when intrathecally or epidurally administered, with a reported incidence between 30 and 100 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10090/abstract/50\">",
"     50",
"    </a>",
"    ]. Pruritus also has been reported as a side effect of a number of molecularly targeted anti-neoplastic agents, including epidermal growth factor inhibitors, tyrosine kinase inhibitors, BRAF inhibitors, and MEK inhibitors [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10090/abstract/51-53\">",
"     51-53",
"    </a>",
"    ]. Drug-induced cholestasis may also induce pruritus [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10090/abstract/54,55\">",
"     54,55",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H690879\">",
"     'Cholestasis'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/19/23863?source=see_link\">",
"     \"Pruritus associated with cholestasis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H690921\">",
"    <span class=\"h2\">",
"     Neurologic disorders (neuropathic itch)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neurologic dysfunction results in the development of itch in multiple disorders, including brachioradial pruritus, notalgia paresthetica, postherpetic neuralgia, and other disorders.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H690928\">",
"    <span class=\"h3\">",
"     Brachioradial pruritus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Brachioradial pruritus presents with localized pruritus involving the proximal dorsolateral forearm. Symptoms may be intermittent, unilateral or bilateral, and in some cases may extend to the upper arm, shoulder, neck, or upper trunk [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10090/abstract/56\">",
"     56",
"    </a>",
"    ]. Current theories of the pathogenesis of the disorder suggest cervical nerve root impingement at the levels of C5 to C8 as a predisposing factor and solar radiation as an exacerbating factor [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10090/abstract/57-59\">",
"     57-59",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Affected individuals are often fair-skinned, middle-aged adults who live in sunny climates and frequently engage in outdoor leisure activities. The condition frequently worsens during the summer months. Symptomatic relief often occurs with application of ice to the affected area (the \"ice-pack sign\"), a finding that may assist with diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10090/abstract/60\">",
"     60",
"    </a>",
"    ]. Rare cases have been associated with spinal tumors, particularly in the presence of motor or sensory neurologic deficits [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10090/abstract/61,62\">",
"     61,62",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/58/6058?source=see_link&amp;anchor=H8354522#H8354522\">",
"     \"Pruritus: Overview of management\", section on 'Brachioradial pruritus'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H690935\">",
"    <span class=\"h3\">",
"     Notalgia paresthetica",
"    </span>",
"    &nbsp;&mdash;&nbsp;Like brachioradial pruritus, notalgia paresthetica is characterized by localized pruritus and appears to be of neurologic origin. The current view on etiology is that the itch is due to nerve entrapment of the posterior rami of spinal nerves that arise from T2 to T6 [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10090/abstract/63\">",
"     63",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The symptoms are unilateral and involve skin medial to the scapular border on the mid or upper back. Cutaneous changes secondary to scratching or rubbing the skin (such as hyperpigmentation) are the only visible findings (",
"    <a class=\"graphic graphic_picture graphicRef56937 \" href=\"UTD.htm?16/43/17076\">",
"     picture 14",
"    </a>",
"    ). Secondary amyloid deposition may be detected in skin biopsies. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/58/6058?source=see_link&amp;anchor=H8354529#H8354529\">",
"     \"Pruritus: Overview of management\", section on 'Notalgia paresthetica'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H690942\">",
"    <span class=\"h3\">",
"     Postherpetic neuralgia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Between 30 and 58 percent of patients with postherpetic neuralgia experience pruritus at the site of herpes zoster [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10090/abstract/64,65\">",
"     64,65",
"    </a>",
"    ]. Symptoms may be most likely to occur in following eruptions on the head, face, or neck [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10090/abstract/64\">",
"     64",
"    </a>",
"    ]. Pruritus also may occur in association with acute herpes zoster. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/58/6058?source=see_link&amp;anchor=H8354536#H8354536\">",
"     \"Pruritus: Overview of management\", section on 'Postherpetic itch'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H690949\">",
"    <span class=\"h3\">",
"     Multiple sclerosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infrequently, patients with multiple sclerosus experience recurrent and severe episodes of generalized pruritus [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10090/abstract/66\">",
"     66",
"    </a>",
"    ]. Symptoms have been attributed to activation of artificial synapses in areas of demyelination [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10090/abstract/34\">",
"     34",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/44/32458?source=see_link&amp;anchor=H13#H13\">",
"     \"Epidemiology and clinical features of multiple sclerosis in adults\", section on 'Sensory symptoms'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H690956\">",
"    <span class=\"h3\">",
"     Other",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neuropathic itch can occur as a result cerebrovascular accidents, trigeminal trophic syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10090/abstract/67\">",
"     67",
"    </a>",
"    ], or Creutzfeldt-Jakob disease [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10090/abstract/68,69\">",
"     68,69",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H690963\">",
"    <span class=\"h2\">",
"     Psychogenic itch",
"    </span>",
"    &nbsp;&mdash;&nbsp;General or localized pruritus can occur in the setting of psychiatric illnesses or somatoform disorders. In a study of 100 psychiatric inpatients, the prevalence of generalized pruritus was 42 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10090/abstract/70\">",
"     70",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    Psychogenic excoriation (aka neurotic excoriation) is a disorder in which individuals excessively pick and scratch normal skin. Affected patients typically complain of significant pruritus. On physical exam, scattered, linear, crusted lesions may be present anywhere on the body within reach of the patient, although they are most often confined to the extremities [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10090/abstract/23\">",
"     23",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/49/13080?source=see_link\">",
"     \"Pathologic skin picking\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Psychologic stress may be associated with the development of symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10090/abstract/71\">",
"     71",
"    </a>",
"    ]. In one study of 68 patients with psychogenic excoriation, 90 percent described a conflict or stressor preceding the onset of the condition [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10090/abstract/72\">",
"     72",
"    </a>",
"    ]. Increased rates of psychiatric diseases, particularly mood and anxiety disorders, have also been identified in patients with this disorder [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10090/abstract/73\">",
"     73",
"    </a>",
"    ]. As an example, a case-control study (n = 100) found that the prevalence of self-reported depression or bipolar disorder was significantly greater among patients with psychogenic excoriation than among controls (42 versus 18 percent and 12 versus 0 percent, respectively) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10090/abstract/74\">",
"     74",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Delusional parasitosis is a separate psychiatric disorder characterized by the patient&rsquo;s false belief that he or she is suffering from a parasitic infection. Patients often complain of pruritus. Delusional parasitosis is discussed in greater detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/4/3145?source=see_link\">",
"     \"Delusional parasitosis: Epidemiology, clinical presentation, assessment and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Due to the increased prevalence of psychopathology among patients with otherwise unexplained pruritus, clinicians should consider the possibility of an underlying psychiatric disorder in such patients.",
"   </p>",
"   <p>",
"    Psychological factors might also affect the severity of pruritus in individuals with pruritus unrelated to a psychological disorder. A study that explored the impact of emotional states on pruritus found that sensitivity to pruritus was greater during exposure to a film that was intended to elicit negative emotions than to a film that was intended to elicit positive emotions [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10090/abstract/75\">",
"     75",
"    </a>",
"    ]. Further studies are necessary to clarify the impact of emotional states on pruritus.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H690970\">",
"    <span class=\"h2\">",
"     Other associations",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H690977\">",
"    <span class=\"h3\">",
"     Advanced age",
"    </span>",
"    &nbsp;&mdash;&nbsp;Idiopathic itch in the elderly, sometimes inappropriately referred to as senile pruritus, is common and presents a diagnostic and therapeutic challenge [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10090/abstract/76\">",
"     76",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Dry skin is probably the most common cause of pruritus in elderly individuals; other causes for pruritus are inflammatory skin diseases, such as eczema and scabies, as well as underlying systemic disorders, such as cholestasis, renal failure, and iron deficiency anemia. However, in some instances, no cause is found. Age-related changes in nerve fibers and loss of input from pain fibers leading to central disinhibition of itch [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10090/abstract/77\">",
"     77",
"    </a>",
"    ] may play a role in otherwise unexplained pruritus.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H690984\">",
"    <span class=\"h3\">",
"     Burns and scars",
"    </span>",
"    &nbsp;&mdash;&nbsp;Burn scars are common in both children and adults and are associated with significant pruritus. A cohort study in 510 adults who were seen in two burn centers found an 87 percent prevalence rate of pruritus three months after a burn injury [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10090/abstract/78\">",
"     78",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/38/37479?source=see_link&amp;anchor=H14#H14\">",
"     \"Treatment of minor thermal burns\", section on 'Pruritus'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Keloids frequently are associated with itch at the periphery of the lesion. These findings probably result from entrapment of small nerve fibers [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10090/abstract/79\">",
"     79",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/51/1847?source=see_link\">",
"     \"Keloids\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H690998\">",
"    <span class=\"h1\">",
"     EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;A key component of patient evaluation is the determination of the presence or absence of primary skin lesions. The presence of primary skin lesions suggests a dermatologic disorder. In patients who present without skin lesions or with only secondary skin lesions (eg, excoriations, hyperpigmentation, or lichenification), the possibility of systemic, neurologic, or psychogenic causes of itch must be considered. Inquiries regarding the location (generalized or localized), temporal nature, and exacerbating and alleviating factors for pruritus can also offer clues for diagnosis.",
"   </p>",
"   <p>",
"    An algorithm describing the approach to the evaluation of patients with pruritus is provided (",
"    <a class=\"graphic graphic_algorithm graphicRef80780 \" href=\"UTD.htm?18/50/19246\">",
"     algorithm 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H691005\">",
"    <span class=\"h2\">",
"     Pruritus with primary skin lesions",
"    </span>",
"    &nbsp;&mdash;&nbsp;The majority of patients who present to outpatient medical clinics with pruritus will have an obvious primary skin disorder that explains their symptoms. The evaluation of such patients involves the identification of the cause of the skin eruption. A skin biopsy may be useful for diagnosis when the etiology is unclear. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/45/35541?source=see_link\">",
"     \"Approach to dermatologic diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Occasionally, the skin findings in patients with primary skin disorders are subtle or simply consist of excoriations caused by excessive scratching. Xerosis may not be apparent unless the skin is inspected closely, when fine scaling and epidermal cracking may be visible [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10090/abstract/80\">",
"     80",
"    </a>",
"    ]. Scabies may not be obvious in patients in whom there are fewer than 10 lesions or who have only a few lesions on the genitalia [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10090/abstract/23\">",
"     23",
"    </a>",
"    ]. Inquiring about symptoms in other family members can be useful for the diagnosis of scabies, as pruritus affecting other household members strongly suggests this disorder. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/2/28712?source=see_link\">",
"     \"Scabies\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Finally, urticaria, by its transient nature, can often be missed. Examining the skin for dermographism is a helpful adjunct in identifying patients with pruritus related to dermatographism. Dermographism is present when stroking the skin firmly produces a linear urticarial itchy wheal within 30 minutes (",
"    <a class=\"graphic graphic_picture graphicRef50823 \" href=\"UTD.htm?30/33/31248\">",
"     picture 15",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/24/21898?source=see_link\">",
"     \"New onset urticaria\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/5/24666?source=see_link&amp;anchor=H10#H10\">",
"     \"Physical urticarias\", section on 'Dermographism'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H691012\">",
"    <span class=\"h2\">",
"     Generalized pruritus without primary skin lesions",
"    </span>",
"    &nbsp;&mdash;&nbsp;A detailed patient history is particularly important in patients with generalized pruritus who lack primary skin lesions, as the differential diagnosis for this presentation is broad and includes disorders that are associated with significant morbidity. In addition to details regarding the nature of pruritus, the following components of the patient history may be useful for diagnosis:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      History of thyroid disorders, liver disease, renal disease, HIV infection, or malignancy",
"     </li>",
"     <li>",
"      Presence of constitutional symptoms (eg, fever, weight loss, night sweats)",
"     </li>",
"     <li>",
"      Medication history",
"     </li>",
"     <li>",
"      Travel history",
"     </li>",
"     <li>",
"      Psychiatric history",
"     </li>",
"     <li>",
"      Pruritus in other household members (suggests scabies without identifiable skin lesions)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In the absence of primary skin findings, the physical examination should focus on looking for evidence of systemic disease. Findings of conjunctival pallor, thyromegaly, splenomegaly, or stigmata of liver disease should be sought out. Lymph nodes should be palpated for signs of lymphadenopathy.",
"   </p>",
"   <p>",
"    Even in the absence of abnormal physical findings, the initial evaluation generally should not include an extensive laboratory investigation looking for the presence of systemic disease. Many authors advocate that such an evaluation be reserved for patients who have no evidence of skin disease on examination and who do not respond to a short course of antipruritic therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?9/54/10090/abstract/23\">",
"     23",
"    </a>",
"    ]. We agree with this approach. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/58/6058?source=see_link\">",
"     \"Pruritus: Overview of management\"",
"    </a>",
"    .) If the pruritus remains undiagnosed and the patient has not responded to initial therapy, subsequent evaluation should include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Complete blood count with differential",
"      </strong>",
"      to evaluate for evidence of malignancy, myeloproliferative disease, or iron deficiency",
"     </li>",
"     <li>",
"      <strong>",
"       Serum bilirubin, transaminases, and alkaline phosphatase",
"      </strong>",
"      to evaluate for evidence of liver disease",
"     </li>",
"     <li>",
"      <strong>",
"       Thyroid stimulating hormone",
"      </strong>",
"      to evaluate for evidence of a thyroid disorder",
"     </li>",
"     <li>",
"      <strong>",
"       BUN and creatinine",
"      </strong>",
"      to evaluate for renal disease",
"     </li>",
"     <li>",
"      <strong>",
"       Chest x-ray",
"      </strong>",
"      to evaluate for evidence of adenopathy",
"     </li>",
"     <li>",
"      <strong>",
"       HIV antibody test",
"      </strong>",
"      in patients with historical risk factors for HIV infection",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Secondary laboratory considerations based upon patient history and suspicion for an underlying disorder include stool examination for ova and parasites, hepatitis B and C serologies, and serum protein electrophoresis and immunoelectrophoresis (if a plasma cell dyscrasia is suspected).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H691019\">",
"    <span class=\"h2\">",
"     Localized pruritus without primary skin lesions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Localized pruritus in the absence of a skin eruption suggests the possibility of neuropathic or psychogenic itch. In particular, associated symptoms of burning sensations, pain, or sensory loss may occur in patients with neuropathic disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H691026\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pruritus is a common disorder that may affect the skin, mucous membranes, and cornea. The pathogenic mechanisms that lead to the sensation of pruritus are not fully understood, but are thought to involve the transmission of signals from peripheral C-nerve fibers to neurons in the spinal cord and brain. A variety of neural mediators may be involved in this process. (See",
"      <a class=\"local\" href=\"#H690760\">",
"       'Epidemiology'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H690767\">",
"       'Pathogenesis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Pruritic disorders can be classified as dermatologic, systemic, neurologic, or psychogenic causes of pruritus. Dermatologic disorders typically present with skin findings that indicate the presence of a primary skin disorder. Secondary signs of pruritus, such as excoriations, skin lichenification, and skin hyperpigmentation may also be present. (See",
"      <a class=\"local\" href=\"#H690774\">",
"       'Classification'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H690788\">",
"       'Dermatologic disorders'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Multiple systemic disorders, some of which are associated with significant morbidity, may present with symptoms of pruritus (",
"      <a class=\"graphic graphic_table graphicRef74678 \" href=\"UTD.htm?2/21/2397\">",
"       table 1",
"      </a>",
"      ). Pruritus may be the initial sign of disease in patients with hematologic malignancies. Pruritus related to solid tumors is uncommon. (See",
"      <a class=\"local\" href=\"#H690865\">",
"       'Systemic disorders'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A key component of the evaluation of patients with pruritus is the assessment of whether a primary skin disorder is present (",
"      <a class=\"graphic graphic_algorithm graphicRef80780 \" href=\"UTD.htm?18/50/19246\">",
"       algorithm 1",
"      </a>",
"      ). Primary skin lesions are subtle in some skin disorders. If primary skin lesions are identified, but the diagnosis remains uncertain, a skin biopsy can be used to assist with diagnosis. (See",
"      <a class=\"local\" href=\"#H690998\">",
"       'Evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The possibility of a systemic disorder should be considered in patients with generalized pruritus and no evidence for primary skin lesions. Along with a careful patient history and physical examination, select laboratory studies can be useful for obtaining a diagnosis. (See",
"      <a class=\"local\" href=\"#H690998\">",
"       'Evaluation'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10090/abstract/1\">",
"      St&auml;nder S, Sch&auml;fer I, Phan NQ, et al. Prevalence of chronic pruritus in Germany: results of a cross-sectional study in a sample working population of 11,730. Dermatology 2010; 221:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10090/abstract/2\">",
"      Dalgard F, Svensson A, Holm J&Oslash;, Sundby J. Self-reported skin morbidity among adults: associations with quality of life and general health in a Norwegian survey. J Investig Dermatol Symp Proc 2004; 9:120.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10090/abstract/3\">",
"      Schmelz M, Schmidt R, Bickel A, et al. Specific C-receptors for itch in human skin. J Neurosci 1997; 17:8003.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10090/abstract/4\">",
"      Reddy VB, Iuga AO, Shimada SG, et al. Cowhage-evoked itch is mediated by a novel cysteine protease: a ligand of protease-activated receptors. J Neurosci 2008; 28:4331.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10090/abstract/5\">",
"      Sun YG, Zhao ZQ, Meng XL, et al. Cellular basis of itch sensation. Science 2009; 325:1531.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10090/abstract/6\">",
"      Davidson S, Giesler GJ. The multiple pathways for itch and their interactions with pain. Trends Neurosci 2010; 33:550.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10090/abstract/7\">",
"      Namer B, Carr R, Johanek LM, et al. Separate peripheral pathways for pruritus in man. J Neurophysiol 2008; 100:2062.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10090/abstract/8\">",
"      Davidson S, Zhang X, Yoon CH, et al. The itch-producing agents histamine and cowhage activate separate populations of primate spinothalamic tract neurons. J Neurosci 2007; 27:10007.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10090/abstract/9\">",
"      Yosipovitch G. The pruritus receptor unit: a target for novel therapies. J Invest Dermatol 2007; 127:1857.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10090/abstract/10\">",
"      Yosipovitch G. Recent advances in pruritus - what we have learned and where are we headed. F1000 Med Rep 2010; 2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10090/abstract/11\">",
"      Metz M, St&auml;nder S. Chronic pruritus--pathogenesis, clinical aspects and treatment. J Eur Acad Dermatol Venereol 2010; 24:1249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10090/abstract/12\">",
"      Ikoma A, Steinhoff M, St&auml;nder S, et al. The neurobiology of itch. Nat Rev Neurosci 2006; 7:535.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10090/abstract/13\">",
"      Ishiuji Y, Coghill RC, Patel TS, et al. Distinct patterns of brain activity evoked by histamine-induced itch reveal an association with itch intensity and disease severity in atopic dermatitis. Br J Dermatol 2009; 161:1072.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10090/abstract/14\">",
"      Davidson S, Zhang X, Khasabov SG, et al. Relief of itch by scratching: state-dependent inhibition of primate spinothalamic tract neurons. Nat Neurosci 2009; 12:544.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10090/abstract/15\">",
"      Yosipovitch G, Ishiuji Y, Patel TS, et al. The brain processing of scratching. J Invest Dermatol 2008; 128:1806.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10090/abstract/16\">",
"      Ishiuji Y, Coghill RC, Patel TS, et al. Repetitive scratching and noxious heat do not inhibit histamine-induced itch in atopic dermatitis. Br J Dermatol 2008; 158:78.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10090/abstract/17\">",
"      St&auml;nder S, Weisshaar E, Mettang T, et al. Clinical classification of itch: a position paper of the International Forum for the Study of Itch. Acta Derm Venereol 2007; 87:291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10090/abstract/18\">",
"      White-Chu EF, Reddy M. Dry skin in the elderly: complexities of a common problem. Clin Dermatol 2011; 29:37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10090/abstract/19\">",
"      Millikan LE. Treating pruritus. What's new in safe relief of symptoms? Postgrad Med 1996; 99:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10090/abstract/20\">",
"      Dawn A, Papoiu AD, Chan YH, et al. Itch characteristics in atopic dermatitis: results of a web-based questionnaire. Br J Dermatol 2009; 160:642.",
"     </a>",
"    </li>",
"    <li>",
"     Yosipovitch G. Epidemiology of itching in skin and systemic disease. In: Itch: Basic mechanisms and therapy, Yosipovitch G, Greaves MW, Fleischer AB Jr, McGlone F.  (Eds), Marcel Dekker, Inc., New York 2004. p.183.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10090/abstract/22\">",
"      Grattan CE, Sabroe RA, Greaves MW. Chronic urticaria. J Am Acad Dermatol 2002; 46:645.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10090/abstract/23\">",
"      Greco PJ, Ende J. Pruritus: a practical approach. J Gen Intern Med 1992; 7:340.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10090/abstract/24\">",
"      Konuk N, Koca R, Atik L, et al. Psychopathology, depression and dissociative experiences in patients with lichen simplex chronicus. Gen Hosp Psychiatry 2007; 29:232.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10090/abstract/25\">",
"      Krueger G, Koo J, Lebwohl M, et al. The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey. Arch Dermatol 2001; 137:280.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10090/abstract/26\">",
"      Yosipovitch G, Goon A, Wee J, et al. The prevalence and clinical characteristics of pruritus among patients with extensive psoriasis. Br J Dermatol 2000; 143:969.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10090/abstract/27\">",
"      Chosidow O. Clinical practices. Scabies. N Engl J Med 2006; 354:1718.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10090/abstract/28\">",
"      Ponticelli C, Bencini PL. Pruritus in dialysis patients: a neglected problem. Nephrol Dial Transplant 1995; 10:2174.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10090/abstract/29\">",
"      St&aring;hle-B&auml;ckdahl M. Uremic pruritus. Clinical and experimental studies. Acta Derm Venereol Suppl (Stockh) 1989; 145:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10090/abstract/30\">",
"      Mettang T, Fritz P, Weber J, et al. Uremic pruritus in patients on hemodialysis or continuous ambulatory peritoneal dialysis (CAPD). The role of plasma histamine and skin mast cells. Clin Nephrol 1990; 34:136.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10090/abstract/31\">",
"      Gilchrest BA, Stern RS, Steinman TI, et al. Clinical features of pruritus among patients undergoing maintenance hemodialysis. Arch Dermatol 1982; 118:154.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10090/abstract/32\">",
"      Patel TS, Freedman BI, Yosipovitch G. An update on pruritus associated with CKD. Am J Kidney Dis 2007; 50:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10090/abstract/33\">",
"      Wang H, Yosipovitch G. New insights into the pathophysiology and treatment of chronic itch in patients with end-stage renal disease, chronic liver disease, and lymphoma. Int J Dermatol 2010; 49:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10090/abstract/34\">",
"      Etter L, Myers SA. Pruritus in systemic disease: mechanisms and management. Dermatol Clin 2002; 20:459.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10090/abstract/35\">",
"      Kremer AE, Martens JJ, Kulik W, et al. Lysophosphatidic acid is a potential mediator of cholestatic pruritus. Gastroenterology 2010; 139:1008.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10090/abstract/36\">",
"      Yosipovitch G. Chronic pruritus: a paraneoplastic sign. Dermatol Ther 2010; 23:590.",
"     </a>",
"    </li>",
"    <li>",
"     Yosipovitch G. Epidemiology of itching in skin and systemic disease. In: Itch: Basic mechanisms and therapy, Yosipovitch G, Greaves MW, Fleischer Jr AB, McGlone F.  (Eds), Marcel Dekker, Inc., New York 2004. p.183.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10090/abstract/38\">",
"      Greaves MW. Itching--research has barely scratched the surface. N Engl J Med 1992; 326:1016.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10090/abstract/39\">",
"      Charlesworth EN, Beltrani VS. Pruritic dermatoses: overview of etiology and therapy. Am J Med 2002; 113 Suppl 9A:25S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10090/abstract/40\">",
"      Lober CW. Should the patient with generalized pruritus be evaluated for malignancy? J Am Acad Dermatol 1988; 19:350.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10090/abstract/41\">",
"      Pujol RM, Gallardo F, Llistosella E, et al. Invisible mycosis fungoides: a diagnostic challenge. J Am Acad Dermatol 2002; 47:S168.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10090/abstract/42\">",
"      Neilly JB, Martin A, Simpson N, MacCuish AC. Pruritus in diabetes mellitus: investigation of prevalence and correlation with diabetes control. Diabetes Care 1986; 9:273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10090/abstract/43\">",
"      Scribner M. Diabetes and pruritus of the scalp. JAMA 1977; 237:1559.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10090/abstract/44\">",
"      Yamaoka H, Sasaki H, Yamasaki H, et al. Truncal pruritus of unknown origin may be a symptom of diabetic polyneuropathy. Diabetes Care 2010; 33:150.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10090/abstract/45\">",
"      Yosipovitch G, Greaves MW, Schmelz M. Itch. Lancet 2003; 361:690.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10090/abstract/46\">",
"      Garman ME, Tyring SK. The cutaneous manifestations of HIV infection. Dermatol Clin 2002; 20:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10090/abstract/47\">",
"      Shirani Z, Kucenic MJ, Carroll CL, et al. Pruritus in adult dermatomyositis. Clin Exp Dermatol 2004; 29:273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10090/abstract/48\">",
"      Razykov I, Thombs BD, Hudson M, et al. Prevalence and clinical correlates of pruritus in patients with systemic sclerosis. Arthritis Rheum 2009; 61:1765.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10090/abstract/49\">",
"      El-Baalbaki G, Razykov I, Hudson M, et al. Association of pruritus with quality of life and disability in systemic sclerosis. Arthritis Care Res (Hoboken) 2010; 62:1489.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10090/abstract/50\">",
"      Szarvas S, Harmon D, Murphy D. Neuraxial opioid-induced pruritus: a review. J Clin Anesth 2003; 15:234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10090/abstract/51\">",
"      Joshi SS, Ortiz S, Witherspoon JN, et al. Effects of epidermal growth factor receptor inhibitor-induced dermatologic toxicities on quality of life. Cancer 2010; 116:3916.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10090/abstract/52\">",
"      Manousaridis I, Mavridou S, Goerdt S, et al. Cutaneous side effects of inhibitors of the RAS/RAF/MEK/ERK signalling pathway and their management. J Eur Acad Dermatol Venereol 2013; 27:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10090/abstract/53\">",
"      Hanaizi Z, van Zwieten-Boot B, Calvo G, et al. The European Medicines Agency review of ipilimumab (Yervoy) for the treatment of advanced (unresectable or metastatic) melanoma in adults who have received prior therapy: summary of the scientific assessment of the Committee for Medicinal Products for Human Use. Eur J Cancer 2012; 48:237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10090/abstract/54\">",
"      Reich A, St&auml;nder S, Szepietowski JC. Drug-induced pruritus: a review. Acta Derm Venereol 2009; 89:236.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10090/abstract/55\">",
"      Padda MS, Sanchez M, Akhtar AJ, Boyer JL. Drug-induced cholestasis. Hepatology 2011; 53:1377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10090/abstract/56\">",
"      Lane JE, McKenzie JT, Spiegel J. Brachioradial pruritus: a case report and review of the literature. Cutis 2008; 81:37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10090/abstract/57\">",
"      Wallengren J, Sundler F. Brachioradial pruritus is associated with a reduction in cutaneous innervation that normalizes during the symptom-free remissions. J Am Acad Dermatol 2005; 52:142.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10090/abstract/58\">",
"      Goodkin R, Wingard E, Bernhard JD. Brachioradial pruritus: cervical spine disease and neurogenic/neuropathic [corrected] pruritus. J Am Acad Dermatol 2003; 48:521.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10090/abstract/59\">",
"      Marziniak M, Phan NQ, Raap U, et al. Brachioradial pruritus as a result of cervical spine pathology: the results of a magnetic resonance tomography study. J Am Acad Dermatol 2011; 65:756.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10090/abstract/60\">",
"      Bernhard JD, Bordeaux JS. Medical pearl: the ice-pack sign in brachioradial pruritus. J Am Acad Dermatol 2005; 52:1073.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10090/abstract/61\">",
"      Kavak A, Dosoglu M. Can a spinal cord tumor cause brachioradial pruritus? J Am Acad Dermatol 2002; 46:437.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10090/abstract/62\">",
"      Fleuret C, Dupr&eacute;-Goetghebeur D, Person H, et al. [Brachioradial pruritus revealing an ependymoma]. Ann Dermatol Venereol 2009; 136:435.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10090/abstract/63\">",
"      Savk O, Savk E. Investigation of spinal pathology in notalgia paresthetica. J Am Acad Dermatol 2005; 52:1085.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10090/abstract/64\">",
"      Oaklander AL, Bowsher D, Galer B, et al. Herpes zoster itch: preliminary epidemiologic data. J Pain 2003; 4:338.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10090/abstract/65\">",
"      Wood GJ, Akiyama T, Carstens E, et al. An insatiable itch. J Pain 2009; 10:792.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10090/abstract/66\">",
"      Koeppel MC, Bramont C, Ceccaldi M, et al. Paroxysmal pruritus and multiple sclerosis. Br J Dermatol 1993; 129:597.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10090/abstract/67\">",
"      Nakamizo S, Miyachi Y, Kabashima K. Treatment of neuropathic itch possibly due to trigeminal trophic syndrome with 0.1% topical tacrolimus and gabapentin. Acta Derm Venereol 2010; 90:654.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10090/abstract/68\">",
"      Cohen OS, Chapman J, Lee H, et al. Pruritus in familial Creutzfeldt-Jakob disease: a common symptom associated with central nervous system pathology. J Neurol 2011; 258:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10090/abstract/69\">",
"      Shabtai H, Nisipeanu P, Chapman J, Korczyn AD. Pruritus in Creutzfeldt-Jakob disease. Neurology 1996; 46:940.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10090/abstract/70\">",
"      Kretzmer GE, Gelkopf M, Kretzmer G, Melamed Y. Idiopathic pruritus in psychiatric inpatients: an explorative study. Gen Hosp Psychiatry 2008; 30:344.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10090/abstract/71\">",
"      Yamamoto Y, Yamazaki S, Hayashino Y, et al. Association between frequency of pruritic symptoms and perceived psychological stress: a Japanese population-based study. Arch Dermatol 2009; 145:1384.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10090/abstract/72\">",
"      Fruensgaard K. Neurotic excoriations. A controlled psychiatric examination. Acta Psychiatr Scand Suppl 1984; 312:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10090/abstract/73\">",
"      Arnold LM, Auchenbach MB, McElroy SL. Psychogenic excoriation. Clinical features, proposed diagnostic criteria, epidemiology and approaches to treatment. CNS Drugs 2001; 15:351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10090/abstract/74\">",
"      Mutasim DF, Adams BB. The psychiatric profile of patients with psychogenic excoriation. J Am Acad Dermatol 2009; 61:611.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10090/abstract/75\">",
"      van Laarhoven AI, Walker AL, Wilder-Smith OH, et al. Role of induced negative and positive emotions in sensitivity to itch and pain in women. Br J Dermatol 2012; 167:262.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10090/abstract/76\">",
"      Patel T, Yosipovitch G. The management of chronic pruritus in the elderly. Skin Therapy Lett 2010; 15:5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10090/abstract/77\">",
"      Namer B. Age related changes in human C-fiber function. Neurosci Lett 2010; 470:185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10090/abstract/78\">",
"      Van Loey NE, Bremer M, Faber AW, et al. Itching following burns: epidemiology and predictors. Br J Dermatol 2008; 158:95.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10090/abstract/79\">",
"      Lee SS, Yosipovitch G, Chan YH, Goh CL. Pruritus, pain, and small nerve fiber function in keloids: a controlled study. J Am Acad Dermatol 2004; 51:1002.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/54/10090/abstract/80\">",
"      Papa CM. Winter itch, dry skin. J Med Soc N J 1980; 77:817.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 16589 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-118.195.65.244-3BAB8F1ACB-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_54_10090=[""].join("\n");
var outline_f9_54_10090=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H691026\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H690753\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H690760\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H690767\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H690774\">",
"      CLASSIFICATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H690781\">",
"      ETIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H690788\">",
"      Dermatologic disorders",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H690795\">",
"      - Xerosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H690802\">",
"      - Atopic dermatitis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H690809\">",
"      - Contact dermatitis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H690816\">",
"      - Urticaria",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H690823\">",
"      - Dermatophytosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H690830\">",
"      - Lichen simplex chronicus",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H690837\">",
"      - Psoriasis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H690844\">",
"      - Scabies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H690851\">",
"      - Pediculosis corporis and pubis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H690858\">",
"      - Allergies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H690865\">",
"      Systemic disorders",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H690872\">",
"      - Renal disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H690879\">",
"      - Cholestasis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H690886\">",
"      - Malignancy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H690893\">",
"      - Thyroid disorders",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H690900\">",
"      - Diabetes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H690907\">",
"      - HIV",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H693620\">",
"      - Connective tissue diseases",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H690914\">",
"      - Medication",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H690921\">",
"      Neurologic disorders (neuropathic itch)",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H690928\">",
"      - Brachioradial pruritus",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H690935\">",
"      - Notalgia paresthetica",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H690942\">",
"      - Postherpetic neuralgia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H690949\">",
"      - Multiple sclerosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H690956\">",
"      - Other",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H690963\">",
"      Psychogenic itch",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H690970\">",
"      Other associations",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H690977\">",
"      - Advanced age",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H690984\">",
"      - Burns and scars",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H690998\">",
"      EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H691005\">",
"      Pruritus with primary skin lesions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H691012\">",
"      Generalized pruritus without primary skin lesions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H691019\">",
"      Localized pruritus without primary skin lesions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H691026\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DERM/16589\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/16589|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?18/50/19246\" title=\"algorithm 1\">",
"      Algorithm for the evaluation of pruritus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/16589|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?16/23/16759\" title=\"picture 1\">",
"      Xerosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?27/57/28575\" title=\"picture 2\">",
"      Flexural atopic dermatitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?33/61/34782\" title=\"picture 3\">",
"      Allergic contact dermatitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?41/28/42432\" title=\"picture 4\">",
"      Irritant contact dermatitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?29/2/29728\" title=\"picture 5A\">",
"      Urticaria 1",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?11/2/11311\" title=\"picture 5B\">",
"      Giant urticaria",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?6/8/6276\" title=\"picture 6\">",
"      Tinea cruris",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?37/34/38435\" title=\"picture 7A\">",
"      Tinea pedis interdigital maceration",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?38/11/39103\" title=\"picture 7B\">",
"      Acute tinea pedis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?9/47/9976\" title=\"picture 8\">",
"      Tinea capitis - black dot",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?5/57/6035\" title=\"picture 9\">",
"      Lichen simplex chronicus ankle",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?4/4/4160\" title=\"picture 10A\">",
"      Interdigital scabies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?16/52/17219\" title=\"picture 10B\">",
"      Penile scabies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?28/26/29091\" title=\"picture 11\">",
"      Scabies burrow 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?32/15/33014\" title=\"picture 12A\">",
"      Pediculosis corporis 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?34/21/35158\" title=\"picture 12B\">",
"      Pediculosis pubis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?19/37/20053\" title=\"picture 13\">",
"      HIV-associated eosinophilic folliculitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?16/43/17076\" title=\"picture 14\">",
"      Notalgia paresthetica",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?30/33/31248\" title=\"picture 15\">",
"      Dermatographism 1",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/16589|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?2/21/2397\" title=\"table 1\">",
"      Causes of pruritus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?40/34/41516\" title=\"table 2\">",
"      Dx criteria atopic dermatitis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/45/35541?source=related_link\">",
"      Approach to dermatologic diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/42/11943?source=related_link\">",
"      Clinical features and diagnosis of allergic contact dermatitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/63/9206?source=related_link\">",
"      Clinical features of the carcinoid syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/13/35034?source=related_link\">",
"      Clinical features, laboratory manifestations, and diagnosis of multiple myeloma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/4/27722?source=related_link\">",
"      Clinical manifestations and diagnosis of adult dermatomyositis and polymyositis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/10/14503?source=related_link\">",
"      Clinical manifestations of hypothyroidism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/42/41641?source=related_link\">",
"      Clinical manifestations, diagnosis, and natural history of primary biliary cirrhosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/1/6170?source=related_link\">",
"      Clinical manifestations, pathogenesis, and classification of mastocytosis (cutaneous and systemic)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/32/4618?source=related_link\">",
"      Clinical manifestations, pathologic features, and diagnosis of mycosis fungoides",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/61/27610?source=related_link\">",
"      Clinical presentation and diagnosis of non-Hodgkin lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/35/568?source=related_link\">",
"      Clinical presentation and patterns of disease distribution in classical Hodgkin lymphoma in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/18/21802?source=related_link\">",
"      Cutaneous manifestations of internal malignancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/4/3145?source=related_link\">",
"      Delusional parasitosis: Epidemiology, clinical presentation, assessment and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/13/5336?source=related_link\">",
"      Dermatitis of the vulva",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/58/7082?source=related_link\">",
"      Dermatophyte (tinea) infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/32/9738?source=related_link\">",
"      Diagnostic approach to the patient with suspected polycythemia vera",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/44/32458?source=related_link\">",
"      Epidemiology and clinical features of multiple sclerosis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/6/24680?source=related_link\">",
"      Epidemiology and clinical manifestations of chronic lymphocytic leukemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/40/42631?source=related_link\">",
"      Epidemiology, clinical manifestations, and diagnosis of atopic dermatitis (eczema)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/62/27625?source=related_link\">",
"      Epidemiology, clinical manifestations, and diagnosis of psoriasis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/41/31381?source=related_link\">",
"      Grover's disease (transient and persistent acantholytic dermatosis)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/50/24359?source=related_link\">",
"      HIV-associated eosinophilic folliculitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/9/15513?source=related_link\">",
"      Initial management of cutaneous dermatomyositis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/32/4617?source=related_link\">",
"      Intrahepatic cholestasis of pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/20/29001?source=related_link\">",
"      Irritant contact dermatitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/51/1847?source=related_link\">",
"      Keloids",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/24/21898?source=related_link\">",
"      New onset urticaria",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/60/14279?source=related_link\">",
"      Overview of the clinical manifestations of hyperthyroidism in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/34/29224?source=related_link\">",
"      Overview of the clinical manifestations of systemic sclerosis (scleroderma) in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/49/13080?source=related_link\">",
"      Pathologic skin picking",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/49/24339?source=related_link\">",
"      Pediculosis corporis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/30/1511?source=related_link\">",
"      Pediculosis pubis and pediculosis ciliaris",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/5/24666?source=related_link\">",
"      Physical urticarias",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/19/23863?source=related_link\">",
"      Pruritus associated with cholestasis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/58/6058?source=related_link\">",
"      Pruritus: Overview of management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/2/28712?source=related_link\">",
"      Scabies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/38/37479?source=related_link\">",
"      Treatment of minor thermal burns",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/49/6937?source=related_link\">",
"      Uremic pruritus",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f9_54_10091="Management atrophic rhinitis";
var content_f9_54_10091=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F55661&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F55661&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Management of atrophic rhinosinusitis",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Daily nasal irrigations with normal or hypertonic saline (200 cc lavage via each nares)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Empiric irrigation with a topical nasal antibiotic for purulence (100 cc lavage to each nares after saline irrigation). Some concentrations recommended include:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Mupirocin: 300 mg/5 mL ampule. Put 1 ampule into clean container and fill to 2 liters with normal saline (0.015 percent)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Tobramycin: 300 mg/5 mL ampule. Put 1 ampule into clean container and fill to 2 liters with normal saline (0.015 percent)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Gentamicin: 1.2 gram/30 mL bottle. Put 1 bottle into clean container and fill to 1 liter with normal saline (0.12 percent)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Ceftazidime: 1 gram suspended in 10 mL of normal saline. Put solution into clean container and fill to 1 liter with normal saline (0.1 percent)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Systemic antibiotics for acute infections",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_54_10091=[""].join("\n");
var outline_f9_54_10091=null;
var title_f9_54_10092="Blantyre coma score";
var content_f9_54_10092=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F74361&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F74361&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Blantyre coma score",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup width=\"90%\">",
"     </colgroup>",
"     <colgroup width=\"10%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\">",
"        Score",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Eye movement",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Watches or follows",
"       </td>",
"       <td class=\"centered\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Fails to watch or follow",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Best motor response",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Localizes painful stimulus",
"       </td>",
"       <td class=\"centered\">",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Withdraws limb from painful stimulus",
"       </td>",
"       <td class=\"centered\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        No response or inappropriate response",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Best verbal response",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Cries appropriately with pain, or, if verbal, speaks",
"       </td>",
"       <td class=\"centered\">",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Moan or abnormal cry with pain",
"       </td>",
"       <td class=\"centered\">",
"        1",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td class=\"indent1\">",
"        No vocal response to pain",
"       </td>",
"       <td class=\"centered\">",
"        0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Total",
"        </strong>",
"       </td>",
"       <td class=\"centered\">",
"        <strong>",
"         &nbsp;",
"        </strong>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    Fully conscious children score 5; children who do not respond to painful stimuli score 0. Response to pain should be assessed via firm nailbed pressure, sternal pressure, and pressure over the supraorbital ridge. Blantyre coma score &le;2 is associated with mortality.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Molyneux ME, Taylor TE, Wirima JJ, Borgstein A. Clinical features and prognostic indicators in paediatric cerebral malaria: a study of 131 comatose Malawian children. Q J Med 1989; 71:441.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_54_10092=[""].join("\n");
var outline_f9_54_10092=null;
var title_f9_54_10093="Birth control pills used for emergency contraception";
var content_f9_54_10093=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F74604&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F74604&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    How to use birth control pills for emergency contraception",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\" rowspan=\"2\">",
"       Brand name",
"      </td>",
"      <td class=\"subtitle1\">",
"       First dose",
"      </td>",
"      <td class=\"subtitle1\">",
"       Second dose",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2\">",
"       Take these pills as soon as possible after unprotected sex. Emergency contraception works up to 5 days after unprotected sex. The sooner you take it, the better it will work.",
"      </td>",
"      <td class=\"subtitle2\">",
"       Take these pills 12 hours after taking the first set of pills.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Alesse",
"      </td>",
"      <td>",
"       5 pink pills",
"      </td>",
"      <td>",
"       5 pink pills",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Aviane",
"      </td>",
"      <td>",
"       5 orange pills",
"      </td>",
"      <td>",
"       5 orange pills",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Cryselle",
"      </td>",
"      <td>",
"       4 white pills",
"      </td>",
"      <td>",
"       4 white pills",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Enpresse",
"      </td>",
"      <td>",
"       4 orange pills",
"      </td>",
"      <td>",
"       4 orange pills",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Jolessa",
"      </td>",
"      <td>",
"       4 pink pills",
"      </td>",
"      <td>",
"       4 pink pills",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Lessina",
"      </td>",
"      <td>",
"       5 pink pills",
"      </td>",
"      <td>",
"       5 pink pills",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Levlen",
"      </td>",
"      <td>",
"       4 light orange pills",
"      </td>",
"      <td>",
"       4 light orange pills",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Levlite",
"      </td>",
"      <td>",
"       5 pink pills",
"      </td>",
"      <td>",
"       5 pink pills",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Levora",
"      </td>",
"      <td>",
"       4 white pills",
"      </td>",
"      <td>",
"       4 white pills",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Lo/Ovral",
"      </td>",
"      <td>",
"       4 white pills",
"      </td>",
"      <td>",
"       4 white pills",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Low-Ogestrel",
"      </td>",
"      <td>",
"       4 white pills",
"      </td>",
"      <td>",
"       4 white pills",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Lutera",
"      </td>",
"      <td>",
"       5 white pills",
"      </td>",
"      <td>",
"       5 white pills",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Lybrel",
"      </td>",
"      <td>",
"       6 yellow pills",
"      </td>",
"      <td>",
"       6 yellow pills",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Nordette",
"      </td>",
"      <td>",
"       4 light orange pills",
"      </td>",
"      <td>",
"       4 light orange pills",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Ogestrel",
"      </td>",
"      <td>",
"       2 white pills",
"      </td>",
"      <td>",
"       2 white pills",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Ovral",
"      </td>",
"      <td>",
"       2 white pills",
"      </td>",
"      <td>",
"       2 white pills",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Ovrette",
"      </td>",
"      <td>",
"       20 yellow pills",
"      </td>",
"      <td>",
"       20 yellow pills",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Portia",
"      </td>",
"      <td>",
"       4 pink pills",
"      </td>",
"      <td>",
"       4 pink pills",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Quasense",
"      </td>",
"      <td>",
"       4 white pills",
"      </td>",
"      <td>",
"       4 white pills",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Seasonale",
"      </td>",
"      <td>",
"       4 pink pills",
"      </td>",
"      <td>",
"       4 pink pills",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Seasonique",
"      </td>",
"      <td>",
"       4 blue-green pills",
"      </td>",
"      <td>",
"       4 blue-green pills",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Tri-Levlen",
"      </td>",
"      <td>",
"       4 yellow pills",
"      </td>",
"      <td>",
"       4 yellow pills",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Triphasil",
"      </td>",
"      <td>",
"       4 yellow pills",
"      </td>",
"      <td>",
"       4 yellow pills",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Trivora",
"      </td>",
"      <td>",
"       4 pink pills",
"      </td>",
"      <td>",
"       4 pink pills",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    If you want to use birth control pills for emergency contraception, you must take two doses 12 hours apart. Find the brand name of the pills you take in the left-hand column. Then see the second and third columns to find out how many of which color pills to take for that brand name. Keep in mind that birth control pills work but are less effective than Plan B&reg; One-Step or Next Choice&reg;, and they are more likely to cause nausea and vomiting.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_54_10093=[""].join("\n");
var outline_f9_54_10093=null;
var title_f9_54_10094="Level of care guidelines for patients with eating disorders";
var content_f9_54_10094=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F73092&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F73092&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Level of care guidelines for patients with eating disorders",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\">",
"        Level 1: Outpatient",
"       </td>",
"       <td class=\"subtitle1\">",
"        Level 2: Intensive outpatient",
"       </td>",
"       <td class=\"subtitle1\">",
"        Level 3: Partial hospitalization (full-day outpatient care)*",
"       </td>",
"       <td class=\"subtitle1\">",
"        Level 4: Residential treatment center",
"       </td>",
"       <td class=\"subtitle1\">",
"        Level 5: Inpatient hospitalization",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Medical status",
"       </td>",
"       <td colspan=\"3\">",
"        Medically stable to the extent that more extensive medical monitoring, as defined in levels 4 and 5, is not required",
"       </td>",
"       <td>",
"        Medically stable to the extent that intravenous fluids, nasogastric tube feedings, or multiple daily laboratory tests are not needed.",
"       </td>",
"       <td>",
"        <p>",
"         For adults: Heart rate &lt;40 bpm; blood pressure &lt;90/60 mmHg; glucose &lt;60 mg/dl; potassium &lt;3 mEq/L; electrolyte imbalance; temperature &lt;97.0&deg;F; dehydration; hepatic, renal, or cardiovascular organ compromise requiring acute treatment; poorly controlled diabetes",
"        </p>",
"        <p>",
"         For children and adolescents: Heart rate near 40 bpm, orthostatic blood pressure changes (&gt;20 bpm increase in heart rate or &gt;10 mmHg to 20 mmHg drop), blood pressure &lt;80/50 mmHg, hypokalemia&bull;, hypophosphatemia, or hypomagnesemia",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Suicidality&Delta;",
"       </td>",
"       <td colspan=\"4\">",
"        If suicidality is present, inpatient monitoring and treatment may be needed depending on the estimated level of risk",
"       </td>",
"       <td>",
"        Specific plan with high lethality or intent; admission may also be indicated in patient with suicidal ideas or after a suicide attempt or aborted attempt, depending on the presence or absence of other factors modulating suicide risk",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Weight as percentage of healthy body weight&loz;",
"       </td>",
"       <td>",
"        Generally &gt;85 percent",
"       </td>",
"       <td>",
"        Generally &gt;80 percent",
"       </td>",
"       <td>",
"        Generally &gt;80 percent",
"       </td>",
"       <td>",
"        Generally &lt;85 percent",
"       </td>",
"       <td>",
"        Generally &lt;70 percent; acute weight decline with food refusal even if not &lt;70 percent of healthy body weight",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Motivation to recover, including cooperativeness, insight, and ability to control obsessive thoughts",
"       </td>",
"       <td>",
"        Fair-to-good motivation",
"       </td>",
"       <td>",
"        Fair motivation",
"       </td>",
"       <td>",
"        Partial motivation; cooperative; patient preoccupied with intrusive, repetitive thoughts&sect; &gt;3 hours/day",
"       </td>",
"       <td>",
"        Poor-to-fair motivation; patient preoccupied with intrusive repetitive thoughts&sect; 4 to 6 hours a day; patient cooperative with highly structured treatment",
"       </td>",
"       <td>",
"        Very poor to poor motivation; patient preoccupied with intrusive repetitive thoughts&sect;; patient uncooperative with treatment or cooperative only in highly structured environment",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Co-occurring disorders (substance use, depression, anxiety)",
"       </td>",
"       <td colspan=\"4\">",
"        Presence of comorbid condition may influence choice of level of care",
"       </td>",
"       <td>",
"        Any existing psychiatric disorder that would require hospitalization",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Structure needed for eating/gaining weight",
"       </td>",
"       <td>",
"        Self-sufficient",
"       </td>",
"       <td>",
"        Self-sufficient",
"       </td>",
"       <td>",
"        Needs some structure to gain weight",
"       </td>",
"       <td>",
"        Needs supervision at all meals or will restrict eating",
"       </td>",
"       <td>",
"        Needs supervision during and after all meals or nasogastric/special feeding modality",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ability to control compulsive exercising",
"       </td>",
"       <td>",
"        Can manage compulsive exercising through self-control",
"       </td>",
"       <td colspan=\"4\">",
"        Some degree of external structure beyond self-control required to prevent patient from compulsive exercising; rarely a sole indication for increasing the level of care",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Purging behavior (laxatives and diuretics)",
"       </td>",
"       <td colspan=\"3\">",
"        Can greatly reduce incidents of purging in an unstructured setting; no significant medical complications, such as electrocardiographic or other abnormalities, suggesting the need for hospitalization",
"       </td>",
"       <td>",
"        Can ask for and use support from others or use cognitive and behavioral skills to inhibit purging",
"       </td>",
"       <td>",
"        Needs supervision during and after all meals and in bathrooms; unable to control multiple daily episodes of purging that are severe, persistent, and disabling, despite appropriate trials of outpatient care, even if routine laboratory test results reveal no obvious metabolic abnormalities",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Environmental stress",
"       </td>",
"       <td colspan=\"2\">",
"        Others able to provide adequate emotional and practical support and structure",
"       </td>",
"       <td>",
"        Others able to provide at least limited support and structure",
"       </td>",
"       <td colspan=\"2\">",
"        Severe family conflict or problems or absence of family so patient is unable to receive structured treatment in home; patient lives alone without adequate support system",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Geographic availability of treatment program",
"       </td>",
"       <td colspan=\"3\">",
"        Patient lives near treatment setting",
"       </td>",
"       <td colspan=\"2\">",
"        Treatment program is too distant for patient to participate from home",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    In general, a given level of care should be considered for patients who meet one or more criteria under a particular level. These guidelines are not absolutes, however, and their application requires physician judgment.",
"    <div class=\"footnotes\">",
"     * This level of care is most effective if administered for at least 8 hours/day, 5 days/week; less intensive care is demonstrably less effective (101).",
"     <br>",
"      &bull; If the patient is dehydrated, whole-body potassium values may be low even if the serum potassium value is in the normal range; determine concurrent urine specific gravity to assess dehydration.",
"      <br>",
"       &Delta; Determining suicide risk is a complex clinical judgment, as is determining the most appropriate treatment setting for patients at risk for suicide. Relevant factors to consider are the patient's concurrent medical conditions, psychosis, substance abuse, other psychiatric symptoms or syndromes, psychosocial supports, past suicidal behaviors, and treatment adherence and the quality of existing physician-patient relationships. These factors are described in greater detail in the APA's",
"       <i>",
"        Practice Guideline for the Assessment and Treatment of Patients With Suicidal Behaviors",
"       </i>",
"       (84).",
"       <br>",
"        &loz; Although this table lists percentages of expected healthy body weight in relation to suggested levels of care, these are only approximations and do not correspond to percentages based on standardized values for the population as a whole. For any given individual, differences in body build, body composition, and other physiological variables may result in considerable differences as to what constitutes a healthy body weight in relation to \"norms.\" For example, for some patients, a healthy body weight may be 110 percent of the standardized value for the population, whereas for other individuals it may be 98 percent. Each individual's physiological differences must be assessed and appreciated. For children, also consider the rate of weight loss. Finally, weight level per se should never be used as the sole criterion for discharge from inpatient care. Many patients require inpatient admission at higher weights and should not be automatically discharged just because they have achieved a certain weight level unless all other factors are appropriately considered. See text for further discussion regarding weight.",
"        <br>",
"         &sect; Individuals may experience these thoughts as consistent with their own deeply held beliefs (in which case they seem to be ego-syntonic and \"overvalued\") or as unwanted and ego-alien repetitive thoughts, consistent with classic obsessive-compulsive disorder phenomenology.",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission, and adapted,&nbsp;from Practice guideline for the treatment of patients with eating disorders, Third Edition. Am J Psychiatry 2006; 163 Suppl 1:1. Copyright &copy; 2006 American Psychiatric Association.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_54_10094=[""].join("\n");
var outline_f9_54_10094=null;
var title_f9_54_10095="Frykman IV radius fracture lateral view";
var content_f9_54_10095=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F79669&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F79669&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Frykman IV radius fracture lateral view",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 346px; height: 468px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The lateral x-ray of the same injury demonstrates significant dorsal displacement and angulation of the distal radial fragment.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Erik L Schroeder, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_54_10095=[""].join("\n");
var outline_f9_54_10095=null;
